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PART I. EVIDENCE FOR AN ACTION OF ANTICHOLINESTERASES ON THE 
CENTRAL NERVOUS SYSTEM OF RABBITS NOT ATTRIBUTABLE TO 
ENZYME INHIBITION 
I. INTRODUCTION 
Electrocorticographic responses to the administration 
of DFP to cats and monkeys consisted of EEG arousal which 
was attenuated by atropine (Wescoe et al. 1948). Johns et 
al. (1951) found that the amount of theophylline required 
18 
to induce cortical EEG seizure activity was decreased by as 
much as one-sixth when given after DFP. Atropine blocked 
the convulsions but its effectiveness was a function of the 
ratio of DFP to theophylline. Johns et al. concluded that 
-. 
atropinic antagonism of DFP-theophylline convulsions occurred 
when the concentration and hence the effect of theophylline 
was minimal. Bouzarth and Himwich (1952) evaluated the 
mechanisms of seizures induced by DFP. They noted that the 
order of appearance of seizures was thalamus, caudate, limbic 
cortex, and finally motor cortex. However, later findings 
have indicated the hippocampus as a primary site of con-
vulsant action in the CNS due to its low epileptogenic 
threshold (Liberson and Akert 1955). Sarin-induced convul-
sions were attenuated by atropine and by PAM (2-pyridin-
aldoxime methiodide), which antagonized the convulsive 
phase of sarin but not the EEG desynchronization. The latter 
finding with PAM is of interest since it is a quaternary 
compound which probably does not gain access to the CNS. 
Wills (1963) discussed the pharmacological antagonism of 
19 
anticholinesterases and suggested that the EEG seizure activ-
ity was the result of stimulation of diencephalic brain 
sites. 
Eserine, in low doses has been shown to evoke a 
transient EEG arousal that is associated with the reversible 
nature of enzyme inhibition (Longo and Silvestrini 1957). 
Holmstedt (1963) pointed cut that neostigmine had an excita-
tory effect on the neuromuscular junction after cholin-
. 
esterase had been inactivated by DFP. Other experiments were 
discussed that utilized the neuromuscular junction responses 
as evidence of anticholinesterase drug effects that were in-
dependent of cholinesterase inhibition. 
Benesov~ et al. (1964) reported that amitryptyline and 
other thymoleptics decreased the duration of Eserine-induced 
arousal and that chlorpromazine and reserpine pretreatment 
prolonged it. The authors attributed the prolonged response 
to the antiadrenergic effects of Eserine. However, Benson 
(1948) had shown "adrenalin" of the swine caudate to inhibit 
butyrylcholinesterase and acetylcholinesterase as measured 
manometrically. He proposed the adrenalin-potentiating 
effect on ACh was attributable to inhibition of cholin-
20 
esterase as well as promoting the synthesis of ACh. 
Goldberg et al. (1963, 1965) found that cholinesterase 
had to be inhibited greater than 21 to 50 per cent in order 
to observe behavioral effects. Also they found that Eserine 
and Carboryl (naphthyl N-methyl carbamate) had central 
agonist properties in addition to inhibition of cholinester-
ase. These responses were antagonized by atropine. 
Bito et al. (1967) noted that chronic administration of 
ecothiophate failed to produce enduring effects, but blocked 
the response to the presence ~f carbachol in the eye of the 
dog. Other responses of the iris were normal and blocked 
by atropine. They concluded that ecothiophate had anti-
parasympathomimetic effects. 
The present study evaluates EEG changes in the presence 
of protected and of markedly inhibited cholinesterase. These 
findings are correlated with biochemical determinations of 
cholinesterase activities as well as with histochemical 
evidence for irreversible enzyme inhibition. 
I. LITERATURE REVIEW 
Survey of the literature of CNS effects of anti-
cholinesterases and its antagonism by anticholinergics was 
facilitated by existent reviews, which were extensively 
utilized due to the excessive number of publications on 
cholinesterases and anticholinesterases that have appeared 
in recent years (250-300 per year, Augustinsson 1963). 
Diamant (1954) tabulated the results of investigation 
21 
of CNS effects from: (1) the reversible inhibitors, Eserine 
and neostigmine, and (2) the.irreversible organophosphorus 
inhibitors, DFP, TEPP, parathion, and tabun. Miller et al. 
(1938 op.cit.) observed that Eserine induced an increase in 
electrical activity of the cortex when applied topically to 
the cortex of cats. Anticholinesterase action on spinal cord 
reflex activity of dogs was shown by Bulbring and Burn (1941 
.2J2.cit.). These investigators administered Eserine arterially 
into the spinal cord and noted that the effects on the lower 
leg reflexes were antagonized by atropine but were enhanced 
by "aarenalin". Williams (1941 ..£E_.cit.) notea that Eserine 
enhanced petit mal EEG paroxysms in humans (cf. Williams and 
Russel (1941 .££.cit.), who also observed atropinic antagonism 
of Eserine). Darrow et al. (1944 op.cit.) observed an 
22 
increase in the fast frequencies of the EEG of cats and a de-
crease in high amplitude slow waves. Atropine antagonized 
the responses. Hyde et al. (1947 op.cit.) found that 
topically applied Eserine potentiated the effects of 
strychnine and pentylenetetrazole on the EEG. Bradley and 
Elkes (1953 .£E_.cit.) noted only a moderate increase in 
electrocortical activity subsequent to the intraperitoneal 
administration of 0.5-1.0 mg/Kg of Eserine. EEG responses 
to the administration of DFP consisted of cortical desyn-
chronization followed by con"'lUlsive activity (Wescoe et al. 
1948 .£E_.cit., Freedman et al. 1949 .£E_.cit., Essig et al. 
1949 .£E_.cit., Bouzarth and Himwich 1952 op.cit. and Johns 
et al. 1951). Furthermore, mechanisms of action in addition 
to cholinesterase inhibition were proposed by several 
authors (Verbeke 1949 £2.· cit., Koppanyi and Karczmar 195,1 
op.cit., Michaelis et al. 1949 op.cit. and Brooks et al. 
1949 .£E_.cit.). In general, the mechanisms of action were 
concluded to be: (1) of a direct pharmacodynamic nature on 
the effector cells, (2) inhibition of cholinesterase along 
with the pharmacodynamic action, (3) histological cellular 
damage, or (4) metabolic effects on cellular respiration. 
Holmstedt (1959) reviewed the effects of organophos-
phorus cholinesterase inhibitors on EEG activity. The 
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literature revealed a prolonged EEG arousal with subconvul-
sant doses of DFP and sarin while higher doses provoked 
diffuse convulsive EEG patterns. Holmstedt pointed out that 
the CNS effects of these anticholinesterases cculd be 
obtained without damage of the blood brain barrier (BBB). 
In addition to inhibition of cholinesterase, sarin, DFP, 
and Eserine had been reported to evoke pressor responses. 
Heath (1961) discussed the protective effect of 
reversible inhibitors (Eserine) on the subsequent adminis-
tration of irreversible inhibitors (TEPP, DFP). He also 
proposed that reversible anticholinesterases, given in the 
presence of irreversible inhibitors, would enhance the degree 
of enzyme inhibition. However, he pointed out that these 
results varied with species, drugs, and doses. 
Loshadkin and Smirnov (1962), in a review of chemical 
and toxicological aspects of organophosphorus anticholin-
esterases, discussed drug action on choline-reactive systems. 
They defined a choline-reactive system as that sequence of 
biochemical events through which ACh is released from nerve 
terminals and acts on "choline receptors". They then 
equated the choline receptor with choline-reactive system. 
Two features common to AChE and choline receptors were 
suggested; first, both were highly specific for the same 
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substrate (ACh); second, excess concentrations of sub-
strates prevented inhibition of ChE by organophosphorus in-
hibitors. Karasik et al. (1946, 1947, 1948 £E_.cit.) as well 
as Zupancic (1953 op.cit.), proposed that cholinesterases 
and choline receptors were one and the same. The reviewers 
pointed out that while the function of choline receptors 
was specific and associated with the presence of sulfhydryl 
groups, the action of sulfhydryl containing inhibitors of 
ChE was non-specific. Loshadkin and Smirnov proposed that 
organophosphorus agents which competed with ACh for ChE, 
could react with the choline'receptors. Similar to the 
review of Diamant (1954), the hypothesis for a combined 
enzyme inhibition with pharmacodynamic action on choline-
reactive systems was suggested. Examples from the litera-
ture were cited by Loshadkin and Smirnov (1962) to include: 
(1) McNamara et al. (1954 op.cit.), who compared the 
response to DFP and TEPP with the histochemical demonstra-
tion of ChE in various organs. They concluded that inhibi-
tion of enzyme alone was insufficient to account for 
mechanisms of toxic action. 
(2) Holaday et al. (1954 op.cit.), who investigated 
pre- and postganglionic action potentials in the presence of 
DFP and compared their findings with the degree of inhibition 
of total and specific cholinesterases. It was concluded 
that changes in transmission of the superior cervical 
ganglion under the influence of DFP could not be explained 
by inhibition of enzyme alone and a direct action of DFP 
on choline receptors was proposed. 
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(3) Roeder and Kennedy (1955 .£E_.cit.), who showed that 
sarin, tabun, and soman competed with ACh for choline 
receptors at synaptic junctions. 
(4) Liljestrand and Zotterman (1954 .££.cit.), who found 
that DFP sensitized choline receptors of the carotid body 
to the action of choline esters. 
(5) Turpaev and Putintseva (1957 .£E_.cit.), who showed 
Fosfakol (diethyl p-nitrophenyl phosphate) to act on 
isolated intestine in the presence of totally inactivated 
cholinesterase. 
(6) Komissarov (1957 .£e_.cit.), who concluded that the 
action of Fosfakol on reflex conduction in rabbit spinal 
cord, would not be explained on the basis of enzyme in-
hibition alone. 
(7) Seminov (1957 £E_.cit.), who showed that the broncho-
spasm induced by Armin (ethyl p-nitrophenyl ester of ethyl-
phosphonic acid), included a cholinomimetic action along with 
the inhibition of enzyme. 
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(8) Murtha et al. (1955 .£E_.cit.), Feldberg (1954 .££_. 
~.), and Hobbiger (1954 .£E_.cit.) were also listed as con-
cluding that the action of anticholinesterases was in some 
way associated with a direct action on choline receptors. 
It should be emphasized that direct actions of the 
anticholinesterases were proposed in addition to the 
evidence for inhibition of enzyme. 
Handbuch der Experimentellen Pharmakologie 15: 11 Cholin-
esterases and Anticholinesterase Agents" provided con-
siderable information pertin~nt to the present investigations. 
Evaluation of brain AChE activities by biochemical and histo-
chemical methods was adequately reviewed (Koelle 1963 
.£E_.cit. and Augustinsson 1963 op.cit.). 
Machne and Unna (1963) reviewed the CNS effects of anti-
cholinesterases. Their discussion revealed that desyn-
chronization of the EEG, attenuation of recruited potentials 
and convulsive EEG patterns could be evoked by the i.v. 
administration of irreversible or reversible inhibitors. 
They pointed out that anticholinesterases enhanced the level 
of spontaneous electrical activity while depressing the 
response to electrical stimulation in isolated cortex. 
Topical application of inhibitors yielded conflicting re-
sults also. However, Sigg et al. (1965) observed an enhance-
ment of the cortical dendritic response following the 
intrapial administration of Eserine in cats. They postu-
lated a muscarinic effect on dendrites since the response 
was sensitive to the blocking action of atropine. 
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The review of Machne and Unna (1963) was controversial 
in that continued reference was made to the CNS effects of 
quaternary compounds, atropine methyl nitrate and neo-
stigmine. It has been established that these drugs 
penetrate the blood brain barrier (BBB) to little if any 
extent (Longo 1962). 
Longo (1962) presented the most significant informa-
tion of pharmacological EEG research in rabbits. He 
reviewed the effects of reversible and irreversible inhibitors 
of cholinesterases and his discussion was in agreement with 
Machne and Unna with regard to the responses to Eserine, 
DFP, atropine, and scopolamine. However, Longo and others 
(Hance et al. 1963) have failed to support the contention of 
Machne and Unna with regard to quaternary compounds. 
Karczmar (1966) reviewed the pharmacology of anticholin-
esterases in extenso. Actions of anticholinesterases on the 
reticular formation and cortex were included and EEG desyn-
chronization was seen as a characteristic feature of i.v. or 
topically applied Eserine. Cholinergic mechanisms in the 
28 
reticular formation responsible for EEG desynchronization 
were discussed (Rinaldi and Himwich 1955 £E_.cit.). The 
effect of anticholinesterases on cholinergic thalamo-
cortical pathways was also presented. Recent studies of 
Shute and Lewis (1963, 1965, 1966) have shown that cholin-
esterase-containing fibers exist throughout the brain. In 
particula~ these fibers run through the ascending reticular 
activating system from the medulla-pons (Holmes and Wolsten-
croft 1964) through the forebrain. Acetylcholine release 
at the cortex has been evoked by electrical stimulation of 
the midbrain reticular formation as well as "spontaneously" 
(Mitchell 1963 and Krnjevic 1967). A cholinergic nature of 
CNS transmission has been implied by the nicotinic 
pharmacological responses of Renshaw cells, (Curtis and 
Eccles 1958) which were associated with the early responses 
of motor axon stimulation, while late muscarinic responses 
have also been observed (Curtis and Ryall 1964). However, 
motoneuron firing has been shown to be depressed by NE in 
the lumbar spinal cord of cats (Weight and Salmoiraghi 
1967). Therefore, sites of action for anticholinesterases 
exist throughout the CNS and their activity can be evaluated 
at all levels from cord to telencephalon. In addition, 
• 
functional interaction with adrenergic systems is probably 
a factor in CNS responses to anticholinesterase drugs 
(Marczynski 1967). 
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II. METHODS AND MATERIALS 
A. GENERAL 
Experimental animals1 were adult, male, New Zealand 
albino rabbits of approximately 2.5-3.5 Kg body weight. 
Larger animals were used for the experimental preparations 
in which the basilar artery was ligated at the midpontine 
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level in order to facilitate the required surgical approaches. 
A standard laboratory animal diet was provided with food and 
water available ad libitum. The animals were retained in the 
animal quarters for a minimum-of one week prior to use and 
were brought to the laboratory on the day of the experiment. 
B. HISTOLOGICAL METHODS 
1. Thionin and Eosin Staining Procedure 
A combination thionin and eosin staining procedure was 
used that revealed cell bodies and fibers in the central 
nervous system. This staining procedure was compatible for 
use with frozen sections (Conn et al. 1962). Sagittal 
sections were prepared from brain tissue of untreated rabbits 
sacrificed by air embolism via the marginal ear vein. The 
brains were kept intact and rapidly removed beginning at the 
1sc1ent1fic Small Animal Laboratory and Farm, Inc., 
Arlington Hts., Ill. 
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olfactory bulbs and extending to the calamus scriptorius, 
placed in a beaker of saline for removal of excess blood and 
bone fragments, and then transferred to a saline dampened 
gauze square for removal of meninges. The removal of these 
membranes prevented the knife from snagging during sectioning 
which would result in artifacts across the surface of the 
section. The brains were then divided in halves by passing 
a large spatula through the midsagittal plane. A flattened 
piece of freezer wrap was placed on the floor of the cryostat 
chamber and the half brain specimen was placed on it with 
the medial surface directed down. This last procedure froze 
the brain with the medial surface flat and permitted 
orientation of the plane of section parallel to the knife 
edge. The result was a marked reduction in the loss of 
important midline structures during the sectioning procedure. 
Brains were frozen at -20°c to -30°c at least 4 hours and in 
most cases 24 hours. Sections were cut at a thickness of 
32 microns and were mounted in permount medium. 
Verification of electrode implantation site was visu-
alized after the staining procedure had been completed. How-
ever, it was possible to trace the electrode tracts while 
sectioning and the subsequent staining procedures were not 
required. Details of the staining schedule are listed in 
appendix A. 
2. Thiocholine Histochemical Procedure 
32 
The in vitro histochemical procedure as outlined by 
Koelle (1951, 1955) for the localization of cholinesterases 
was modified to include in vivo and in vitro procedures 
(Koelle 1957). Control sections were obtained from rabbits 
sacrificed by air metabolism. Brains were prepared in the 
same manner as described above except that the frozen 
sections were 16 microns in thickness. Details of the 
staining schedule are listed in appendix A. 
Irreversible inhibition of cholinesterase was induced 
by the intravenous administration of DFP (l.0-3.0 mg/Kg ) or 
of sarin (20.0-50.0 mcgm/Kg ). Brains were quickly removed 
after the animals had convulsed and died. Frozen brain 
sections from these animals were processed through the same 
staining procedure as controls (vide supra). Untreated 
control sections were run concurrently with the sections 
that had been exposed to anticholinesterases in vivo and 
served as internal controls for the histochemical demonstra-
tion of the enzyme. 
Physostigmine (100.0-150.0 mcgm/Kg i.v.) was used to 
inhibit cholinesterase reversibly. It was given 5 minutes 
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prior to DFP or sarin which were given in the doses in-
dicated above. After the animals convulsed and died, the 
brains were removed for histochemical analyses. The same 
staining procedure for cholinesterases was used throughout. 
C. BIOCHEMICAL METHODS 
1. Warburg Procedure 
A standard manometric procedure for the determination 
of cholinesterase activity was used (Koppanyi and Karczmar 
1964). Brains of animals sacrificed by air embolism were 
divided at the midsagittal pl?ne and one-half was added to 
bicarbonate buffer (1:50 w/v). Ultrasonic homogenization 
of the tissue required less than 2 minutes and a chilled 
solution was used to reduce the effects of heat. Acetyl-
cholinesterase (AChE) and butyrylcholinesterase (BuChE, 
ChE) activities were determined using methacholine and 
butyrylcholine as substrates. Control untreated brain 
samples were included with the experimental samples and 
readings were taken at ten-minute intervals for up to an 
hour. Microliters co2 formed per unit time are expressed as 
percentages. 
Experimental samples from animals included those 
treated (1) with sarin (20.0 mcgm/Kg i.v.), (2) with DFP 
(l.O mg/Kg i.v.), (3) with sarin in the presence of atropine 
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methyl nitrate (l.O mg/Kg i.v.), and (4) with sarin 
followed by atropine sulfate (5.0 mg/Kg i.v.). The rabbits 
were prepared for EEG recording (vide infra) and were main-
tained with artificial respiration after exposure to toxic 
amounts of the anticholinesterases. Histochemical analysis 
(vide supra) was carried out on the other half of these 
brains. The biochemical determination of AChE and BuChE 
activities served as a control measure to correlate with 
histochemical findings and electrophysiological responses 
during conditions in which the.enzyme activity was irrevers-
ibly inhibited. 
D. PHYSIOLOGICAL METHODS 
1. Electroencephalography 
EEG recordings from unanesthetized restrained animals 
in acute experiments necessitated development and modifica-
tion of equipment. An animal restraining board fitted with 
a headholder was used for immobilization of the rabbits 
during the recording sessions. Openings cut into the bottom 
of the board permitted access to the ventral anatomy of the 
rabbit. Thus, tracheotomy as well as arterial and venous 
cannulation could be carried out under local anesthesia. The 
rabbit could then be returned to the supine position for 
implantation of brain electrodes without being released from 
Figure 1 
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Legend for Figure 2 
Steps in the Construction of EEG Electrodes: The components 
of an electrode are laid out in figure 2. The electrode hub 
(cf. Electrode Hub Diagram) two twisted 0.010 inch diameter 
formvar insulated nichrome wires, and three insulated 
stranded wires are assembled as indicated to form the com-
pleted electrode as seen on the right side of the figure 
according to the scale. 
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the restraining board. 
The steps in the construction of the concentric tripolar 
cortical and subcortical EEG electrodes are illustrated in 
figure 2. A detailed description is provided in appendix A. 
The procedure for implantation of electrodes was carried 
out under local anesthesia. An incision was made in the 
scalp that extended from the nasion, caudally to the cervical 
vertebra. After the calvarian surface was exposed and local 
tissue and bone bleeding controlled, the coronal and mid-
sagi ttal bone sutures were located. The interstice of the 
sutures was used as an anterior-posterior zero (AP zero) 
reference point. Sawyers• atlas for the rabbit diencephalon 
(1954) was used as a guide for the coordinates. The skull 
was trephined at selected sites by a No. 51 drill held in an 
X-Acto model makers pin vise. This size of opening in the 
bone permitted a tight fit of the electrode shank so that 
further fixation of the electrode to the skull was generally 
unnecessary. However, dental acrylic could be used to affix 
the electrode to the bone. After cutting the nichrome wire 
depth electrodes to the appropriate length, they were manually 
implanted according to selected stereotaxic coordinates (see 
appendix A). The electrode hub recorded EEG activity from 
the cortex while the depth electrodes in that same assembly 
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recorded activity from selected subcortical structures. 
Bipolar electrical stimulation of brain sites was carried 
out through the appropriate depth electrodes. The co-
ordinates of brain sites for recording and for stimulating 
are designated in appendix A. They are: basal olfactory 
area (BOA), lenticular nucleus (LN), left or right anterior 
motor cortex (L,RAC), left or right posterior cortex 
(L,RPC), reticular formation of the brain stem (RF), 
occipital cortex (o.c.), and anterior dorsal thalamic 
nuclei (ADN). Electrode pla~ement was verified histo-
logically at the termination of ·the experiment. During the 
experiment, the characteristics of the EEG patterns as well 
as the responses to electrical stimulation of the brain 
were used as an index of the accuracy of electrode place-
ment. Bipolar recording technique was routinely used and 
the electrode combinations are as indicated in the relevant 
figures. 
A minimum of 30 minutes was allowed for the recovery 
of the experimental subjects after the implantation pro-
cedure was completed. A dimly lighted room was used for 
recording sessions. A seven channel, ink writing Grass 
Model IIID electroencephalograph was used. Recording 
speed and amplification are as indicated by the calibra-
tions in the figures. Six of the seven channels were used 
for obtaining EEG information and the remaining channel 
recorded either blood pressure or heart rate. Heart rate 
was obtained from leads placed across two limbs. The 
blood pressure was recorded directly from the femoral 
artery via a Statham pressure transducer and was amplified 
by a low level D.C. Grass preamplifier. Pressure was 
usually recorded as a mean value by using the 1/2 amplitude 
high frequency control on the recorder. Periodic control 
recordings were obtained at a full frequency amplification 
in order to observe the wave form. Blood clotting was 
controlled by the use of heparinized saline (20 units/ml) 
in the cannula. 
40 
After recovery, EEG activity was evaluated to deter-
mine if the implantation of electrodes had produced extensive 
brain damage. EEG alerting responses to stimuli of sound 
(clapping of the hands), touch (lightly stroking the anima1 1 s 
back), and pain (pinching the hind leg of the rabbit) were 
observed. These also gave an indication of the general 
condition of the animal. Saline injections were given as a 
control measure with the volume equivalent to the volume of 
the drug to be given. 
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2. Ligation of the Basilar Artery 
Drug injections into the arterial circulation of the 
brain minimizes effects due to peripheral actions of 
drugs. Procedures used include injections into either the 
vertebral or carotid arterial blood supplies in animals 
with their basilar artery ligated at the midpontine level 
(Jolly 1956 and Magni 1962). This method was applied to the 
present study. 
The animals were anesthetized with diethyl ether and 
2% procaine local anesthesia p~ior to a tracheotomy. 
Following surgery, ether was expelled in the respired air 
and the local anesthesia was maintained at wound sites. The 
rabbits were immobilized with curare and supported by 
artificial respiration. The trachea above the point of in-
sertion of the cannula and the larynx were removed. The 
musculature at the base of the brain was retracted to expose 
the basi-occipital bone. Ligation of veins encountered 
during this procedure was critical. An 8mm x 5mm rectan-
gular area of outer bone was removed by drilling two holes 
through the outer layer, 2 mm anterior to the foraman 
magnum and then working cephalad with rongeurs. Bone bleed-
ing was controlled by the use of bone wax. The basilar was 
exposed by removing the rectangular inner layer of bone 
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beginning at the caudal border of the opening and exposing 
the artery through the dura along the ventral midline of 
the pons. After rupturing the dura, the basilar was freed 
by a small blunted dental pick. Caution was required at 
this point, to prevent rupture of the artery or of its 
penetrating branches. The artery was ligated by passing a 
6-0 suture under it with a miniature blunted "U" shaped 
needle and then tying the suture with forceps. The opening 
in the basioccipital bone was packed with gelfoam. Implan-
tation of electrodes (vide suera) required that the rabbit 
be placed on its abdomen after which it was placed on its 
back for the remainder of the experiment. 
The jugular and subclavian veins were exposed and 
separated from the underlying subclavian and innominate 
arteries. The origin of the vertebral artery was exposed 
and the omocervical and internal mammary arteries ligated. 
The subclavian artery was cannulated (PE#60); so that the 
tip of the cannula rested approximately 5.0 mm from the 
origin of the vertebral artery. Intravertebral arterial 
injections were carried out by occluding the subclavian 
artery between the carotid and the vertebral arteries and 
then injecting retrogradly through the cannula. After the 
injection, the subclavian was released. The bifurcation of 
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the common carotid was exposed and the external branch 
cannulated (PE#lO) with the tip of the cannula at the 
bifurcation. Intracarotid arterial injections were then 
made without interruption of the blood flow (fig. 17). 
Electrical activity of the brain stem posterior to the 
position of the tie could be obtained by inserting an 
electrode through the opening used to approach the basilar. 
Mineral oil was applied in place of the gelfoam. Blood 
pressure could also be recorded by cannulating the contra-
lateral external carotid. 
The functional state of the brain was revealed by the 
spontaneous EEG and its response to the control EEG arousal 
stimuli of sound, touch, and pain. Physiological saline at 
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room temperature injected intracarotidly or intravertebrally 
served as a control for EEG responses to anticholinesterases 
(AntiChE's). 
The distribution of materials injected into these two 
arterial paths was shown in two different preparations 
(fig. 18) by the administration of a monastral blue dye 
diluted 1:1 with saline. The aorta was clamped about 5 
seconds after the dye had been given and prevented a gener-
alized distribution by recirculation. 
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E. PHARMACOLOGICAL METHODS 
1. Drugs and Dosages 
Atropine methyl nitrate was used as a peripherally acting 
anticholinergic that does not readily penetrate the blood 
brain barrier (BBB). Untoward cardiovascular responses to 
centrally acting anticholinesterases were adequately 
attenuated by intravenous doses of 0.5- 2.0 mg/Kg. 
Physostigmine (Eserine) was used as a reversible in-
hibitor of cholinesterases that readily penetrated the BBB. 
EEG desynchronization without seizure activity was found, 
during preliminary studies, to b~ evoked by intravenous doses 
of 100-150 mcgm/Kg. EEG and classical grand mal convulsive 
episodes resulted from doses of 200.0 mcgm/Kg or greater. 
DFP and sarin, which are irreversible inhibitors of 
cholinesterase that readily penetrate the BBB, have marked 
effects on the electrical activity of the CNS (Diamant 
1954). DFP was diluted with saline prior to injection and 
used within 15 minutes. EEG desynchronization was evoked 
by 0.5 mg/Kg i.v. and convulsions and death by 2.0-3.0 mg/Kg 
i.v. as determined in preliminary studies. If additional 
doses were to be given, artificial respiration was usually 
needed. Sarin was diluted with saline and used within 15 
minutes. EEG arousal was elicited by 10.0 mcgm/Kg i.v. 
I 
I 
1 
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while 20 mcgm/Kg i.v. evoked an alert pattern followed by 
convulsive activity. Doses of 50.0 mcgm/Kg i.v. or greater, 
evoked a prompt EEG alert pattern followed by convulsions. 
Death occurred within minutes. 
In the preparation with the basilar artery ligated at 
the midpontine level, doses were given via the internal 
carotid (i.ct.) or the vertebral artery (i.vt., cf. 
figs. 21, 23). Drugs were not administered on the basis of 
unit body weight because preliminary studies showed that 
the responses to the drugs were determined by the specific 
dose given and not by drug wt. per unit body wt. This dose 
is referred to in the figures as 11 total dose". 
The dosages of anticholinesterases included (1) Eserine 
given alone as well as in the presence of the irreversible 
inhibitors and (2) DFP or sarin given alone as well as in the 
presence of Eserine. The administration of Eserine was 
given to protect cholinesterase from irreversible inhibition 
by subsequent injections of DFP or sarin even in amounts 
that evoked convulsions and death. On the other hand, 
initial administration of DFP or sarin permitted the obser-
vation of the effects of Eserine in the presence of ir-
reversibly inhibited enzyme. 
III. RESULTS 
A. CONTROL OBSERVATIONS 
1. Histological 
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The results of the thionin and eosin staining procedure 
on the rabbit brain sections are revealed in figures 3a 
through 3d. Line drawings accompany these figures and pro-
vide an identification of relevant anatomical sites. Veri-
fication of sites of electrode implantation in experimental 
animals was readily obtained after this master set of control 
sections had been prepared. A~atomical sites of electrode 
implantation for recording and/or stimulation are as in-
dicated in the appropriate sections. In addition, this 
sagittal section atlas of the rabbit brain served as an 
orientation for histochemical studies of cholinesterase 
localization. The results of the thiocholine procedure are 
illustrated in figures 5a through 5c. These sections are 
also accompanied by line drawings to indicate significant 
anatomical areas. The areas with the most intense stain 
reveal the highest concentration of cholinesterase. These 
sites are the caudate nucleus, lenticular nucleus, anterior 
dorsal nuclei of the thalamus, pulvinar and reticular 
thalamic nuclei, superior colliculus, amygdaloid nuclei, 
--~--·--·-----
and hippocampus. Other areas that revealed an intense 
stain are the nuclei cuneatus and gracilis of the ponto-
medullary area as well as midbrain masses such as the 
nucleus rubra and substantia nigra. 
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a.c. 
a.c.p. 
a.d.n. 
a.m.n. 
amyg. n. 
a.n. 
caps.e. 
caps.1. 
cblm. 
c.c. 
cen.ctx. 
cen. gr. 
cen. ov. 
cer. pea. 
claus. 
1.coll. 
s.coll. 
cor. rad. 
fim. 
forn. 
SAGITTAL BRAIN SECTIONS 
LIST OF ABBREVIATIONS: 
anterior commissure 
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anterior cerebellar peduncle 
anterior dorsal thalamic nuclei 
anterior medial thalamic nuclei 
amygdaloid nuclei 
anterior thalamic nuclei 
external capsule 
internal capsule 
cerebellum 
corpus callosum 
central cortex 
central grey matter 
centrum ovale 
cerebral peduncle 
claustrum 
inferior colliculus 
superior colliculus 
corona radiata 
fimbria of the hippocampus 
f ornix 
fr.ctx. 
d.hpc. 
v.hpc. 
i.m.l.tr. 
l.gen. 
l.t.n. 
lemn. 
ma.b. 
mam.th.tr. 
m.lat.n. 
med.n. 
medulla 
meyn.tr. 
m.c.p. 
n.amb. 
n.cau. 
n.gr., cun. 
n.1.p. 
n.lent. 
n.ol. 
occ.ctx. 
op.rad. 
p.c. 
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frontal cortex 
dorsal hippocampus 
ventral hippocampus 
intermediolateral thalamic tract 
lateral geniculate body 
lateral thalamic nuclei 
lemnisci 
mamillary bodies 
mamillothalamic tract 
mediolateral thalamic nuclei 
medial thalamic nuclei 
medulla oblongata 
Meynert's tract 
mid-cerebellar peduncle 
nucleus ambiguous 
caudate nucleus 
cuneate and/or gracilis nuclei 
interpenduncular nucleus 
lenticular nucleus 
olivary nuclei 
occipital cortex 
optic radiation 
posterior commissure 
~: 
I 
i 
p.c.p. 
pons 
pul. n. 
pyrm. tr. 
r.n. 
ret. sub. 
ret.th.n. 
thalamus 
sep. pel. 
III.N.tr. 
III.n. 
VI.n. 
posterior cerebellar peduncle 
pons 
pulvinar nucleus 
pyramidal tract 
red nucleus 
reticular substance 
reticular thalamic nuclei 
thalamus 
septum pellucidum 
oqculomotor nerve tract 
occulomotor nucleus 
abducents nucleus 
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Figure ;a 
cen.ctx. 
0-cen.Qr. 
medulla 
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. Figure 3b 
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Figure 4 
MODE OF ACTION OF THIOCHOLINE PROCEDURE 
Reaction 11A11 
2 CH3 COSCH2CH2N(CH3 ~0H + ( NH2CH2COO~ Cu+2H20+ ChE 
( Acetytlhiocholine) i (Copper Glyclnate) (Water) (Chollnestwa .. ) 
Cu( SCH CH N(CM ) OH) + 2 NH CH COOH + 2CH CO OH 
2 2 ""33 2 2 2 3 
( Copperthlochollne) (Glycine) 
Reaction 11811 
Cu(SCH2CH2N(C~)30H)2 + (Nf\l2 S 
"""""'""""" i """'"""''""'' 
CuS + 2NH SCH CH N(CM ) OH 
4 2 2 ""33 
( Copp or) (Ammonlumthiochollno) Sulfide 
~.::..---~~-,~~=----:.~~--:..._ __ -_ 
(Acetic Acid ) 
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Legend for Figure 4 
Postulated Sequence of Events for Histochemical Thiocholine 
Procedure that Reveals the Distribution of Cholinesterase: 
60 
The mode of action of the thiocholine procedure is postulated 
to occur as two reactions. Reaction 11 A11 involves the inter-
action of acetylthiocholine with-cholinesterase in the 
incubation medium that contains copper glycinate. The inter-
mediate copper thiocholine thus formed takes part in reaction 
11 B11 with the ammonium sulfide (developer solution). Copper 
sulfide is the resultant product that is present at those 
sites in which cholinesterase is to be found. 
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Irreversible inhibition of cholinesterase is shown in 
the results of the thiocholine procedure applied to animals 
injected with DFP 2.0-5.0 mg/Kg i.v. or with sarin 20.0-
100.0 mcgm/Kg i.v. Brain sections of these experimental 
subjects are shown in figures 6a through 6c. The blank 
stained sections appeared as a translucent film on the 
microscopic slides after the thiocholine staining procedure 
and necessitated marked overdevelopment and overexposure 
during photographic processing. Counterstaining procedures 
were avoi~ed so that only the localization of cholin-
. 
esterases was revealed. Areas of ·shading that appear on the 
blank sections reflect differences in tissue density and 
outline anatomical structures but do not indicate a deposi-
tion of copper sulfide which would suggest the presence of 
cholinesterase. On the other hand, reversible inhibition of 
cholinesterase by Eserine in amounts of 50.0-150.0 mcgm/Kg 
i.v. did not prevent the selective staining of brain 
cholinesterase. These sections stained similar to the un-
treated controls (cf. fig. 29 and fig. 5a). 
The brain sites supplied by the vertebral and carotid 
blood supplies are shown by the distribution of monastral 
blue dye as seen in figure 18. The position of the arterial 
pressure deadpoint that results from the meeting of the 
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two pressure heads of cerebral arterial blood flow, the 
vertebral supply and the internal carotid supply, was 
firmly established by ligation of the basilar artery at 
the midpontine level. Dye injection through the vertebral 
artery produced the results shown in figure 18 upper 
section. The vertebral arterial contribution to the blood 
supply of the brain and drugs injected into this artery 
initially infuse upper spinal cord and the bulbar pontine 
reticular substance in the caudal brain stem. The section 
of brain in the lower half o~ figure 18 reveals that brain 
sites cephalad to the position bf the ligature receive 
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blood from the internal branch of the carotid via the circle 
of Willis. Thus, the more rostral brain stem and the 
cerebral hemispheres are exposed initially to drugs given 
by the intracarotid route of administration. Diagrammatic 
illustration of the ventral surface of the rabbit brain is 
shown in figure 17 and is described in the legend for that 
figure. 
2. Biochemical 
The results of the manometric determination of the 
activity of AChE and of BuChE are expressed in Table I and 
appendix A. Raw data was expressed as microliters of co2 
evolved from brain tissue read at the times and under the 
TABLE I. CORRELATION OF HISTOCHEMICAL AND BIOCHEMICAL CHOLINESTERASE DATA 
Drug Histochemical Biochemical 
ChE Stain AChE Activityl BuChE Activity1 
Control Present 100.0 100.02 
Sarin Absent 1.6 44.6 
DFP Absent 8.2 17.1 
Sarin and 
Atropine Methyl Nitrate Absent 7.7 39.2 
Sarin and 
Atropine Sulfate Absent 10.6 34.3 
1 Expressed as per cent of control (100.0%). 
2BuChE activity at 100.0% was only 10-15% of AChE control (cf. text 
and appendix A) . 
-.:i 
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conditions referred to in the figures and Methods. Brain 
tissue controls as well as reagent controls were run with 
each experimental determination. The enzyme activity of 
the control samples was arbitrarily designated as 100%. 
Experimental values were expressed as a percentage of 
their respective control. While the enzyme activity of 
BuChE and of AChE is set equal at 100% (Table I), actual 
BuChE activity was far less than that of AChE (appendix 
A). BuChE activity was only 10% to 15% of the activity of 
AChE. 
3. Electrophysiological 
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The electrodes as constructed provided few difficulties 
and artifact free recordings were constantly obtained. 
Verification of the site of implantation was determined 
histologically as well as from the characteristic type of 
EEG pattern or of response to electrical stimulation. 
Thus, cortical slow waves and spindle activity, hippo-
campal theta rhythm, occasional olfactory bursts, and 
classical recruitment were all used as indices of accurate 
placement. Typical EEG patterns in the control animal are 
represented by the tracings found in figures 7 through 10. 
In general, a spectrum of EEG activity was shown in the 
rabbit. The predominant pattern was one of slow wave sleep 
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Control EEG Pattern Response to Stimulation: The resting EEG pattern (left side 
of tracings) is interrupted by the sound of hand clapping (arro~s) to evoke a 
desynchronized EEG alert pattern. This is brief in duration (right side of figure) 
as the pattern returns to one of slow wave sleep. 
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Figure 9 
CONTROL EEG-RESPONSE TO PAIN 
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Control EEG Pattern Response to Stimulation: Pain stimulation induced by pinching 
the hind leg of the rabbit evokes a desynchronized EEG pattern (arrows). Note 
that the response persists after the stimulation has terminated. 
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Figure 10 
CONTROL EEG-RETICULAR FORMATION STIMULATION 
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Control EEG Pattern Response to Stimulation: Electrical stimulation of the 
mesodiencephalic reticular formation (arrows, 200 c/s 2.0 volts, 0.7 msec duration) 
elicits an EEG arousal response that outlasts the period of stimulation. 
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with random 8-14 c/s activity appearing in the cortices. 
This synchronized pattern was periodically interrupted by 
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an abrupt desynchronization evoked by either an uncontrolled 
stimulation or by the presence of sound, tactile, or painful 
stimuli (figs. 7, 8, 9), as well as by the direct electrical 
stimulation of the reticular formation of the midbrain. As 
is seen in figure 7, the response to sound was generally 
not an enduring one and the tracings reverted back to the 
synchronized state within a few seconds after the stimulus 
was withdrawn. Hippocampal leads showed a marked hyper-
synchronization during the presentation of the stimulus as 
contrasted to the cortical responses during the EEG arousal 
state. The other control figures showed a similar pattern 
of response. Tactile stimuli provided an EEG alert pattern 
but this desynchronization generally was more persistent as 
shown in figure 8 in which a painful stimulus was used to 
elicit an abrupt arousal as indicated by the arrows. Direct 
electrical stimulation of the midbrain reticular formation 
at the parameters indicated in figure 10 elicited a response 
similar to that from painful stimuli in that the desyn-
chronization was long lasting. 
All animals were tested for these responses as indica-
tions of a general physiological state during a control 
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period. The characteristics of the tracings as well as 
histological identification verified site of implantation. 
And the responsitivity of the rabbit to the several stimuli 
as indicated above showed whether or not extensive damage 
had occurred during the implantation procedure, such as a 
subdural hematoma or massive trauma to the brain tissue 
resulting from displacement of the electrode. Animals not 
responsive to the stimuli in a manner similar to these just 
described were rejected as experimental subjects. 
B. EXPERIMENTAL OBSERVATIONS 
1. Histological 
Figure 30 reveals a blank thiocholine result following 
the administration of 50.0 mcgm/Kg i.v. of sarin and its 
subsequent antagonism by atropine sulfate (5.0 mg/Kg i.v.). 
This result could not be differentiated from those brain 
sections found in animals receiving only an irreversible 
inhibitor (cf. figs. 6a, 6b, 6c). Similar results were 
noted with rabbits pretreated with sarin or DFP and sub-
sequently exposed to convulsant doses of Eserine. On the 
other hand, irreversible inhibition of cholinesterase by 
sarin (50.0-100.0 mcgm/Kg i.v.) was blocked by the prior 
administration of Eserine (50.0-150.0 mcgm/Kg i.v.). 
Convulsions and death occurred buthistochemically, the 
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brain sections showed areas of intense staining comparable 
to controls (fig. 29, cf. figs. 5a, 5b, 5c). 
2. Biochemical 
The effects of AntiChE 1 s on the activity of cholines-
terase are indicated in Table I and appendix A. Sarin 
(20.0 mcgm/Kg i.v.) markedly reduced AChE activity as did 
DFP. Neither atropine sulfate nor atropine methyl nitrate 
altered this effect as inhibition of enzyme activity con-
tinued at a high level. BuChE activity also was greatly 
reduced under these same conoitions and while the per cent 
of reduction is less, again there was approximately 90% less 
activity compared to that of AChE (cf. appendix A). 
3. Electrophysiological 
Control tracings prior to the administration of sarin 
are shown in figure 11. The response to sound stimulation 
was similar to that obtained previously (cf. fig. 7) and 
indicated a satisfactory preparation. Sarin (20.0 mcgm/Kg 
i.v.) evoked a classical grand mal EEG convulsive pattern 
as shown in figure 12. A slight rise in mean arterial 
blood pressure and bradycardia was noted. Atropine sulfate 
(5.0 mg/Kg i.v.) given at the height of the convulsive 
activity antagonized it and restored the tracings to a 
non-convulsive pattern typical of that seen after atropine 
Figure 11 
CONTROL EEG- PRIOR TO ADMINISTRATION OF SARIN 
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Control EEG Pattern: Resting EEG pattern with slow wave EEG sleep interrupted 
by the clapping of hands to induce a sound stimulation (arrows) with resulting 
EEG alert pattern. 
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Figure 12 
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Initial Sarin Seizure: Grand mal type convulsive pattern induced by the i.v. 
administration of 20 mcgm/Kg of sarin. This figure reveals the onset of the 
seizure which quickly develops into a diffuse pattern of convulsive EEG activity. 
Note the onset of the pattern at the right side of the tracings and the slight 
rise in mean blood pressure. Sarin was injected approximately 2 minutes earlier. 
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Figure 13 
ATROPINE ANTAGONISES SARIN 
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Antagonism of the Sarin Seizure: Atropine sulfate 5.0 mg/Kg i.v. given at the 
height of the anticholinesterase induced convulsion, antagonizes the seizure and 
reveals a control pattern similar to that seen after only atropine. Uninterrupted 
brain wave tracings show slow waves and occasional 8-14 c/s spindles. These tracings 
were made approximately 15 minutes after those seen in figure 12. 
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Figure 14 
SARIN CONVULSION IN PRESENCE OF ATROPINE 
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Additional Dose of Sarin Provokes a Second Convulsion: The administration of a 
second injection of sarin (40 mcgm/Kg i.v.) in the presence of atropine as a 
continuation of the previous record, again evokes a diffuse EEG seizure pattern 
with a more marked presser response perhaps due to the higher dose. Moreover, 
atropine sulfate (5.0 mg/Kg i.v.) given at the arrow rapidly antagonizes the 
convulsive pattern (cf. Figure 13 ). 
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only (Longo 1962). Blood pressure and heart rate changes 
were also antagonized as shown in figure 13. EEG con-
vulsions were readily initiated by the administration of 
another dose of sarin (40.0 mcgm/Kg i.v.) as seen in 
figure 14. Blood pressure was elevated and a slight brady-
cardia was detected. The seizure pattern which began in 
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the hippocampus (left side of figure) spread to the rest of 
the brain and a second dose of atropine sulfate (5.0 mg/Kg 
i.v.) was given at the height of the convulsion (arrow). The 
EEG tracings showed a cessation of the grand mal waves in-
~ 
dicating the onset of antagonism (cf. right side of fig. 14). 
However, shortly after atropine had been given, the brain 
waves began to show an increased delta activity as indicated 
in figure 15. The rabbit then failed to respond to control 
stimuli which indicated an atropinic blockade. The mean 
blood pressure was also at pre-sarin levels. An additional 
injection of sarin (40 mcgm/Kg i.v.) again evoked a con-
vulsive EEG pattern but did not induce a pressor response 
(fig. 16). 
Ligation of the basilar artery had no effect on the 
electrical activity of the brain which showed the same EEG 
and reaction to stimuli as that seen in the control animals 
(figs. 19, 20, cf. fig. 7). Injections of 2.0 ml of saline 
at the rate of 1.0 ml/20 seconds into either the carotid or 
the vertebral arterial circulation did not alter the spon-
taneous EEG activity or blood pressure. Control tracings 
of synchronized EEG activity are shown in figure 19 and of 
desynchronized activity in figure 20. 
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The response to the intracarotid administration of sub-
convulsant doses of Eserine occurred in two stages shown in 
figures 21 and 22. Synchronized EEG activity appeared in the 
cortices with a slight transi~nt decrease in blood pressure 
that appeared within seconds after the drug administration 
(arrow), and persisted for about 1 minute. Desynchronized 
EEG activity then appeared which was the second phase of the 
response. This EEG alert persisted for up to 15 minutes and 
was accompanied by a pressor response that began after the 
onset of the EEG arousal (fig. 22 (arrow)). EEG tracings 
resumed pre-drug characteristics 30 to 40 minutes after the 
injection. 
Sarin administered intravertebrally (10 mcgm/Kg , fig. 23) 
evoked an initial convulsion in the hippocampus that was some-
what localized. Figure 24 reveals the diffuse convulsive 
activity that followed approximately 20 seconds after the 
appearance of the limited seizure. 
EKG 
LAC-LN-
Figure 15 
. 
ATROPINE ANTAGONISES 2nd SARIN INJECTION 
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LH-RF--
EEG Pattern of 2nd Atropine Antagonism of 2nd Sarin Seizure: Brain wave tracings 
taken shortly after the preceding Figure show the antagonism of the sarin grand 
mal seizure activity by atropine sulfate. Note also the lowering of the mean 
blood pressure to pre-convulsion levels. 
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Figure 16 
FINAL SARIN CONVULSION IN PRESENCE OF ATROPINE 
LH-Rf'--'YTllU"'Ytl 
BP- I 
IOOmmHQ IOOpVL-HC 
Sarin (40 mcgm/Kg i.v.) Again Evokes a Convulsion in the Presence of Atropine: 
The administration of an additional dose of 40 mcgm/Kg i.v. of sarin provokes a 
seizure in the presence of atropine. This tracing is a continuation of the 
previous recordings. Note that the seizure is evoked but that the level of 
atropinization is sufficient to block the pressor response (See mean blood 
pressure). The seizure developed approximately 2 minutes after sarin was given. \D I-' 
Figure 17 92 
Basilar Artery Ligation 
carotid t1xl. 
communicating post or/. 
carotid comm. 
carotid comm. 
omoct1rvlca/ art 
Legend for Figure 17 93 
Anatomical Considerations in Basilar Artery Ligation in the Rabbit: The 
position of the ligation of the basilar artery is at the point of reference as 
indicated in the figure for 'basilar art. ' The external carotid cannulation 
extends to the bifurcation of the internal and external carotids. The 
subclavian artery is also cannulated. The omocervical and internal 
mammary arteries are tied while the innominate is raised by means of a 
loop of suture thread at the time of injection. This latter procedure pre-
vents injected materials from passing into the common carotid and then 
into the forebrain via the internal carotid and Circle of Willis. Injections 
into the external carotid follow the flow of. blood into the internal carotid 
and the Circle of Willis thus supplying the anterior brainstem and telen-
cephalon. The injection of substances into the subclavian artery with the 
innominate temporarily occluded courses up the vertebral and basilar to 
the position of the tie. This type of administration will supply the bulbar 
pontine reticular formation and those structures in the medulla and parts 
of the pons (cf. Figure 18 Dye Distribution). 
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Legend for Figure 18 
Distribution of Monastral Blue Dye in Two Rabbit Brains with 
Ligation of the Basilar Artery at the Mid-Pontine Level: In 
the brain represented by the upper section, the injection was 
made into the vertebral artery. Note that the distribution 
of dye is restricted to the caudal pontine-medullary area 
which includes the bulbar-pontine reticular formation . 
. 
The lower half of the figure is from a brain in which the 
injection of the dye was made into the internal carotid from 
the external carotid. Note the limitation of the dye distri-
bution to those structures more anterior to include the 
mesodiencephalic reticular substance. 
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Figure 19 
EEG SYNCHRONIZATION-CONTROL 
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100 mm Hg IOOµV L__ sec 
Control EEG Pattern: Synchronized or slow wave EEG sleep pattern in the resting 
animal with the basilar artery ligated at the mid-pontine level. Note the high 
amplitude, slow frequency patterns primarily in the cortices (LAC-BOA, RAC-LN, 
L-RPC) while the LN-BOA is primarily a low amplitude tracing and the leads from 
the hippocampus reveal marked theta rhythm, (llI-LN and RH-BOA). 
(BP) is recorded as a mean pressure. 
The blood pressure 
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Figure 20 
EEG DESYNCHRONIZATION- CONTROL 
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Control EEG Pattern: Desynchronized EEG activity during the control phase reveals 
a decreased amplitude and faster frequency of the tracings. Note the marked theta 
rhythm, especially in the leads from the hippocampus. The basilar artery was 
ligated at the mid-pontine level. 
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Figure 21 
INTRACAROTIO ESERINE-RESPONSE "A• 
LAC-BOl\-'¥w~MJh~~~Ar~JA\~t~~~wwvlv./1v~~~~~ 
RAc-LN-~~~w.~ .. ~'~Ji)Mv"1-.,~~Wc~..JM~~~v.;.WtJW~ll~~\~f~··i/wrkM~/\~ 
LH-LN-'VW'ifV\WMWNvrJt1~1~~~"A\\\~"trWttvVJ\'i/W1NV1/'frwJMVviA~l1/Nif.t'""'\tllMNi/vW/1!t"f',W-KffAVN//v'v'v\\;/:N,".fViti/iJYv</,;,pifiNWv.i-~~ 
RH-soA-rt/0N1~'Y./YvVMV..W.11MV·MMW/rN.J.J.J.M'VVvWN'M"fi\!JhVNMrY11NNNrlWN~¥l·Wf mwwt('(\~ .. ~,,.~­
L-RPc-Vf~lfW/IJINfWJ~~~1hr~~~\AN/i"l~ff1{'N~~Wf~~~Jt/vfWNW11Pv~11rn1"·{://'~~(JYw~1f~~ 
BP-- ~-_L__----~~~~--
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Initial Response to an Intracarotid Injection of Eserine with the Basilar Artery 
Tied: Eserine (100 mcgm total dose) administered at the arrow elicits an increased 
EEG sleep pattern shortly after the injection (right side of figure). This effect 
is accompanied by little if any change in mean blood pressure. The synchronized 
pattern is most evident in channels 2, 3, and 6. \..0 
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Figure 22 
INTRACAROTID E'SERINE- RESPONSE 11 8 11 
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Pressor Response and EEG Alert after Intracarotid Eserine in the Basilar Tied 
Preparation: Subsequent to the previous record (-Response 11 A") an EEG de synchroni-
zation occurs followed by a rise in mean blood pressure (beginning at the arrow). 
The time lapse between the two figures, Response "A" and Response "B", is approxi-
mately two minutes. 
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Figure 23 
INTRAVERTEBRAL SARIN-LOCAL CONVULSION 
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Initial Response to the Intravertebral Arterial Administration of Sarin in the Rabbit 
with the Basilar Tied: Sarin (10 mcgm total dose) given intravertebrally to the rabbit 
with the basilar artery ligated at the mid pontine level induces a biphasic response. 
The initial phase consists of a localized seizure limited somewhat to the hippocampus 
(LH-LN and RH-BOA). Note the reflection of the seizure in the posterior cortices over-
lying the dorsal hippocampus. The 2nd phase is in the following figure. 
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Figure 24 
INTRAVERTEBRAL SARIN TOTAL CONVULSION 
LN-BOA-~~~fm'f~­
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Second Phase of Intravertebral Sarin: Subsequent to the previous response in 
the preceding figure, grand mal type EEG seizure activity spreads to the entire 
brain as is evident from these tracings. Note the typical seizure activity as 
intermittent spike activity is associated with high frequency burst activity. 
The time between the tracings in figures 23 and 24 is approximately 20 seconds. 
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Figure 25 
INTRACAROTID SARIN AFTER ESERINE 
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Sarin Convulsio~ in the Presence of Eserine: The intracarotid administration 
of sarin (50 mcgm ~otal dose) elicits a grand mal convulsion (right side of 
tracings) in the presence of a subconvulsant dose of eserine. Note the fall in 
mean bloo5 pressure and the initial phase of its recovery on the far right side 
~ 
of the traci~g. Eserine (100 mcgm/Kg i.v.) had been given approximately 10 minutes g 
prior to these tracings. Sarin was given about 30 seconds before the seizure activity. 
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CONTROL- RECRUITMENT 
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Recruitment During the Control Phase Prior to the Administration of Eserine 
Followed by Sarin: Stimulation of the anterior dorsal thalamic nulcei elicits 
typical recruitment responses from the cortices. The stimulus of 8.0 c/s, 0.8 
!....! 
0 
VJ 
msec and at a voltage greater than threshold was presented as indicated by the arrows. 

SARIN IN PRESENCE OF ESERINE 
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Intravenous Administration of Sarin Elicits Seizure in the Presence of Eserine: 
Sarin was injected (50 rncgrn/Kg i.v.) in the presence of 100 mcgm/Kg i.v. of 
Eserine. Eserine had been injected 8.0 minutes prior to the administration of 
the Sarin and the sarin induced convulsion appeared within one to two minutes. 
Note the diffuse nature of the seizure and the artifact in the EKG which resulted 
from the fasiculations elicited by the anticholinesterases. Histocherni.:;al analysis 
of this brain revealed absence of irreversible inhibition of acetylcholinesterase 
( cf. Figure 29) • 
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Legend for Figure 29 
Sarin Convulsion Does Not Irreversibly Inhibit Cholinesterase in the Presence 
of Eserine: Histochemical analysis by the thiocholine procedure reveals 
cholinesterase in the sagittal section of the rabbit brain. Note the dense 
areas representing sites of cholinesterase in the caudate nucleus, superior 
colliculus, thalamic nuclei, amygdala, and medullary nuclei. Pretreatment 
with Eserine has prevented the irreversible inhibition as normally seen with 
this dose of sarin (figure 6a ). This figure represents the brain from the 
animal used in the experiment shown in the figure 28 . 
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Legend for Figure 30 
Sagittal Section of Rabbit Brain Exposed to Sarin and 
Atropine Sulfate and Processed by the Thiocholine Procedure 
for Demonstration of Cholinesterase: The brain used in this 
figure represents the effect of treatment with an irreversible 
inhibitor of cholinesterase, sarin. A sarin induced con-
vulsion (50 mcgm/Kg i.v.) had been antagonized by atropine 
sulfate (5.0 mg/Kg i.v.). Note the absence of intense areas 
of staining as compared with the control sections (cf. Figure 
5a). The photographic processing of these 11 blank 11 sections 
required intense over-development while the control cho-
linesterase sections did not. 
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On the other hand sarin, given by the carotid route of 
administration, did not reveal a localized seizure followed 
by a diffuse one but rather showed only a generalized con-
vulsive pattern (fig. 25). Pretreatment with Eserine (100 
mcgm/Kg i.v.) had evoked a desynchronized EEG with an 
elevated blood pressure (see left side of tracings fig. 25). 
Sarin injected intracarotidly on this background of 
reversibly inhibited AChE not only evoked seizure activity 
but also induced a marked transient depressor response and 
bradycardia. 
Figure 26 shows cortical recruitment evoked by thalamic 
stimulation as indicated in the legend (see also Part II). 
A control response to the dose of Eserine that attenuated re-
cruitment and induced a desynchronized EEG pattern was 
obtained prior to the intravenous administration of 50.0 
mcgm/Kg of sarin (fig. 27). Diffuse EEG convulsive episodes 
occurred after the administration of sarin (fig. 28) and the 
animal died shortly after these tracings were made. Sub-
sequent histochemical analysis of the brain showed an 
absence of irreversible enzyme inhibition (fig. 29). 
IV. DISCUSSION 
Anatomical findings in the rabbit brain stained with 
thionin and eosin agreed with the stereotaxic atlas of 
Monnier and Gangloff (1961), but contained greater detail 
(cf. Fifkova and Mar~ala 1960, Sawyer et al. 1954, Meesen 
and Olszewski 1949, Young 1936, Kappers et al. 1936, and 
Winkler and Potter 1911). Tissue processing with frozen 
sections permitted the determination of the sites of im-
plantation of electrodes in less than an hour as compared 
to a formalin-fixed, frozen sect.ion method (McBride and 
Klemm 1968) . 
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The thiocholine procedure (Koelle 1955) was applied to 
rabbit brain tissue and subsequently modified (see Methods). 
Histochemical evidence of irreversible inhibition of 
cholinesterase or of protection from irreversible enzyme 
inhibition was of interest in the current studies. There-
fore, only the thiocholine procedure that revealed all 
cholinesterases was used. Furthermore, the rabbit brain has 
been reported to contain little BuChE in contrast to other 
species (Gerebtzoff 1959). But the brains of different 
mammalian species appear to have greater AChE than BuChE 
activity (Augustinsson 1948, Ord and Thompson 1950). 
114 
Localization of cholinesterases in the non-drugged rabbit 
brain (figs. 5a, 5b, 5c), agreed with previous observations 
in rats (Koelle 1963) and in rabbits (Gerebtzoff 1959), 
though the procedures differed. No attempt was made to 
evaluate cellular localization of the enzyme in the current 
studies. The thiocholine procedure of Koelle (1949, 1950, 
1951, 1955) is basically an in vitro method that uses com-
binations of inhibitors and substrates that are specific for 
AChE and BuChE. Counterstaining as well as post-fixation 
with formalin are included. ~ disadvantage of this method 
is the diffusion artifact that appears following long term 
incubation. Prefixation in 10% formalin was introduced as a 
modification of Koelle's method (Coers 1953, Couteaux 1958, 
and Gerebtzoff 1959) and the diffusion artifact was minimized 
as a result of inactivation of cholinesterase by the fixative 
(Taxi 1952). Bergner and Bayliss (1952) have proposed a mode 
of action for the thiocholine histochemical process and this 
appears in figure 4. 
The biochemical study of Aprison et al. (1954) showed 
variations in AChE activity in several parts of the rabbit 
brain with the highest values appearing in the caudate 
nucleus. Our histochemical data (figs. 5a, 5b, 5c), in 
general correlated with their observations and the most 
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intense stain for AChE appeared in the caudate nucleus. The 
inhibition of brain cholinesterase by the organophosphates 
(figs. 6a, 6b, 6c), corroborate previous biochemical 
findings (Holmstedt 1963). Also, the irreversibility of the 
inhibition was reflected by the negative (blank) histo-
chemical stain for cholinesterases (figs. 6a, 6b, 6c, 30). 
Atropine sulfate and atropine methyl nitrate failed to 
antagonize this inhibition of cholinesterases as seen with 
histochemical observations (fig. 30) and biochemical 
findings (Table I). Atropine ~ulfate has been shown to 
produce a considerable increase in the release of acetyl-
choline from the cortices of several species (Beani et al. 
1964, Polak 1967, Beaniet al. 1968). However, the mechanism 
for producing this effect is unclear and Beani et al. (1968) 
summarized some of the tentative explanations. Mechanisms 
proposed, include the following: (1) blockade of post-
synaptic sites to prevent uptake of released ACh (Celesia 
and Jasper 1966), (2) blockade of a negative feedback 
mechanism that results in an increased rate of firing of 
corticopetal cholinergic paths (Mcintosh 1963), and (3) 
blockade of a negative feedback mechanism that is located 
intracortically and acts on cholinergic terminals (Polak 
1967). Furthermore, the anticholinesterase properties of 
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atropine might be a factor (Vincent and Parant 1956, 
Todrick 1954, and Gyermek 1955). It has been shown that the 
acute toxicity of anticholinesterases can be additive and 
perhaps reveal potentiation (Frawley et al. 1952, 1957). 
This would result in an increased accumulation of ACh. 
Cholinergic desynchronization of the EEG would be blocked 
by the competitive antimuscarinic actions of atropine at 
post-synaptic sites. While our data did not show an in-
creased inhibition of cholinesterases in the presence of 
atropine, the enzyme was already maximally inhibited (fig. 
29, cf. Koppanyi and Karczmar 1951). Based on the observa-
tions cited above (Table I), the presence of the anti-
cholinergics did not reduce cholinesterase inhibition. 
The EEG of the rabbit at rest and during activation was 
similar to that described by Longo (1962) (figs. 7, 8, 9, 
10). Intravenous sarin (20.0 mcgm/Kg, fig. 11), elicited 
a convulsive pattern (cf. Longo 1962) and the dose approxi-
mated the LD 50 for rabbits (Holmstedt 1963). Atropine 
antagonism of the EEG response to sarin has been known 
(Machne and Unna 1963) and present findings are similar. The 
reciprocal nature of this response (figs. 13, 14, 15) as 
pointed out by Longo (1962) depends on the amounts given. 
This reciprocal antagonism of anticholinesterases and anti-
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cholinergics at the central nervous system in terms of the 
basic pharmacology of atropine (Goodman and Gilman 1965) 
suggests a competitive antagonism. The onset of anti-
cholinesterase-induced convulsions is accompanied by hyper-
tensive blood pressure responses which persist for the dura-
tion of that paroxysmal EEG activity (Longo 1962). This was 
found to be the case in the presence of reciprocal antag-
onism concomitant with EEG changes. However, at a sufficient-
ly high dose of atropine (fig. 16, 10.0 mg/Kg i.v. total 
dose), blood pressure failed bo rise though the EEG and 
behavioral response to sarin was a convulsion. 
Activity of brain cholinesterases after the first 
injection of sarin and after the AntiChE had been antagonized 
by atropine showed marked attenuation (Table I). Further-
more, the histochemical evidence supported this finding 
(figs. 6a, 6b, 6c). Therefore, after the first injection of 
sarin, cholinesterase was irreversibly inhibited and after 
repeated reciprocal antagonism with atropine the irreversible 
nature of the inhibition was unchanged (cf. Koppanyi and 
Karczmar 1951). Effects of the irreversible anticholin-
esterase, when produced in the presence of maximally 
inhibited enzyme, cannot be attributed to irreversible 
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inhibition. Reciprocal antagonism of these effects with 
atropine also occurred in the same manner as seen after the 
initial dose of sarin and on a background of irreversibly 
inhibited brain cholinesterase. 
Experiments were then designed to protect brain cholin-
e sterases from irreversible inhibition (cf. Koelle 1957), 
and this data is shown in figure 29. Eserine readily 
penetrated the BBB and produced a transient sequence of 
effects on the EEG (Longo 1962 and Longo and Silvestrini 
1957) which were also noted in the current studies (figs. 
21, 22, and Part II). Marked attenuation of thalamocortical 
recruitment (see Part II) is a characteristic feature of the 
action of Eserine in rabbits and the studies of Hance et al. 
(1963) revealed that EEG desynchronization and marked 
attenuation of the surface negative component of the re-
cruited potentials were the most significant effects produced 
in cats. Figure 27 shows the degree of attenuation of re-
cruitment and the EEG arousal evoked by Eserine as compared 
to a pre-drug state during a moderately desynchronized EEG 
background (fig. 26). These responses served as controls for 
the effectiveness of that dose of Eserine. In the presence 
of Eserine, the administration of 50.0 mcgm/Kg i.v. of sarin, 
a dose that approximates 2 times the LD 50 for rabbits 
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(Holmstedt 1963), evoked a convulsion (fig. 28). At this 
time, brain cholinesterase was reversibly inhibited by 
Eserine (Long 1963). Histochemical data (fig. 29), showed 
that irreversible inhibition of the enzyme had not occurred 
and areas of intense staining appear comparable to the un-
treated rabbit brain (figs. 5a, 5b, 5c). Protection of 
cholinesterase from irreversible inhibition by the prior 
administration of a reversible inhibitor was used by Koelle 
(1946, 1957). He noted that the concentrations of AChE 
varied according to the activi~y and dose of the reversible 
inhibitors but not the irreversible ones. In earlier studies, 
Koelle (1946) suggested that Eserine could be displaced from 
cholinesterase by DFP. Our data indicates that brain AChE 
reversibly inhibited by Eserine is not susceptible to marked 
irreversible inhibition by sarin or DFP. The lack of agree-
ment may be in the amounts of drugs given. However, the time 
of sacrifice after the administration of the irreversible 
inhibitor may have greater importance. Attenuation of 
recruitment by DFP in the presence of Eserine is reversible 
following the first exposure but repetition of this procedure 
results finally in an EEG response and attenuation of recruit-
ment that is consistent with irreversible inhibition (un-
published preliminary studies). Histochemical evaluation of 
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these rabbit brains revealed irreversible inhibition of 
cholinesterase. The seizure induced by sarin in the presence 
of Eserine does not appear to be due to irreversible in-
hibition of that enzyme which normally occurs with sarin 
given alone (cf. fig. 30). 
The biphasic response to the intracarotid administra-
tion of Eserine was somewhat unexpected. The transient fall 
in blood pressure and concomitant synchronization of the EEG 
could be attributed to a muscarinic action of Eserine (fig. 
21). The subsequent EEG arousal (fig. 22) could be due to 
. 
nicotinic actions of Eserine and/or the increased concen-
tration of ACh that attends inhibition of AChE. Silvette et 
al. (1962), Domino (1967), and Longo et al. (1967) have 
shown EEG desynchronization to be the initial response to the 
intravenous administration of nicotine. An increased synchro-
nization of activity may follow. In addition, Schaeppi 
(1968) injected nicotine intracarotidly or intravertebrally 
into cats and found that either route of administration 
elicited results similar to the intravenous injections. How-
ever, the intravertebral injection appeared to be more ef-
fective and produced direct effects on cardiovascular centers 
in the brain that were independent of the effects of nicotine 
on the EEG. Schaeppi attributed the EEG arousal to an action 
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on an unspecified ascending desynchronizing system and the 
subsequent EEG synchronization on another unspecified 
ascending synchronizing system. Longo (1966) showed that 
atropine blocked the EEG and motor convulsions evoked by 
cortical application of a combination of Eserine and acetyl-
choline. Furthermore, Domino (1968) found mecamylamine to 
be an ineffective antagonist of either Eserine or pilo-
carpine-induced EEG and behavioral arousal in cats. Atropine 
readily blocked these responses. Responses to Eserine seen 
in the current experiment (figs. 21, 22) may be the result 
of muscarinic-cholinergic stimulation since atropine 
antagonizes them (Longo 1962). In addition, the pressor 
response to the intracarotid administration of Eserine 
supports the findings of Varagid and Krstit (1966). These 
authors noted that the Eserine evoked pressor response in 
rats was blocked by lesions in the lateral hypothalamus. 
Intravertebral administration of sarin produced a bi-
phasic response (figs. 23, 24) of convulsive EEG patterns 
that were initially localized and then developed into a 
grand mal pattern. Intracarotid administration of sarin in 
the presence of Eserine (fig. 25) also elicited a seizure 
pattern which had a diffuse and abrupt onset. The convulsive 
activity of sarin did not appear to be restricted to specific 
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sites of the forebrain and hindbrain, and occurred in the 
presence of Eserine-inhibited enzyme (fig. 29). Micro-
injections of sarin given bilaterally into the lateral 
reticular nucleus of the medulla of rabbits resulted in 
apnea, which could be antagonized by atropine given intra-
venously (Stewart and Anderson 1968). Hypotensive responses 
also were evoked and were antagonized by atropine. Micro-
injections of sarin into more medial areas of the reticular 
formation produced tachypnea, bradycardia, and hypotension. 
Tachycardia was not seen but hypertensive responses could be 
evoked. All of these responses were antagonized by atropine. 
The bradycardia was of interest because it could be blocked 
by a bilateral vagisection and could not be elicited by 
microinjections of sarin into the area of the nucleus 
solitarius or the dorsal nucleus of the vagus. Stewart 
suggested that rhythmicity of the medullary respiratory cen-
ter is under a muscarinic inhibitory control in a way 
analagous to the relationships found between vagus nerve and 
cardiac pacemaker. 
Cholinoceptive neurones of the ponto-medullary brainstem 
of cats revealed excitatory nicotinic and inhibitory muscarin-
ic responses to iontophoretically applied drugs (Bradley et 
al. 1966). Dihydro beta-erythroidine blocked the excitatory 
responses while atropine antagonized both excitatory and 
inhibitory effects. In addition, Bradley and co-workers 
noted that the iontophoretic application of Eserine and 
neostigmine potentiated the effects of ACh and also had 
actions per~ different from ACh. Eserine had an 
excitatory effect on neurons that were inhibited by ACh. 
123 
Cholinergicity of the ascending pathways of the CNS has 
been implied by several lines of evidence. Cholinoceptivity 
of the brainstem neurons has been established (vide supra). 
Cortical cholinergic mechanisms have been discussed by 
Krnjevi6 (1967) who pointed out the presence of ACh sen-
sitive cells in the cortex as well as choline acetylase and 
AChE. Evidence for cholinergic innervation arriving from 
subcortical origins was based on electrophysiological, 
histochemical, and biochemical data. ACh-sensitive cortical 
cells responded to thalamic stimulation and these responses 
were potentiated by ACh or Eserine. Atropine antagonized 
these responses. AChE-staining fibers that projected to 
the forebrain could be traced to several subcortical sites 
to include the septum pellucidum, lenticular nucleus, and 
the midbrain reticular formation. cortical release of ACh, 
measured biochemically, showed that as cerebral activity 
decreased during anesthesia, so did the amount of ACh being 
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released. 
Shute and Lewis (1966J 1966a) have compared their 
findings for cholinergic pathways in the rat brain with the 
histochemical fluorescence data for monoaminergic pathways 
(Dahlstrom and Fuxe 1964). Shute and Lewis concluded that 
the 2 ascending systems paralleled one another but that 
electrocortical arousal was more likely a cholinergic event 
rather than monoaminergic. They cited as evidence their 
observations that monoaminergic cells did not extend to the 
forebrain telencephalon as diq the cholinergic ones. How-
~ 
ever, Anden et al. (1966) proposed a forebrain extension of 
monoaminergic pathways. Cuculic et al. (1968) postulated 
that the final link in the electrocortical arousal was a 
cholinergic one. They arrived at their conclusions from 
data obtained by the direct application of cholinolytic 
substances on the cortex. Atropine antagonized both 
cholinomimetic and adrenomimetic agonists (cf. White and 
Daigneault 1959). 
Therefore, the evidence of cholinergic pathways from 
the reticular formation to the cortex presents multiple 
sites of action for anticholinesterases. Anticholin-
esterases can act not only indirectly, by enhancing the 
action of ACh, but also directly as was shown by Bradley 
--
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et al. (1966) at the cellular level and also in the current 
--
study where it was demonstrated that anticholinesterases 
could evoke responses in the presence of inhibited enzyme. 
The presence of parallel monoaminergic and cholinergic path-
ways suggests cholinergic-adrenergic interrelationships. 
Part II of the dissertation presents evidence for an 
adrenergic-cholinergic interaction at the thalamocortical 
level. 
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V. SUMMARY 
Figure 31 reviews histochemical, electrophysiological, 
and biochemical evidence for the direct action of anti-
cholinesterases. The "Histochemical Data'' shown in the 
column on the left hand side of the figure (read down) in-
dicates that Eserine evoked an EEG alert at which time the 
administration of sarin or DFP evoked a convulsion and 
death. The thiocholine procedure for cholinesterase re-
vealed a stain which indicated non-irreversible inhibition 
of the enzyme. On the other hand, histochemical data also 
showed that if sarin or DFP were given first (2nd column 
Histochemical Data) then an EEG alert would also be evoked 
during which time the administration of Eserine evoked a 
convulsion and death as before. However, the thiocholine 
procedure now revealed a blank result which indicated irre-
versible inhibition of enzyme. 
The "Electrophysiological Data" shown in the middle 
column reflects the reciprocal antagonism between anti-
cholinesterase and anticholinergic drugs. Sarin evoked an 
EEG alert which led to a convulsion and was antagonized by 
atropine. Subsequent injections of sarin (2nd Sarin In-
jection; 3rd Sarin Injection) again evoked EEG alert patterns 
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and convulsive episodes which were similarly antagonized by 
atropine. Biochemical Data (right hand column) revealed 
that the activity of ChE was irreversibly inhibited approx-
imately 95% after the first injection of sarin and that 
atropine antagonism did not change this effect of sarin. 
Thus, after the initial, irreversible inhibition of ChE, the 
interaction between sarin and atropine occurred in the 
presence of maximally inhibited enzyme. 
Therefore, in summary: 
(1) EEG responses to the adm~nistration of anticholinester-
ases were evaluated in the presence of (a) irreversibly 
inhibited enzyme and (b) in the presence of cholin-
esterase that was protected from an irreversible in-
hibitor by the presence of a reversible inhibitor. 
(2) Reciprocal antagonism between sarin and atropine was 
repeatedly demonstrated in the same animal. Biochemical 
and histochemical findings indicated maximal irrevers-
ible inhibition of brain cholinesterase after the first 
injection of sarin. 
(3) Sarin evoked grand mal seizures and death when given 
after Eserine. Histochemical data showed that sarin 
failed to irreversibly inhibit brain cholinesterase. 
-Figure 31 
DIRECT ACTION OF ANTICHE'S 
Histochemical Data Elect rophysiolog ica I 
Eserine 
EEG Alert 
Sarin-DFP 
Convulsion 
and 
Death 
Thiocholine 
Stain 
Sarin-DFP 
EEG Alert 
Eserine 
Convulsion 
and 
Death 
Data 
Sarin 
EEG Alert -i>Convulsion 
Atropine -Antagonism. 
2nd Sarin Injection 
EEG Alert -1>Convulsion 
Atropine-Antagonism 
Thiocholine 3rd Sarin Injection 
Blank 
EEG Alert -1>Convulsion 
Biochemical Data 
ChE Inhibition After Sarin: 
> 953 
ChE Inhibition After Sarin 
and Atropine: 
> 953 
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(4) A direct action of anticholinesterases is proposed in 
addition to inhibition of enzyme. 
129 
PART II. EVIDENCE FOR AN ADRENERGICALLY MEDIATED ACTION 
OF ANTICHOLINESTERASES IN THE CENTRAL NERVOUS SYSTEM 
OF RABBITS 
130 
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I. INTRODUCTION 
Electrocortical desynchronization by cholinomimetics 
and anticholinesterases with the demonstration of antagonism 
by antimuscarinic drugs has suggested cholinergically-
media ted events (Wescoe et al. 1948, Funderburk and Case 
1951, Bradley and Elkes 1953). Mediation by adrenergic 
mechanisms has also been proposed (Bonvallet et al. 1954, 
Dell 1961). However, difficulty in interpretation of results 
has occurred since the administration of norepinephrine (NE) 
or epinephrine (EPI) resulted in_EEG desynchronization, or 
synchronization or no effect (see Longo 1962 and Baust and 
Niemczyk 1964 for reviews). The monoamines, NE, EPI, and 
dopamine (DA) penetrate the blood brain barrier (BBB) to 
little if any extent (Weil-Malherbe 1961) and therefore CNS 
responses attributable to a direct action following intra-
venous administration is questionable. Adrenomimetic drugs 
such as amphetamines and other phenylethanolamines that 
readily gain access to the CNS showed EEG desynchronization 
consistently which was associated with behavioral arousal 
in unanesthetized preparations (Longo and Silvestrini 1957, 
Bradley 1968). Inhibition of monoamineoxidase followed by 
the administration of L-DOPA, the precursor of NE and EPI, 
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resulted in an EEG and behavioral arousal associated with 
marked increases in brain biogenic amine levels (Everett 
1961). Furthermore, reserpine-depletion of biogenic amines 
and behavioral sedation in monkeys has been reversed by the 
administration of a monoaminoxidase inhibitor (MAOI) plus 
L-DOPA (Everett et al. 1963). 
EEG responses to cholinomimetics and adrenomimetics 
were readily blocked by atropine (White and Daigneault 1959) 
as well as by the alpha blockers phenoxybenzamine and 
chlorpromazine (Goldstein and Munoz 1961, MuNoz and Gold-
stein 1961). Though anticholinergics and adrenergic 
blockers may share similar effects there are notable 
differences including the failure of amphetamine to reverse 
the EEG synchronization induced by scopolamine (Longo 1962). 
Interrelationships between cholinergic and adrenergic systems 
associated with EEG desynchronization and behavioral arousal 
have been suggested by White and Daigneault (1959), Bradley 
(1961), Dell (1961), and White et al. (1965). Desynchronizatior 
of the EEG by anticholinesterases is presumably evoked 
through cholinomimetic mechanisms that may be indirect via 
increases in acetylcholine (ACh) concentrations as well as 
direct actions (Bradley et al. 1966, cf. Part I). Ampheta-
mine also evokes an EEG arousal through adrenomimetic 
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mechanisms that may be indirect as well as direct (Bradley 
1961). Both classes of drugs have been demonstrated to act 
at a level of the mesodiencephalic activating system 
(Rinaldi and Himwich 1955a, 1955b, Van Meter and Ayala 1961). 
The threshold of thalamocortical recruitment evoked by 
stimulation of the anterior nuclei of the thalamus was in-
creased by EEG arousal (Longo 1962). EEG desynchronization 
evoked by stimulation of the midbrain reticular formation or 
by anticholinesterases was a more effective antagonist of re-
cruitment than amphetamine-induced EEG arousal, which did 
not attenuate recruitment (Longo and Silvestrini 1957). 
The present studies were undertaken to evaluate the 
interrelationship between cholinergic and adrenergic 
mechanisms in the attenuation of thalamocortical recruit-
ment by an anticholinesterase. 
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I. LITERATURE REVIEW 
Early studies on evoked thalamocortical potentials in 
cats revealed augmenting potentials which followed high 
frequency stimulation (up to 120 c/s) of the lateral 
thalamic nuclei. These potentials were localized to the 
sensorimotor cortices and showed a biphasic positive-
negative waveform. Stimulation frequencies of 5-15 c/s 
applied to midline thalamic nuclei evoked recruited poten-
tials of 20-34 msec latency with a surface negativity and 
wide distribution over the cerebral cortex (Morison and 
Dempsey 1941-42, Dempsey and Morison 1941-42). Cortical 
and subcortical sites of action for generating recruited 
potentials were proposed (Verzeano et al. 1953). Ajmone-
Marsan (1958) used cats anesthetized with pentobarbital and 
observed that the characteristic latency of recruitment was 
a function of the waxing and waning of the evoked responses. 
He concluded that thalamocortical recruitment resulted from 
activation of either longer or shorter chains of neurons 
and that the latency was not a function of conduction time 
between thalamus and cortex but occurred at the thalamic 
level. He postulated that during recruitment two separate 
but interrelated electrical fields arose in the brain and 
that these could account for the recruiting phenomena. 
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Jasper (1949) noted a diffuse projection system that ascended 
from the lower brain stem to cerebral cortex which included 
thalamocortical pathways necessary for recruitment. Longo 
(1962) gave a description of recruitment in rabbits and 
pointed out that Stoupel and Terzuolo (1954) also found re-
cruited potentials in response to caudate nucleus stimula-
tion. Bishop et al. (1961) observed that thalamic augmenting 
potentials and recruiting potentials were mutually occlusive, 
had similar excitation characteristics and distribution in 
the various layers of the cortex. They concluded that the 
difference between thalamocortical recruitment and augment-
ing potentials was an operational one in that stimulation of 
thalamic relay nuclei evoked augmenting potentials along 
with primary sensory projection responses. Velasco and 
Lindsley (1965) suggested that orbital cortex played a 
crucial role in regulation of thalamocortical recruitment in 
cats. They based their conclusions on ablation studies in 
which removal of orbital cortex alone abolished recruited 
potentials. Involvement of the limbic system was revealed 
by Sparks and Powell (1966) who observed that conditioning 
stimuli to the hippocampus, mamillary bodies, or septal 
nuclei attenuated late components of recruited potentials that 
had been elicited by stimulation of the anterior dorsal 
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nuclei of the thalamus. Sparks and Powell concluded that 
limbic projection to the anterior thalamus modified its 
excitability and this in turn influenced the level of 
cortical excitability. Spindle bursts during EEG slow wave 
sleep were also found to be abolished by orbito-frontal 
cortical ablations in gallamine immobilized cats (Velasco 
et al. 1968). It was concluded that the orbito-frontal 
cortex was an essential anatomical link in a thalamocortical 
synchronizing system for spindle bursts and recruitment. 
With the introduction of,fast wave or paradoxical sleep 
hypotheses (Dement 1958, Jouvet 1962), Yamaguchi et al. 
(1964) noted that elicitation of recruitment during para-
doxical sleep was questionable. They also observed that the 
degree of attenuation of recruitment during paradoxical 
sleep was greater than that seen during relaxed wakefulness. 
In addition, these authors noted that high frequency stimula-
tion of the thalamus evoked EEG and behavioral arousal. 
Giaquinto (1968) divided sleep and wakefulness into 4 cycles: 
(1) strong arousal, (2) relaxed wakefulness, (3) slow wave 
sleep, and (4) rapid sleep (paradoxical). He found a high 
threshold for recruitment, a high level of electromyographic 
activity and a desynchronized EEG during strong arousal; no 
paradoxical sleep, but low voltage fast EEG activity with 
moderate electromyographic activity during relaxed wake-
fulness; a low threshold for recruitment during slow wave 
sleep; and paradoxical sleep revealed no difference in 
threshold for recruitment from that seen during relaxed 
wakefulness, a threshold which had been relatively high. 
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Abeles (1967, 1967a, 1967b) evaluated the excitability 
of brainstem (nucleus solitarius) and thalamic neurons in-
volved in elicitation of EEG synchronization and desynchroni-
zation. He found that the chronaxie of "desynchronizing" 
neurons was less than that of ,"synchronizing" ones and con-
cluded that desynchronization was more readily obtainable 
than synchronization. He postulated that there were not 
two different sets of neurons but probably a common set that 
responded to synchronizing or desynchronizing stimuli. 
Serotonergic sleep (Koella and Czicman 1966, Jouvet 
1967, Koella et al. 1968) has been induced by the intra-
carotid administration of serotonin which penetrated the 
blood brain barrier at the area postrema. Koella and 
Czicman postulated that the injected serotonin then stimula-
ted the nucleus solitarius and serotonergic sleep was 
mediated via the tractus solitarius to the midline nuclei 
and diffuse projection system of the thalamus. 
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Anderson and Curtis (1964) found ACh-sensitive neurons 
of the ventro-lateral thalamus to respond with inhibition 
followed by excitation and the excitation was a mixed 
muscarinic and nicotinic type. However, Mccance et al. 
(1968) evaluated the responses of the ventral thalamic nuclei 
to iontophoretically applied carbachol, ACh, acetyl beta-
methacholine, butyrylcholine, propriocholine, nicotine, 
Eserine, neostigmine, tensilon, dihydro beta-erythroidine, 
hexamethonium, atropine, and hyoscine. These authors found 
that muscarinic agonists were more effective than the nico-
. 
tinic ones. Atropine blocked most of the responses but di-
hydro beta-erythroidine was much less effective. Anti-
cholinesterases enhanced the responses and Mccance et al. 
concluded that cholinoceptive responses of the ventral 
thalamic nuclei of the cat were pharmacologically muscarinic. 
Correlation of activity from reticular and thalamic 
units with states of sleep, wakefulness, and anesthesia show-
ed a general decrease in activity with variable patterns of 
bursts but no unique differences in activity that could be 
associated with any given state (Goodman and Mann 1967). It 
was concluded that the characteristics of spontaneous firing 
of thalamic and reticular units could not be used to 
differentiate between wakefulness, sleep, or anesthesia. 
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However, Phillis and Tebecis (1967) found that pentobarbital 
blocked the ACh excitatory and the NE inhibitory effects on 
thalamic neurons without altering the levels of excitation 
of the neurons which remained responsive. In addition, 
Findlay and Hayward (1966) noted bimodal firing of massa 
intermedia neurons of rabbits during synchronized sleep but 
electrical silence during desynchronization. 
Recent studies of Andersen et al. (1967, 1967a) and 
--
Andersen and Andersson (1968) have revealed that the thalamus 
served as a pacemaker site during barbiturate anesthesia. 
Independent rhythmic discharges were generated through their 
respective projections to the cortex, to control the 
rhythms of that cortical "column". The thalamic origin of 
recruitment and spindle burst activity was postulated to 
occur as the result of post inhibitory excitation which in-
duced an increasing synchronized discharge of thalamic neurons 
and this accounted for the waxing of potentials seen during 
recruitment. Eventually, these inhibitory neurons get "out 
of phase" and the waning of potentials results. Increased 
unit firing was demonstrated to correlate with increased 
amplitude of cortical response. In addition, a functional 
relationship between thalamus and caudate was implied by the 
....... 
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presence of caudate responses to thalamic stimulation. 
Kaji et al. (1968) established the existence of con-
nections from anterior thalamic nuclei to the caudate with 
their studies on recruiting responses in caudate nucleus. 
They observed that caudate recruitment depended on the level 
of cortical activity much in tbe same manner as thalamo-
cortical recruitment. Unit analysis of caudate-cortical 
excitatory fiber tract responses in cats disclosed caudato-
cortical connections of a direct nature rather than collater-
al or corticopetal tracts from lower levels (Rocha-Miranda 
1965). This data contrasts with that of Demetrescu and 
Demetrescu (1962), who had found the activating or facilita-
tory effects of caudate activity seen during light barbi-
turate anesthesia, suppressed by reticular formation lesions. 
At the same time, depressant effects of the caudate were not 
altered by the lesions of the reticular formation. 
Single shock stimulation of the caudate evoked spindle 
bursts, the threshold of which was raised by pentylene-
tetrazole and decreased by chlorpromazine, pentobarbital and 
alpha blockers (Tokizane et al. 1957). It was concluded 
that reticular formation activity influenced the threshold 
of caudate spindles and that the spindles were a reflection 
of the state of cortical excitability. In a sequence of 
--
studies on the caudate spindle (Buchwald et al. 1961, 
Heuser et al. 1961, Buchwald et al. 196la, Buchwald et al. 
196lb), it was found that (1) caudate spindles evoked by 
single shock stimuli to the head of the caudate nucleus 
were attenuated by high frequency stimulation of the mid-
brain reticular formation, hypothalamus, globus pallidus, 
or centrum medianum, as well as by catnip. High frequency 
stimulation of the mid-amygdaloid area, rostral, midline, 
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and relay nuclei of the thalamus failed to block caudate 
spindles; (2) cortical sites of caudate spindling and re-
cruitment were the same; (3) functional integrity of the 
anterior ventral nuclei of the thalamus was necessary for 
caudate spindle activity as well as for electrocortical 
arousal induced by stimulation of the caudate; and (4) ether 
and locally applied procaine blocked spindles while pento-
barbi tal and sleep facilitated then. A "Caudate Loop" was 
proposed in the path from the reticular formation to the 
cerebral cortex. Afferent connections from anterior ventral 
thalamic nuclei to the caudate and back formed the loop. 
Ventral thalamic afferents also projected to the cortex. Low 
frequency stimulation of this loop antagonized the ascending 
arousal system and evoked spindle bursts and behavioral in-
hibition. It was suggested that this caudate inhibitory 
loop functionally balanced the alerting system proposed by 
Morruzzi and Magoun (1949). Frequency, intensity, and 
anatomical site of stimulation were considered as critical 
factors. 
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Horvath et al. (1964) compared caudate-spindle thres-
holds with those evoked by internal capsule stimulation in 
flaxedilized cats, and found a lower threshold in the caudate. 
Goldring et al. (1963) had not been able to evoke caudate 
spindles in monkeys and had noted a neuroanatomical 
difference between the cat and the macaque monkey. Afferent 
sensorimotor cortical fibers of the cat run adjacent to the 
caudate while the sensorimotor cortex of the monkey was 
caudal to the caudate nucleus. These authors noted that 
internal capsular stimulation evoked recruitment and con-
cluded that caudato-cortical responses should not be used as 
evidence for anatomical pathways. 
An ascending inhibitory system that included the caudate 
nucleus was proposed by Demetrescu and Demetrescu (1962). 
Evoked potentials from optic tract and optic radiations of 
the visual system; from medl~l geniculate body stimulation 
of the auditory system; and from stimulation of the ventral 
posterior thalamic nuclei of the somesthetic system; were 
all depressed by 40-100 c/s stimulation of the caudate. On 
-the other hand, stimulation of the midline thalamic nuclei 
facilitated evoked potentials from all of the above areas 
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where caudate stimulation had shown depression of responses. 
Caudate depression of responses was not antagonized by 
lesions of the reticular formation. Demtrescu and Demetrescu I 
1l (1962a) proposed an ascending inhibitory path that extended 
from the pontine-reticular formation to the caudate nucleus 
and the cerebral cortex. This ascending inhibitory path 
was ventral to, and paralleled the ascending reticular 
activating system. The inhibitory system was under control 
of the activating one and operated via a feedback servo 
mechanism. 
Eserine injected into the caudate nucleus, was found to 
block spindling and subsequently could evoke seizures 
(Rakic et al. 1962). These seizures could be antagonized 
by unilateral lesions in the cortex and rostral extralaminar 
thalamus, as well as bilateral lesions in the posterior 
hypothalamus and the posterior intralaminar thalamus. These 
findings were interpreted to mean that Eserine interrupted 
the inhibitory influence of the caudate and permitted the 
excitatory one to obtain (cf. Demetrescu and Demetrescu 
1962). The result was a lowered seizure threshold. 
I 
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Traczyk and Sadowski (1962) noted that slow intravenous 
infusion of Eserine increased spontaneous spindling followed 
by a desynchronization of the EEG. In subsequent studies 
Traczyk and Sadowski (1964) compared ACh concentrations in 
caudate with EEG activity in cerveau isole' cats. They 
found that EEG synchronization in midbrain transected animals 
was associated with high ACh concentrations and that de-
synchronization of the EEG was attended by low ACh content 
of the caudate. On the other hand, caudate-ACh concentra-
tions were low in desynchroni~ed controls; in cerveau isole' 
preparations receiving caudate stimulation at 5 c/s and 50 
c/s; and after atropine. Eserine or caudate stimulation at 
high frequencies (300 c/s) in cerveau isole' preparations re-
sulted in high concentrations of ACh in caudate nucleus. 
They concluded that the lack of agreement between stimulus 
response and drug actions on caudate nucleus was explained 
by the existence of and the operation of different (undefined) 
transmitter systems. 
Collins and Simonton (1967) observed that caudate 
conditioning stimuli depressed responses in the limbic system 
of chloralosed cats. Extracellular microelectrode studies 
showed that caudate stimulation inhibited centrum medianum 
unit activity and this effect could be antagonized by strych-
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nine and picrotoxin more than by pentylenetetrazole. Ampheta-
mine, caffeine, imipramine, chlorpromazine, and mephenesin 
were without effect on the caudate inhibition of the centrum 
medianum. Caudate-induced inhibition of evoked responses in 
the limbic system was not antagonized by strychnine. These 
authors concluded that caudate conditioning of limbic responses 
resulted in strychnine-like action. 
Neurons of the caudate as well as the hypothalamus have 
been shown to respond to iontophoretically-applied ACh with 
either inhibition or excitatiDn (Bloom et al. 1963, Bloom 
et al. 1964). High concentrations of ACh (Aprison and 
Nathan 1957) along with high synthesis rates (Feldberg and 
Vogt 1948) have been reported for caudate nucleus. Marked 
concentrations of AChE are also evident (see Part I). 
Stimulation of the ventral anterior thalamic nuclei evoked 
the release of ACh from the caudate. Also, the response to 
cholinergic stimulation of the caudate and the response to 
stimulation of the ventralis anterialis was the same 
(McLennan and York 1966). Therefore, a "cholinergic link" 
may exist between the thalamus and the caudate. 
The Burn-Rand Concept (Burn and Rand 1959, Burn and 
Rand 1962, Burn and Rand 1965), suggested that stimulation 
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of postganglionic sympathetic nerve fibers evoked the re-
lease of ACh which then promoted the entry of calcium into 
the nerve ending and enhanced the release of bound NE. 
Norepinephrine then acted as a neurotransmitter having been 
released by a 11 cholinergic link". The cholinergic link 
hypothesis has been included in recent reviews (Burn 1966, 
Ferry 1966, Karczmar 1967, Marczynski 1967). 
Karczmar (1967) pointed out evidence obtained by the 
use of anticholinesterases for a cholinergic link but 
limited most of his comments ~o the peripheral nervous 
system. Burn (1968) suggested that if acetylcholine was 
released by the stimulation of postganglionic sympathetic 
nerve stimulation and in turn released NE, then anticholin-
esterases should enhance the observed responses. Further-
more, anticholinesterases should reveal a greater facilita-
tion of response at low frequencies of stimulation than at 
high ones, since the low frequency of stimulation would 
permit more opportunity for AChE-hydrolysis of ACh. The 
following evidence was presented by Burn (1968): Eserine 
increased the response of the atropinized cat nictitating 
membrane by 51 per cent at stimulation frequencies of 1 c/s, 
by 8 per cent at 10 c/s, and by 2 per cent at 20 c/s; con-
....... 
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tractions of the atropinized taenia of the guinea pig was 
similarly affected; stimulation of the sympathetic fibers 
to the isolated rabbit nerve-heart preparation showed an 
enhanced chronotropic response to the administration of 
Eserine in the presence of atropine; results with contrac-
tion of the dog rectractor penis muscle preparation showed 
a greater enhancement of contraction at low frequency 
stimulation than at high, after the administration of 
Eserine in the presence of atropine; reduction of femoral 
arterial blood flow following.sympathetic nerve stimulation 
was enhanced by the administration of Eserine in the 
atropinized dog and low frequency stimulation was affected 
more than high; rabbit ear vasoconstriction was similarly 
enhanced by Eserine in the absence of atropine; and finally, 
renal blood flow, following sympathetic nerve stimulation, 
reflected greater vasoconstriction in presence of Eserine 
at stimulation frequencies of 1/sec than at 10 per sec. 
Hemicholinium reversed these responses and choline antag-
onized the effect of hemicholinium. In addition, hemi-
cholinium has been shown to block the response to stimula-
tion of postganglionic fibers in cat atria, guinea pig 
colon, rabbit ear vessels, and cat spleen, all of which 
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could be reversed by the administration of choline. Finally, 
botulinum toxin has been shown to block the response of cat 
tail pilomotor muscle to sympathetic stimulation (cited in 
Burn 1968). 
Ferry (1966) reviewed the cholinergic link concept and 
concluded that the evidence was not strong enough to support 
the hypothesis. He pointed out that while the presence of 
ACh had been shown to result in the release of NE from the 
spleen, antidromic impulses could have been initiated in 
the "c" fibers. These antidromic impulses would pass up the 
splenic nerve to then act as a postganglionic stimulant 
which resulted in the passage of impulses back down the 
splenic postganglionic nerve and the release of NE at the 
nerve ending. In other words, ACh first stimulated post-
ganglionic fibers which in turn released NE. Electron-
microscopic investigations of Thoenen et al. (1966) revealed 
that the spleen of the cat showed only adrenergic nerve 
endings on the basis of osmiophillic granules that were 
observed, while the vas deferens of the guinea pig showed 
both adrenergic and cholinergic elements lying membrane to 
membrane and encased in the same Schwann cell. They studied 
the effect of anticholinesterases on sympathetic nerve 
stimulation and ACh injection in the perfused spleen of 
the cat and found no change to nerve stimulation but an 
enhanced response to injected ACh. It was concluded that 
while the Burn-Rand Hypothesis may apply in some cases it 
should not be assumed to apply in all cases. Karczmar 
(1967) also pointed out that the cholinergic link concept 
may not apply to all species particularly in view of the 
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evidence of Koelle that some sympathetic tracts of the cat 
histochemically demonstrate very little ChE as compared to 
the rabbit. Boura and Green (1965) suggested that the 
effects of the xylocholine and bretyllium were poor evidence 
in support of the cholinergic link since their duration of 
action was so brief in comparison with other adrenergic 
neuron blocking drugs. They pointed out that the contrac-
tion of the cat nictitating membrane to stimulation of the 
sympathetic nerve was not effectively blocked by hemi-
cholinium but was blocked by adrenergic neuron blocking 
drugs. The histochemical data of Koelle would support this 
observation (vide supra). Birmingham (1966) interpreted 
the results of his experimental data to mean that a cholin-
ergic link was not required to evoke a response in the post-
ganglionic adrenergic nerve following preganglionic stimula-
tion. He concluded that anticholinesterase enhancement of 
guinea pig vas deferens response could be explained by 
alternative mechanisms. One suggestion was a purely 
cholinergic sequence of events involving postganglionic 
nerves and muscarinic smooth muscle receptors, while the 
other interpretation was a cholinergic mechanism with the 
preganglionic cholinergic nerves increasing the release of 
postganglionic NE. 
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Histochemical evidence has been put forward by 
Jacobowitz (1965) and Jacobowitz and Koelle (1965). Their 
studies have shown the existence of AChE and catecholamine 
fluorescence in the same nerve trunk, the guinea pig vas 
deferens. Koelle's Percussive Theory was invoked to explain 
the existence of presynaptic AChE in the ganglion (Koelle 
1961, 1962). Rand and Wilson (1967) noted that bretylium 
and guanethidine antagonized the effects of ACh on the 
rabbit colon, responses to sympathetic and parasympathetic 
stimulation; blocked the response to vagal stimulation of 
rabbit atria; and blocked the effects of ACh on guinea pig 
ileum, rat bladder, and chick biventer cervicis muscle. 
They interpreted their results as being in agreement with 
a cholinergic link hypothesis. Varagid et al. (1962) and 
Varagic and Krstic (1966) noted that the hypertensive 
response to Eserine seen in rats was blocked by reserpine, 
and lateral hypothalamic lesions. They concluded that the 
hypertensive response to Eserine was mediated via the CNS. 
Kaul and Grewal (1968) observed that Eserine increased the 
catecholamine output of the adrenals of rats by a factor 
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of 3 to 4 times and that this effect was not seen in pithed 
animals. They concluded that peripheral release of cate-
cholamines played little role in the hypertensive response 
to Eserine seen in rats. This conclusion was strengthened 
by their observation that adrenalectomy failed to decrease 
Eserine-induced hypertension and if anything increased it. 
Guth and Amaro (1969) suggested a possible cholinergic link 
in olivocochlear inhibition since atropine and nicotinic 
blocking agents failed to antagonize the blockade while 
hemicholinium was effective. Choline reversed the hemi-
cholinium antagonism of inhibition of VIIIth nerve action 
potentials. 
Van Meter and Karczmar (1967) proposed that the Eserine 
attenuation of thalamocortical recruitment was dependent on 
endogenous catecholamines in the CNS. In the presence of 
amines depleted by reserpine or aMPT, Eserine failed to 
attenuate recruitment while MAOI plus DOPA restored brain 
biogenic amines and also restored the effectiveness of 
--
Eserine as a blocker of thalamocortical recruitment. It 
was concluded that an "adrenergic link" was involved in 
the Eserine antagonism of recruitment. 
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At about the same time, Marczynski (1967) expressed 
the opinion that some of the CNS responses of Eserine might 
be explained by the Burn-Rand Hypothesis. He pointed out 
that the optimal frequency for thalamocortical recruitment 
(5-7 c/s) had been shown to produce maximal release of ACh 
from the caudate. Therefore, the inhibitory "Caudate Loop" 
as proposed by Heuser et al. (1961) and the studies of 
Buchwald (1961) could well be the site of the "adrenergic 
link" for the anticholinesterase induced antagonism of 
thalamocortical recruitment as seen in the present studies. 
Tremorine, a muscarinic agonist has been shown to 
evoke a release of brain catecholamines (Friedman and Anton 
1967), and to antagonize reserpine or chlorpromazine 
induced sedation in rabbits (Leslie 1965). George et al. 
(1966) have shown that the active metabolite of tremorine, 
oxotremorine, induced tremor following microinjection into 
pontomedullary sites of the rat brain. Other sites of 
action were proposed and included the basal forebrain area. 
All effects were antagonized by atropine. On the other hand, 
........ 
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connor et al. (1967) have noted that intracaudate injection 
of carbachol induced tremor which was antagonized by the 
subsequent administration of catecholamines into the caudate 
nucleus. Alpha agonists and blockers were without signifi-
cant effects while beta agonists antagonized carbachol 
tremor and beta blockers inhibited that antagonism. In 
addition intracaudate administration of ATP blocked the 
tremor and thus indicated a beta "metabolic'' effect. The 
authors concluded that a neurohumoral balance was necessary 
in the caudate for the regulation of physiological tremor. 
In other words, a cholinergic-adrenergic balance. 
Interactions between cholinergic and adrenergic mecha-
nisms in the CNS have been implicated in a series of studies. 
Longo (1956) noted that while atropine and scopolamine 
failed to antagonize the neurovegetative responses to direct 
electrical stimulation of the hypothalamus, EEG arousal was 
antagonized. White and Daigneault (1959) observed that 
atropine could block the EEG desynchronization resulting from 
brain stem lesions, from cholinomimetic agonists and from 
adrenomimetic agonists. They concluded that the same area 
of the brain stem was involved in EEG desynchronization 
evoked by cholinergic or adrenergic stimulation. Later 
-studies have shown that Eserine antagonized alpha blockade 
(White et al. 1965). Malcolm et al. (1967) have shown 
an interrelationship between cholinergic and adrenergic 
mechanisms at the level of the cerebral cortex. They 
interpreted their data to represent a scheme similar to 
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that proposed by Eccles and Libet for the superior cervical 
ganglion of the rabbit (cited in Eccles 1964). That is, that 
the adrenergic "P" wave acted as a modulator to decrease 
sensitivity. Cuculic et al. (1968) studied the action of 
drugs applied to the cortices.of rabbits and observed that 
cholinolytic agents applied to the cortex blocked desyn-
chronization evoked by peripheral stimulation, and by intra-
venous anticholinesterases, or amphetamine. These workers 
suggested that the final corticopetal link in EEG desyn-
chronization was located near the cortical surface and was 
cholinergic in nature. 
Jouvet (1967) proposed that paradoxical sleep was 
mediated by NE. Microinjection of oxotremorine or carbachol 
into the ponto-mesencephalic reticular formation also in-
duced paradoxical sleep and this was antagonized by atropine 
sulfate (George et al. 1964). Ledebur and Tissot (1966) 
induced paradoxical sleep by the administration of DOPA into 
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the bulbo-pontine reticular substance, while 5 hydroxytryp-
tophan induced either a synchronized or a desynchronized 
EEG when it was given locally into the sleep centers of 
"Moruzzi" or of "Jouvet". Post-pontine transection of the 
medulla of rabbits resulted in an EEG arousal and Bueno et 
~· (1968a) proposed the existence of a synchronizing center 
in the lower brainstem. Precollicular decerebration of cats 
induced the random appearance of paradoxical sleep 
(Matsuzaki et al. 1967). The administration of Eserine 
evoked episodes of paradoxical sleep and atropine sulfate, 
but not atropine methyl nitrate, was an effective antagonist. 
Sterman et al. (1965) had observed that slow wave sleep 
and paradoxical sleep showed circadian patterns. Reis et al. 
(1968) found circadian rhythm of NE concentrations to exist 
regionally in cat brain. A comparison of these two studies 
showed that peaks of NE concentration occurred in the 
superior colliculi, pons and substantia nigra that coincided 
with the paradoxical sleep patterns. 
The study of the effects of intravenously administered 
NE, EPI, or DA in the CNS is limited because of the BBB 
(Weil-Malherbe 1961). The administration of a MAOI plus 
L-DOPA promotes the synthesis of these catecholamines and 
their effects on the CNS can be observed (Everett 1961). 
Depletion of brain biogenic amines can be accomplished by 
the administration of tetrabenazine (Quinn et al. 1959), 
reserpine (Costa et al. 1962), or inhibition of synthesis 
by CMPT (Spector et al. 1965). 
Hemicholinium (HC-3) has been shown to alter the syn-
thesis of ACh by decreasing the availability of choline 
156 
with a resulting depletion of transmitter. Stitzel et al. 
(1965) evaluated the effect of HC-3 on catecholamine-
depleting actions of reserpine and other drugs. They re-
ported that HC-3 had no effect on the depletion of catechol-
amines from the CNS but did alter the release from adrenal 
medulla. Their conclusion was that HC-3 had no effect on the 
release of NE from the brain. However, no considerations 
of the BBB were made and there was absence of controls on 
ACh levels in the brain in the presence of HC-3. Domino et 
al. (1968) found that HC-3 had little effect and was un-
predictable when given intravenously in amounts of 5-10 mg/ 
Kg as compared to the 10 mcgm/Kg dose reported by Stitzel 
et al. (1965). 
Frazier et al. (1969) applied HC-3 to the inside of squid 
axons, blocked the action potential and could not reverse 
the block by giving choline. They concluded that HC-3 
antagonized the early transient and late steady state com-
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ponents of the membrane ionic conductances. In other words, 
they proposed that the effect of HC-3 was on membrane con-
ductances rather than a cholinergic mechanism. 
Nicotinic stimulation of the CNS is dependent on the 
dose of alkaloid being used. Nicotine per~ in repeated 
low doses of 2 mcgm/Kg i.v. over a period of 20 minutes has 
been reported to evoke an electrocortical arousal with an 
increase release of ACh, while higher doses reversed this 
effect and induced a sleep pattern with a decreased ACh 
release (Armitage et al. 19691. Longo et al. (1967) had 
found a species variability in response to nicotine. EEG 
convulsions were evoked in rabbits, guinea pigs, and rats 
but not in cats. Cats revealed only motor convulsions and 
not EEG paroxysms. Mecamylamine was a more effective 
antagonist of the nicotinic actions of both nicotine and 
arecoline than was dihydro beta-erythroidine. Westfall et 
al. (1967) concluded that nicotine released NE in the CNS 
and noted that DA concentrations were also down 30 minutes 
after injection. However, Domino (1967) pointed out that 
nicotine also released ACh, serotonin, and vasopressin in 
addition to the release of catecholamines in the CNS. He 
noted that a low dose of nicotine evoked an EEG desyn-
chronization that correlated with a behavioral arousal but 
--
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felt that actions of nicotine were too wide spread and that 
it was a poor drug of choice for determination of specific 
effects. 
While the concept of steady state synthesis rate of 
NE (Brodie et al. 1966a) has proved useful in evaluation of 
catecholamine action in the CNS, the determination of 
synthesis rates must be viewed with some caution. Thoenen 
et al. (1969) have found that tyrosine hydroxylase activity 
--
after the administration of drugs could be increased. Phe-
noxybenzamine administration s.howed an increased NE synthesis 
which they attributed to an increased membrane transport of 
tyrosine and not due to increased enzyme activity. Nerve 
stimulation also evoked the same response, and according to 
Thoenen et al. two mechanisms could be involved, (1) rapid 
regulation by end product inhibition, tyrosine transport and 
cofactor concentrations and (2) increased enzyme activity 
due to an increased amount of enzyme protein, which would 
require several hours before an increased enzyme activity 
appeared. 
Finally, the adrenergic mechanisms in the CNS have 
been chiefly concerned with DA and NE but recently evidence 
has been presented that suggests the synthesis of EPI in the 
CNS (Ciaranello et al. 1969 and Pohorecky et al. 1969). If 
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these results are accurate~ the response of the EEG to the 
administration of alpha blockers such as chlorpromazine and 
phenoxybenzamine could be explained on the basis of an un-
masked beta effect and additional considerations for the 
role of EPI and the proposed beta receptor cyclic 3'5' 
adenosine monophosphate must now be considered for the 
central nervous system as well (Robison et al. 1967 cited 
in Burn 1968). 
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II. METHODS AND MATERIALS 
A. GENERAL 
The experimental subjects and their maintenance was the 
same as described in Part I. In cases where chronic drug 
administration was indicated the animals were dosed in their 
cages in the animal quarters and were brought to the 
laboratory on the day of the experimental recording. 
B. PHYSIOLOGICAL 
1. Electroencephalography 
> 
EEG recordings were obtained from the animals as described 
in Part I. 
2. Evoked Potentials 
Thalamocortical recruited potentials were evoked by 
electrical stimulation of the anterior dorsal nuclei of 
the thalamus. Square wave pulses were delivered from Tek-
tronix type 161 and 162 pulse and waveform generator com-
binations (see appendix B) and were monitored by CRO. Stirn-
ulus artifact was attenuated by means of a Bioelectric ISA 
stimulus isolation unit. Stimulus parameters consisted of a 
frequency of 8.o-8.5 c/s at durations of l.O msec or less. 
Threshold voltages varied from animal to animal, as well as, 
from that required during a synchronized background of EEG 
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activity compared with that required during a background 
of desynchronized EEG potentials. A stimulus voltage was 
determined that was sufficient to evoke recruitment during 
EEG alert tracings induced by peripheral alerting stimuli 
(see Part I), or even by direct electrical stimulation of 
the reticular substance. Stimulus parameters for reticular 
formation stimulation were 200 c/s, 0.2 msec, for 5-10 
seconds. The voltage that was adequate to evoke recruit-
ment during a period of EEG desynchronization was referred 
to as suprathreshold. The recruited potentials were re-
corded from the cortices and with the EEG were displayed on 
a Grass Model IIID electroencephalograph. In addition, 
recruitment was amplified and monitored by CRO. The 
experimental animals received no anesthesia except for 2% 
procaine applied to the wound sites. Restriction of move-
ment was obtained by use of the animal restraining board 
fitted with a headholder as described in Part I. Electrode 
placement was verified as before (see Part I). Either 
arterial blood pressure (femoral artery) or heart rate 
was monitored with the EEG tracings. 
Integrator analysis of recruited potentials was ob-
tained by a relay controlled integration unit (see appendix 
B). The integrator was normally off except during the 
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stimulation and was triggered by the stimulator just prior 
to the appearance of the stimulus train at the electrode. 
The CRO sweep was also triggered in the same manner. In 
the case of data integration, the stimuli were presented 
for a period of two seconds which was adequate for show-
ing the rising phase and the peak amplitude of the recruit-
ed potentials. Data from one channel was selected for ana-
lysis by this method and the selection of the channel was 
based on control observations from the leads exhibiting the 
most evident thalamocortical recruitment. Responses to the 
various drugs were evident and attempts to quantify them 
were not necessary. During any given observation period, 
the stimuli were presented once every 10 seconds for a 
period of 2 seconds. 
Supra threshold voltages for evoking recrui tment··were 
kept constant in any given experiment for the pre- and 
post-drug conditions. 
C. HISTOLOGICAL 
1. Thionin and Eosin Staining Procedure 
The general staining procedure as outlined in Part I 
and appendix A was used to verify electrode placement. 
Also, electrode tracts were identified during the section-
ing procedure that was carried out in the cryostat as 
described in Part I. 
D. BIOCHEMICAL 
1. Fluorometric 
Determination of norepinephrine (NE) levels was made 
by the method of Shore and Olin (1958) and is outlined in 
appendix B. The following brain parts of each of 54 
animals were used: (1) cerebral cortex, (2) hippocampus, 
(3) cerebellum, (4) midbrain, and (5) medulla-pons. Animals 
were sacrificed either by air embolism or by decapitation. 
Control samples included untr~ated rabbits not subjected 
to other experimental procedures; as well as animals sub-
jected to the experimental procedures excluding electrical 
stimulation and drugs. Determinations were also made in 
animals subjected to depletion of brain NE by reserpine or 
alpha methyl para-tyrosine, as well as animals in which NE 
levels had been raised by the administration of MAOI and 
L-DOPA (vide infra) (see Tables II and III). 
E. PHARMACOLOGICAL 
1. Drugs and Dosages 
Brain catecholamines were depleted by the administration 
of reserpine (2.0 mg/Kg i.v.) daily for two days prior to 
the recording day (Table III). Inhibition of synthesis at 
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the tyrosine hydroxylase step was also used as a specific 
method of lowering brain levels of NE. Alpha methyl para-
tyrosine (200 mg/Kg i.p.) was given as a liquid suspension 
in tragacanth for two days preceding the recording day 
(Table III, cf. Table II, and cf. Spector et al. (1965). 
Following depletion of catecholamines, the tissue levels 
in the brain were restored by the administration of 
pargyline (12.5 mg/Kg i.v.) given one hour prior to the 
injection of L-DOPA (100 mg/Kg i.p.). In addition, normal 
tissue levels of brain biogen~c amines could be raised by 
the combination of the monoamine oxidase inhibitor and 
L-DOPA (Table III, cf. Everett 1961). 
Eserine salicylate was given intravenously in amounts 
of l00.0-150.0 mcgm/Kg This dose range was found to be 
adequate to evoke an EEG arousal and to markedly attenuate 
or block recruitment in control animals (fig. 34). 
Similarly, doses of (0.5-1.0 mg/Kg i.v.) DFP and 10.0-15.0 
mcgm/Kg i.v. of sarin were found to be adequate in 
eliciting the above effects. These anticholinesterases were 
given to animals with modified tissue levels of NE. NE 
concentrations in the brain were modified by: (1) reserpine 
or alpha methyl para-tyrosine induced depletion, (2) deple-
tion followed by the restoration of NE concentrations 
induced by the combination of pargyline and L-DOPA, and 
(3) by the combination of pargyline and L-DOPA without 
prior depletion of biogenic amines. 
EEG tracings were made routinely and thalamocortical 
recruitment was evoked during control periods, in the presence 
of physostigmine, of DFP, and of sarin. These electro-
physiological recordings were also obtained during con-
ditions of NE depletion, as well as after the restoration 
of depleted NE. AntiChE's were administered in the presence 
of these altered states of br~in NE concentrations. Tissue 
levels of brain NE were monitored in each case and these, 
along with the EEG and recruitment data, were correlated 
with the pharmacological procedures (Table III). 
D(-) - INPEA, (D(-)-l-(4 1Nitrophenyl)-2-isopropylamino-
ethanol HCl) was administered to evaluate the effects of 
beta adrenergic blockade on EEG activity and on thalamo-
cortical recruitment. Alpha adrenergic blockade was achieved 
by intravenous phenoxybenzamine (5.0 mg/Kg). Eserine (100 
mcgm/Kg i.v.) was selected to evaluate antagonism of the 
EEG effects of the blockade of adrenergic receptors by an 
anticholinesterase. Thalamocortical recruitment was also 
evaluated in the presence of alpha blockade and in the 
presence of subsequent antagonism by an anticholinesterase. 
Gross behavioral observations of the animals in their 
cages were made prior to the electrophysiological or bio-
chemical observations in order that central and autonomic 
nervous system activity could be evaluated. Criteria 
used were (1) pupillary diameter, (2) GI tract activity 
(defecation), and (3) the general motor activity of the 
experimental animals compared to control subjects or to 
their own premedication activity. 
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III. RESULTS 
A. CONTROL OBSERVATIONS 
1. Histological 
The results of the thionin and eosin staining procedure 
are presented in Part I together with the designation of 
the sites used for stimulation of the brain and for re-
cording. 
2. Biochemical 
Norepinephrine concentrations from the brains of 5 
control animals are presented in Table II. These values 
served as a reference for brain NE concentrations in un-
treated animals (see Table III). 
Inhibition of synthesis with alpha methyl para-tyrosine 
showed a progressive decrease in NE concentration in rabbits 
sacrificed at 4, 16, and 24 hours after the drug (Table II). 
These values served as a reference for rabbit brain NE 
depletion by alpha methyl para-tyrosine in subsequent studies 
(see Table III). 
Table II shows that reserpine induced a rapid fall in 
brain NE at 4 hours and that this degree of depletion was 
maintained in animals sacrificed at 16 and 24 hours after 
injection. These values served as a reference for brain NE 
TABLE II. CONTROL BRAIN NE CONCENTRATIONSa 
Time Brain Site 
(Hours) Cortex ·· Hippocampus Mi db rain Medulla Poffs - -Cerebellum 
0:00 
(N=5) 238 (±105) 469 (±130) 360 (± 81) 505 (±135) 235 (±56) 
Reserpine (2.0 m~/K~. i.v.~ 
4:00 
(N=3) 89 (± 7) 122 (± 54) 73 (± 94) 133 ( ± 31) 106 (±23) 
16:00 
(N=3) 87 (± 24) 154 (± 34) 93 ( ± 30) 105 (± 8) 199 (± 6) 
24:00 
(N=3) 53 (± 25) 66 (± 28) 56 ( ± 18) 62 ( ± 24) 65 (±55) 
aMPT (200 mg/K~. i.p.~ 
4:00 
(N=3) 54 (± 47) 267 (±154) 191 ( ±142) 209 ( ±164) 106 (±89) 
16:00 
(N=3) 48 (± 33) 99 (± 8) 70 ( ± 16) 126 (± 36) 76 (±33) 
24:00 
(N=3) 25 (± 1) 61 (± 17) 62 (± 17) 33 ( ± 19) 33 (± 1) 1--J 
m 
a ()) Expressed as ng/Gm tissue 
depleted by reserpine in subsequent studied (see Table III). 
3. Electrophysiological 
Control EEG patterns and responses to stimuli were the 
same as described in Part I. In addition, thalamocortical 
recruitment was evoked during a background of synchronized 
and desynchronized EEG activity (figs. 32 and 33). Presen-
tation of the stimuli is indicated in the figures and the 
parameters of stimulation are stated in Methods and 
Materials (vide supra). 
B. EXPERIMENTAL OBSERVATIOES 
1. Biochemical 
Table III reveals that reserpine markedly depleted 
brain NE concentrations while reserpine treatment followed 
by pargyline and L-DOPA restored these concentrations towards 
control levels. Alpha methyl para-tyrosine, also markedly 
depleted brain NE and this was likewise restored by the 
combination of monoamineoxidase inhibitor and L-DOPA. 
Finally, the MAOI and L-DOPA treatment resulted in an in-
crease in brain NE. 
2. Electrophysiology 
The administration of physostigmine (150.0 mcgm/Kg 
i.v.) was followed by a period of approximately 2 minutes 
of continuous slow wave EEG sleep. An uninterrupted 
desynchronized EEG pattern followed and maximal intensity 
appeared at about 5 minutes after the injection. During 
the period of maximal intensity of EEG desynchronization, 
the supra-threshold stimulus of the pre-drug state failed 
170 
to evoke a response and the recruited potentials were 
attenuated (fig. 27, Part I). During the recovery from 
Eserine (100 mcgm/Kg i.v.) recruitment reappeared while the 
EEG was still desynchronized (fig. 35). EEG tracings re-
sumed pre-drug characteristiQs after 30-40 minutes. DFP, 
on the other hand, elicited a desynchronized EEG pattern 
that endured for more than 2 hours during which time re-
cruitment was attenuated (fig. 36). Scopolamine (100 mcgm/ 
Kg i.v.) readily antagonized both the EEG desynchroniza-
tion (fig. 37) and the attenuation of recruitment (fig. 38) 
evoked by DFP. Chlorpromazine was also an effective 
antagonist (fig. 39). Atropine sulfate (3.0 mg/Kg i.v.) 
induced a slow wave EEG sleep pattern but did not alter 
recruitment as is seen in figure 40. However, the adminis-
tration of sarin (15 mcgm/Kg i.v.) after that dose of 
atropine resulted in an EEG alert pattern and attenuated 
recruitment (fig. 41). 
Figure 32 
I RECRUITMENT - SYNCHRONIZED EEG 
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Control Thalamo-Cortical Recruitment: Thalamo-cortical recruitment evoked during 
a period of synchronized EEG activity. Note the waxing and waning of the potentials 
during the period of stimulation (arrows) 
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Figure 33 
RECRUITMENT-DESYNCHRONISED EEG 
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Control Thalamo-Cortical Recruitment: Thalamo-cortical recruitment evoked during 
a period of EEG activity that is desynchronous or alert. The waxing and waning 
of the recruited potentials appears during the period of stimulus application 
(bet~\een arrows) and is elicited by the same stimulation parameters as seen in 
the co~trol thalamo-cortical recruitment during a period of synchronized EEG 
activity. 
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TABLE III. CORRELATION OF PHARMACOLOGICAL, BIOCHEMICAL AND ELECTROPHYSIOLOGICAL 
DATA 
Pharma- NE Brain Concentrations 1 EEG Pattern Recruitment 
cologicaJ with 
Procedure CTX HPC MB MP CBL Eserine 
Control Synchronized Attenuated 
(N=6) 231(±94) 468(±118) 348(±73) 496(±123) 233(±51) Desynchronized 
Reserpine 
(N=5) 55(±20) 64(± 21) 38(±14) 83(± 37) 83(±43) Synchronized Present 
Reserpine 
followed 
by MAOI & Present 
L-DOPA followed by 
(N=5) 160(±39) 335(± 31) 233(±27) 347(± 41) 146(±21) Desynchronized Attenuation 
aMPT 
(N=5) 36(±17) 48(± 11) 63(±17) 36(± 14) 47(±14) Synchronized Present 
aMPT 
followed 
by MAOI & Present 
L-DOPA followed by (N=5) 142(±36) 333(± 31) 246(±36) 406(± 34) 156( ±33) Desynchronized Attenuation 
MAOI & 
L-DOPA 
(N=5) 306(±61) 603(±174) 609(±40) 604(±140) 239(±io7 Desynchronized Attenuated 
1 Expressed as ng/Gm tissue I-' 
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Legend for Table III 
Surrunary Correlation of Pharmacological, Biochemical and 
Electrophysiological Data: The table represents experiments 
in which pharmacological, biochemical, and electrophysiolog-
ical data were correlated. The left side of the table 
represents the pharmacological procedure used to alter brain 
levels of catecholamines and in particular, norepinephrine. 
The values of brain tissue concentrations are represented 
as pg/Gm tissue for the selected brain parts as shown in the 
table. The effect of Eserine on thalamo-cortical recruit-
ment in rows three and five is interpreted as meaning that 
the recruited potentials that were evoked in the presence of 
Eserine after depletion of norepinephrine by reserpine or 
alpha methyl para-tyrosine, were attenuated by Eserine after 
norepinephrine levels had been restored by the administra-
tion of MAOI and DOPA. See text for complete description. 

Figure 35 
RECOVERY OF RECRUITMENT PRIOR TO EEG AFTER ESERINE 
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Appearance of Recruitment Prior to a Synchronized EEG after Eserine: During the 
course of recovery following the administration of 100 mcgm/Kg i.v. of Eserine, 
recruited potentials can be evoked (arrows) while the EEG tracings are still 
desynchronized. The pressor response is still evident (see BP). Stimulus parameters 
as in the previous tracing. Tracings were made 20 minutes after injection. I-' 
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Figure 36 
DFP ANTAGONISM OF RECRUITMENT 
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Persistent EEG Desynchronization and Attenuation of Thalamo-Cortical Recruitment 
Induced by DFP: DFP (2.0 mg/Kg i.v.) administered approximately three hours prior 
to this tracing. Desynchronization of the EEG was evident at approximately three 
minutes after the injection and persisted. Recruitment was also attenuated for the 
same period of time. The stimulus applied between the arrows is 8.0 c/s, 0.9 msec, ~ 
. --:] 
and a voltage greater than the threshold. 
Figure 37 
SCOPOLAMINE ANTAGONISM OF DFP 
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Scopolamine Reversal of DFP Induced EEG Desynchronization: Scopolamine (100 
mcgm/Kg i.v.) antagonizes the EEG alert pattern elicited by the anticholinesterase 
and evokes a synchronized pattern. DFP (2.0 mg/Kg i.v.) two hours earlier and these 
tracings were made approximately twenty minutes after the injection of scopolamine. 
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Figure 38 
RECRUITMENT AFTER SCOPOLAMINE 
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Scopolamine Antagonism of DFP Fails to Alter Recruitment: Thalamo-cortical 
recruited potentials are readily evoked by the same stimulus parameters as used 
earlier (arrows). These tracings were made 5 minutes after those seen in figure 37. 
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Figure 39 
ESERINE ATTENUATION OF RECRUITMENT ANTAGONIZED 
BY CHLORPROMAZINE 
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Legend for Figure 39 
f_hlorpromazine Reversal of Eserine Desynchronization and 
Blockade of Recruitment: Chlorpromazine (2.0 mg/Kg i.v.) 
administered two minutes after the intravenous administration 
of Eserine (100 mcgm/Kg i.v.) prevents the EEG alert pattern 
and antagonizes the depression of recruitment seen at this 
dose of the anticholinesterase. Stimulation was applied 
between the arrows and stimulus values are 8.0 c/s, 0.8 msec 
and a voltage greater than threshold. A previous dose of 
Eserine had been administered as a control and was effective 
in desynchronizing the EEG and in attenuating the thalamo-
cortical recruited potentials. This figure was taken at 
eight minutes after the injection of Eserine. 
Figure 40 
RECRUITMENT IN PRESENCE OF ATROPINE 
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Failure of Atropine to Block Recruitment: Atropine sulfate (3.0 mg/Kg i.v,) fails 
to markedly attenuate the thalamo-cortical recruited potentials presented between 
the arrows. St irnulus parameters are 8. 0 c/s, 0. 6 msec with a voltage greater than 
threshold. Tracings were made 20 minutes after the atropine had been given. 
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Figure 41 
SARIN ATTENUATION OF RECRUITMENT PRECEDED BY 
ATROPINE 
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Sarin Reverses Atropine EEG Sleep and Attenuates Recruitment: 
IOOµV L-
sec 
Sarin (15.0 mcgm/Kg 
i.v.) given subsequent to the atropine from the previous record reverses the atropine 
induced synchronization and elicits a persistent desynchronized pattern. Note that 
thalamic stimulation to evoke cortical recruitment, with the same stimulus values, 
is markedly attenuated. The stimuli were effected between the arrows. Tracings 
were made 15 minutes after the injection of sarin. 
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Figure 42 
CHRONIC RESERPINE CONTROL EEG 
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Note the Rabbit EEG after Two Days Pretreatment with Reserpine 2.0 mg/Kg per Day: 
predominant slow wave sleep pattern apparent in all leads, with random 8-14 c/s 
EEG sleep spindles. Catecholamines are at markedly low levels (cf. Table III). 
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RECRUITMENT AFTER RESERPINE DEPLETION OF NE 
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Recruitment in the Chronically Reserpinized Rabbit: Thalamo-cortical recruitment 
is evoked (channel 3, RAC-OC) by stimulation of the thalamic nuclei 8.0 c/s, 0.9 
msec at a voltage greater than threshold (arrows). Note the synchronized EEG 
background activity (cf. Table for depleted levels of norepinephrine). 
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Figure 44 
RECRUITMENT AFTER ESERINE WITH CATECHOLAMt£ DEPLETION •A• 
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Effect of Eserine on Chronically Reserpinized Rabbit: (cont) Eserine 100 mcgm/Kg. 
1.v. fails to attenuate the recruited thalamo-cortical potentials approximately 
eight minutes after the administration of the anticholinesterase. A decrease in 
recruitment was not observed at this dose. Note the desynchronized EEG pattern. 
The stimulus was 7.5 c/s, 0.8 msec, at voltages greater than threshold and was 
applied as indicated by the arrows. 
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Figure 45 
RECRUITMENT AFTER ESERINE wmt CATECHOLAMtilE DEPLETION •e• 
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Effect of Eserine on Chronically Reserpinized Rabbit: (cont) Eserine 200 mcgm/Kg 
i.v. fails to alter the recruited thalamo-cortical potentials at approximately 
eight minutes after the administration of the cholinesterase inhibitor. Stimulus 
parameters as in the previous figure. This figure represents data from the same 
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Figure 46 
RECRUITMENT AFTER DFP WITH DEPLETION OF CATECHOLAMINES 
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Effect of DFP on Chronically Reserpinized Rabbit: DFP 2.0 mg/Kg i.v. fails to 
alter the recruited potentials after two days of reserpine pretreatment. Stimulus 
parameters are the same as in the previous figures. The desynchronous EEG pattern 
was persistent for greater than two hours. This figure was taken at ten minutes 
after the administration of the anticholinesterase. 
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Figure 47 
RECRUITMENT IN PRESENCE OF MAOI 
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Pargyline Fails to Block Recruitment: Pargyline 12.5 mg/Kg i.v. fails to attenuate 
the recruited potentials at 40 minutes after injection. Stimulus unaltered from the 
previous figure and was presented between the arrows. Note the artifact on the right 
side of the tracings due to movement of the unanesthetized animal. 
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Figure 48 
ESERINE ATTENUATION OF RECRUITMENT AFTER 
MAOI AND DOPA 
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Legend for Figure 48 
Effect of Eserine with Restored Catecholamines: Eserine 
100 mcgm/Kg i.v. is effective in attenuation of recruitment 
in the chronically reserpinized rabbit after the catechol-
amine stores have been restored by the administration of 
pargyline and DOPA {100 mg/Kg i.v.). The norepinephrine 
precursor was given 40 minutes prior to the administration 
of the anticholinesterase. The figure was taken at approxi-
mately eight minutes after the administration of Eserine. 
Stimulus parameters are unchanged from the previous figures 
and are presented as indicated by the arrows in the figure 
(cf. norepinephrine values in brain tissue Table III). 
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EEG AFTER aMPT INHIBITED SYNTHESIS OF NE 
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EEG Activity in Presence of Low Levels of Norepinephrine: The ongoing EEG activity 
of the rabbit after markedly low levels of norepinephrine are established following 
the administration of alpha methyl para tyrosine. Note the slow wave EEG sleep 
pattern with 8-14 c/s activity but this can be interrupted by a sound stimulus 
resulting in a desynchronization (left center of figure) of the tracings. 
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Figure 50 
RECRUITMENT AFTER oMPT INHIBITED SYNTHESIS OF NE 
RF-BOA~W,~eU,,\J.J'.tltr NW"/v."1 1,. ,,.~ ''1-1'""' •·w~~,w-, -'v'fl'r"'''v-.,,.,.,_~,.,...,..~.,-, .. ,;,,., A ,~.,.,,'/Vv......,..,.Jw"<.•,,.,-.....,._~ L-RPC-~1~~l',, ·,·,·,',,.'' ,,,,·:, ~
, RAc-oc-vv-vv~vWv0JJ)M!i})J;W~ /\JJJ j/v'.J1UJJJJ)JJ1,UJJJJJJ,IJJJJJ))Jv'J)J)JJJJJJJJJJ.JJJJPf~\,~~~~ 
' LH-80A~..,,,~~t;vlljrl~~W0Mt[fi.J~#'.flV<'\J.~ri\J!fl~4i-A ijt~l!"/A.ill,.!;:\~·~~l+'~~~'t.vi'-l1~~·~~~v,·~,.1A.,.;~L"i0~~·~ 
: I 1Y1 I l I I j j 1 l I I j I I I t I i '. i ~l 1 I t l , . 111 ! I I I 11 I It I I l I I ~ I I I I I I I l I I' ' I I ! i t l I t ! \I It l t 
: • lA .M A /\ • lJ1 
. RH-RF-·•·'f"'.l"V'..J-.. rvhvvv"'v'!Y.t-f'i/11v.f1µJ..>,~.;.,.v· V \.fl,,J ''''l\;.J~~~~ .. ) . J-~J .. /'.,,.\.;'.;.,,,,~,y,;\~/virJ1-.f'.tJ{/""'-..NN./\i'~ 
.... -~f ~(·J~W!11~Nl~1tW\~W/.M}J»»,\Ji\N¥.l,U.!,1,WA!.\f1J+H~~,\/-~,µ,1~~ 
EKG-~~-.J..-4-J..-J,.....J~-~-lv-·i--4.-J.--J.--t.-J,.....J~,---J._J~.~'ljli"~~"-!·;I~~_,~~~ 
1001..v._ __ 
sec 
Recruitment in the Presence of Low Levels of Norepinephrine: Cortical recruitment 
following stimulation of the thalamus is evident. Note the response in the lead 
from RAC-OC, as the cortical potentials wax and wane in a typical recruited pattern. 
The rabbit had received aMPT (200 mg/Kg i.p.) for two days prior to these tracings. 
See Table III for brain NE concentrations (cf. also Table II). 1-1 \,.() 
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Figure 51 
RECRUITMENT AFTER ESERINE WITH NE DEPLETION 
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Eserine Fails to Block Recruitment in the Presence of Depleted Norepinephrine: 
Physostigmine (100 mcgm/Kg i.v.) fails to attenuate the recruited cortical 
potentials while inducing a desynchronous EEG pattern (note, lead RAC-OC). 
Tracings were made 8.o minutes after the administration of Eserine. 
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Reserpine (2.0 mg/Kg/day i.v.) administered for two 
days evoked an EEG pattern that was predominantly slow wave 
sleep (fig. 42) and did not alter thalamocortical recruit-
ment (fig. 43). Eserine (100.0 mcgm/Kg i.v.) then failed 
to attenuate the evoked cortical response (fig. 44) and 
induced an EEG arousal pattern (cf. fig. 34). Doubling the 
dose of Eserine (200.0 mcgm/Kg i.v.) also failed to block 
the recruited potentials (fig. 45). Finally, DFP (fig. 46) 
as well was ineffective in antagonizing thalamocortical 
recruitment. However, restoDation of brain NE levels to 
control levels by the administration of a combination of 
MAOI and L-DOPA (figs. 47 and 48) did not alter recruited 
responses per ~, but the effectiveness of Eserine to 
attenuate recruitment was restored (fig. 48, cf. fig. 34). 
The chronic administration of alpha methyl para-
tyrosine resulted in the appearance of a predominantly slow 
wave EEG sleep pattern, during which time peripheral 
stimulation (see Part I), could evoke an arousal response 
(fig. 49). Recruitment was not attenuated by alpha methyl 
para-tyrosine (fig. 50), and Eserine (150 mcgm/Kg i.v.) 
failed to attenuate the evoked recruited potentials (fig. 
51). If brain NE levels were restored by the administra-
tion of pargyline and L-DOPA (Table III), Eserine was again 
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effective and attenuated the thalamocortical recruited 
potentials in the same manner as was seen in the reserpine 
sequence (vide supra) (cf. fig. 48). 
The results of the effects of increased brain NE on the 
Eserine induced attenuation of thalamocortical recruitment 
are shown in figures 52, 53, 54, and 55. Figure 52 reveals 
that 50.0 mcgm/Kg i.v. of Eserine was insufficient to 
antagonize recruitment. The evoked responses were most 
evident in channel number two (RAC-LN) and served as a 
control. Inhibition of MAO with pargyline (25 mg/Kg i.v.) 
failed to alter the effectiveness of this low dose of 
Eserine (fig. 53). However, L-DOPA, (100 mg/Kg i.p.) in 
combination with the MAOI, increased the effectiveness of 
the low dose of Eserine and the recruited potentials were 
attenuated (fig. 54, RAC-LN). Partial recovery of recruit-
ment occurred 40 minutes to one hour after the Eserine 
injection (fig. 55) at a time when NE levels were being in-
creased (cf. Table III). 
Adrenergic blockade affected EEG activity, thalamo-
cortical recruitment, and the effects of AntiChE's on these 
potentials as indicated in figures 56 through 65. Integra-
tion of the evoked potentials was carried out and control 
Figure 52 
RECRUITMENT WITH 50 mcgm I KQ ESERINE 
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Legend for Figure 52 
Low Dose of Eserine Elicits Desynchronization of EEG but 
Fails to Attenuate Recruitment: Eserine (50 mcgm/Kg i.v.) 
induces an EEG alert pattern but does not depress thalamo-
cortical recruitment. The stimulus is 8 c/s, 0.8 msec, 
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and a voltage greater than control. The stimulus is once 
every ten seconds for a duration of two seconds as indicated 
by the solid bars. Note the recruited potentials from the 
second channel (RAC-LN). This tracing was taken at approxi-
mately seven minutes after the administration of the 
cholinesterase inhibitor. 
Figure 53 
RECRUITMENT WITH 50 mcgm/Kg ESERINE 
IN PRESENCE OF MAOI 
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Pargyline Fails to Enhance the Effect of Eserine: 
I0011VL--11c 
Pargyline ( 25. 0 mg/Kg i. v.) 
given one hour prior to the administration of 50 mcgm/Kg of Eserine does not 
provoke a marked attenuation of recruitment at seven minutes after the administra-
tion of the latter drug. Stimuli are unchanged from the previous Figure 52 and 
are presented as indicated by the solid bars. 
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Figure 54 
ESERINE ATTENUATION OF RECRUITMENT 
IN PRESENCE OF MAOI 8 DOPA 
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Legend for Figure 54 
Increased Brain Level of Norepinephrine Enhances Effect 
of Eserine: DOPA (100 mg/Kg i.v.) administered one hour 
after pargyline and 40 minutes prior to the time of these 
tracings reveals an enhancement pf the effect of 50 mcgm/Kg 
i.v. of Eserine on the thalamo-cortical evoked recruitment 
at eight minutes after injection. While the potentials 
are still present, note the attenuation most evident in 
the second channel (RAC-LN). Note the movement artifacts 
appearing as slow wave excursions particularly in the first 
four channels. Stimulus is unaltered from the previous 
figure. 
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Figure 55 
PARTIAL RECOVERY OF RECRUITMENT AFTER 
ESERINE IN PRESENCE OF MAOI a DOPA 
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Decrease of Attenuation of Recruitment as the Duration of Action of Eserine Elapses: 
Forty minutes after the administration of 50 mcgm/Kg i.v. of Eserine the thalamo-
cortical recruited potentials begin to reappear (note channel 2 RAC-LN). Stimulus 
parameters are the same as previously shown in the preceding figures. 
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Figure 56 
CONTROL RECRUITMENT- SYNCHRONIZED EEG 
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Legend for Figure 56 
Integrator Analysis of Thalamo-Cortical Recruitment: Control 
period of thalamo-cortical recruitment on a background of 
synchronous EEG activity. Channel 2 {LAC-BOA) is being 
analysed by integration and the result appears in channel 7 
in this and in subsequent figur~s {INTGR.). Also, the dotted 
line has been drawn to indicate the peaks during the control 
period, and is the reference level in the subsequent figures 
utilizing integration analysis of recruited potentials. 
Stimulation parameters are: 8.0 c/s, 0.8 msec, for two 
seconds at a voltage greater than the threshold. The 
stimulus was presented once every ten seconds. Note the 
relative constancy of the amplitude of the response as 
reflected by the integrator. 
Figure 57 
CONTROL RECRUITMENT- DESYNCHRONIZED EEG 
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Integrator Analysis of Thalamo-Cortical Recruitment: Control period of thalamo-
cortical recruitment during a phase of desynchronous EEG activity. Note that 
the integrated response from channel 2 appears slightly greater than that seen 
during EEG sleep patterns. Stimulus parameters are as previously stated. 
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Figure 58 
ESERINE ANTAGONISM OF RECRUITMENT 
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INTGR. 
Drug Attenuation of Recruited Potentials: The effect of 100 mcgm/Kg i.v. of 
eserine on thalamo-cortical recruitment shows a marked attenuation of the 
integrated potentials. Control level is indicated by the dotted line. Stimula-
tion parameters as presented in the previous tracings. 
approximately 7.0 minutes after injection. 
Tracings were made 
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Figure 59 
ATROPINE METHYL NITRATE FAILS TO ALTER ESERINE 
ANTAGONISM OF RECRUITMENT 
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Eserine Attenuation of Recruitment in the Presence of Atropine Methyl Nitrate: 
Eserine (100 mcgm/Kg i.v.) markedly attenuates thalamo-cortical recruitment when 
given after the quaternary atropinic agent. 
data below the control levels (dotted line). 
from the previous recordings. 
Note the marked decrease of integrated 
Stimulus parameters are unchanged 
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Figure 60 
;(A) EFFECT OF PHENOXYBENZAMINE ON RECRUITMENT 
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Initial Effect of Phenoxybenzamine on EEG and Thalamo-Cortical Recruited Potentials: 
Phenoxybenzamine, 5.0 mg/Kg i.v. induces an initial transient EEG arousal lasting 
a few minutes that also attenuates the evoked thalamo-cortical recruitment response. 
The pre-drug control level of integrated signals is indicated by the dotted line. 
Stimulus parameters are 8.0 c/s, 0,8 msec, two seconds duration and the stimulus is I\) 0 
co 
presented once every ten seconds. Again, channel 2 is being utilized for integration. 
Figure 61 
',CB) EFFECT OF PHENOXYBENZAMINE ON RECRUITMENT 
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Persistent Effect of Phenoxybenzamine on EEG and Thalamo-Cortical Recruited 
Potentials: Following the initial transient effects as seen in the previous 
figure for phenoxybenzamine 5,0 mg/Kg i.v., a persistent synchronous EEG pattern 
ensues and the attenuation of recruitment is reversed as indicated by the inte-
grated data in channel 7. Note that the amplitudes of the signals are greater 
than those seen during the control period (dotted line) of synchronous activity. 
Stimulation parameters as in the previous phenoxybenzamine recording. I\) 0 
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Figure 62 
ESERINE ANTAGONISM OF RECRUITMENT IN PRESENCE 
OF PHENOXYBENZAMINE 
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Eserine Reversal of the Phenoxybenzamine Enhancement of Thalamo-Cortical Recruitment: 
Eserine (100 mcgm/Kg i.v.) reverses the synchronous EEG pattern elicited by the 
administration of phenoxybenzamine and induces a pronounced attenuation of the 
, 
evoked recruitment. Note the desynchronized EEG pattern and the integrated 
potentials values below control levels (dotted line). Stimulation parameters are 
~ 
the same as in the previous tracings. Recordings were made 7,0 minutes after Eserine.~ 
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data during synchronized and desynchronized EEG background 
activity is shown in figures 56 and 57. Amplitudes of the 
integrated responses were relatively constant and recruit-
ment evoked during the EEG alert appeared to be somewhat 
greater than that seen during the slow wave EEG sleep 
pattern. Eserine (100 mcgm/Kg i.v.) antagonism of recruit-
ment was reflected by a marked transient reduction in 
integrated response that was at a maximal stage 7 minutes 
after injection (fig. 58). Atropine methyl nitrate (1.0 
mg/Kg i.v.) failed to antagonize the effect of Eserine 
(100 mcgm/Kg i.v.) on EEG activity as well as on the 
evoked potentials (fig. 59, cf. fig. 58). 
Phenoxybenzamine elicited a biphasic response on 
recruitment and EEG activity (figs. 60 and 61). The initial 
effect (fig. 60) was an EEG desynchronization that lasted 
approximately 2 minutes during which time thalamocortical 
recruitment was attenuated. Synchronized EEG patterns 
followed (fig. 61) and the integrated response to recruit-
ment exceeded control levels. This alpha adrenergic 
blockade was readily antagonized by Eserine (100 mcgm/Kg 
i.v.) and EEG desynchronization as well as attenuation of 
recruitment occurred (fig. 62). The subsequent adminis-
tration of phenoxybenzamine in a lower dose (2.5 mg/Kg 
i.v.) elicited antagonism of the AntiChE-attenuated 
recruitment, but not the EEG alert pattern of Eserine 
(fig. 63). 
Control responses prior to beta blockade are shown 
in figure 64. After the administration of 2.0 mg/Kg 
i.v. of D(-) INPEA an EEG arousal was evoked and recruit-
ment was attenuated as is shown in figure 65. 
Proposed intracellular pathways for the biosynthesis 
and fate of NE are included f0r reference in figures 66 
and 67 (cf. Wurtman 1966). 
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Phenoxybenzamine Reversal of the Eserine Antagonism of Thalamo-Cortical Recruitment: 
Phenoxybenzamine (2.5 mg/Kg i.v.) antagonizes the attenuation of recruitment induced 
by Eserine but does not evoke a synchronous EEG pattern. Note that the amplitude 
of the integrated potentials (channel 7) is somewhat greater than the control levels 
as indicated by the dotted line. Stimulus parameters are unchanged. Tracings were I\) 1--' 
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made 10 minutes after injection. 
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Control Thalamo-Cortical Recruitment: Evoked potentials during a phase of 
desynchronous EEG activity prior to the administration of D(-) - INPEA. Stimulus 
parameters are 8.5 c/s, 0.9 msec for two seconds at voltage greater than threshold. 
The stimulus uas presented once every ten seconds. 
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Figure 65 
D (-)- INPEA EVOKED EEG DESYNCHRONIZATION ANU 
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Effect of D(-) - INPEA on EEG and Recruitment: Marked EEG arousal patterns are 
evoked by the intravenous administration of 2.0 mg/Kg of D(-) - INPEA. Note the 
attenuation of the recruited potentials in the data integrated from channel 2 and 
reco~ded in channel 7. The dotted line represents the control level from the 
previous record. Stimulus parameters are unaltered. Tracings were made 15 minutes 
after injection. 
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Figure 66 
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Legend for Figure 66 
Proposed Intracellular Pathway of Biosynthesis of Norepinephrine in Brain 
and Peripheral Nerve Tissue: Circulating tyrosine is proported to be picked 
up by an active transport mechanism into the neuron or sympathetic nerve 
ending. After entry into the mitochrondria the tyrosine is hydroxylated by 
tyrosine hydroxylase and the DOPA thus formed is decarboxylated to form 
dopamine. Dopamine is then oxidized by dopamine beta oxidase to form the 
postulated neurotransmitter norepinephrine. 
-Figure 67 
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Legend for Figure 67 
Proposed Intracellular Pathway of Fate of Norepinephrine in 
Brain and Peripheral Nerve Tissue: Within the brain or 
sympathetic nerve ending, norepinephrine exists in the 
bound state (NE) which is in equilibrium with the free 
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state (NE). Also an equilibrium exists between the free 
norepinephrine and the oxidative enzyme within the 
mitochondria, MAO. The release of NE follows the arrival an 
impulse and this released NE can be either rebound back into 
the nervous tissues; react with the receptor; be converted 
to normetanephrine by COMT of the parenchymal cells and 
then picked up by the circulation; or incorporated directly 
into the circulation. If the NE is shunted into t£1e MAO 
pathway, the DHMA or DHPG thus formed may also be acted upon 
by COMT of the parenchymal cells and then incorporated into 
the circulation as DHMA, DHPG VMA or MHPG. 
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IV. DISCUSSION 
The increased parasympathetic activity in rabbits after 
chronic biogenic amine depletion included miosis, ptosis, 
diarrhea and decreased spontaneous motor activity. Similar 
effects have been noted by Malhotra and Pundlik (1959) and 
Haggendal et al. (1967). Bhargava (1967) suggested that 
alpha methyl DOPA and reserpine promoted the release of ACh 
and facilitated parasympathetic activity. In the present 
studies, hypotension, bradycardia, and death appeared in 
response to doses of Eserine that were not lethal in the 
presence of normal autonomic nervous system balance. There-
fore, an evaluation of the effects of anticholinesterases 
in the CNS of animals with depleted biogenic amines required 
protection of the cardiovascular system. The antimuscarinic 
properties of atropine methyl nitrate were effective as a 
prophylactic measure for the potentiated cardiovascular 
responses subsequent to intravenously administered anti-
cholinesterases. However, attenuated responses to periph-
eral and direct CNS stimulation have been attributed to 
methyl atropine (Riehl et al. 1960). An increased EEG 
arousal threshold to reticular formation stimulation in the 
presence of atropine methyl nitrate was observed. Unlike 
221 
Riehl et al. (1960), the present experiments showed atro-
pine methyl nitrate did not attenuate EEG arousal responses 
nor thalamocortical recruitment. Quaternary amines of 
poor lipid solubility have restricted access to the CNS 
due to the blood brain barrier (BBB) (Weil-Malherbe 1961). 
Methyl atropine was selected as a prophylactic agent since 
its antimuscarinic properties are primarily restricted to 
the periphery. Moreover, Hance et al. (1963) noted that 
atropine methyl nitrate (0.05-5.0 mg/Kg i.v.) had no con-
sistent effect on EEG activi~y of cats and had minimal, if 
any effects on cortical evoked responses. Rosecrans et al. 
(1968) found hyoscine but not atropine methyl nitrate 
effective in depression of conditioned response pole 
jumping in rats. Also, methyl atropine partially antag-
onized the effect of Eserine on the conditioned response. 
They concluded that drug action occurred in the periphery 
and suggested that peripheral cholinergic blockade may in-
fluence CNS responses and must be considered in the 
evaluation of central effects of anticholinesterases. 
Although quaternary anticholinesterases such as neo-
stigmine fail to penetrate the BBB and reveal little or no 
direct CNS activity (Longo 1962), Paulet et al. (1957) 
suggested that neostigmine along with parathion and 
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octamethylpyrophosphoramide (OMPA) increased the per-
meability of the BBB to another drug, sulfanilamide. How-
ever, this effect was not attributable to inhibition of 
cholinesterase. Aasseth and Barstad (1968) revealed that 
quaternary anticholinesterases did not increase existing 
brain cholinesterase inhibition. Mazel and Bush (1969) 
concluded that the Eserine-induced increased onset and 
duration of barbital sleep was not due to an increased 
permeability of the BBB but was mediated through the 
peripheral nervous system. ~inally, Koelle and Steiner 
(1956) demonstrated that tertiary cholinesterase inhibitors 
did not enhance the penetration of quaternary anticholin-
esterases through the BBB. 
Reserpine depletion of brain NE occurred rapidly and 
was maintained by chronic administration (Table II, cf. 
Table III, Pletscher et al. 1956, Weil-Malherbe and Bone 
1959, Costa et al. 1962, Brodie et al. 1966, H~ggendal 
et at. 1967, and Kety 1967). The values for depletion of 
brain NE seen in Table II served as control references for 
subsequent experiments in which reserpine-induced NE 
depletion was desired (cf. figs. 42 through 46). The action 
of reserpine has been described as "hit and run". It is 
..... 
metabolized and disappears from brain tissue in 1-2 hours 
(in rabbit) while a marked depletion of biogenic amines 
continues for up to 36 hours (Hess et al. 1956). Costa 
~ al. (1962) reported that rabbit brain NE was depleted 
to 12 per cent of control value at 4 hours after 1.5 mg/ 
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Kg i.v. However, Anden (1967) observed a differential 
depletion of rat brain monoamines after acute reserpine 
treatment. Low doses of reserpine (l.O mg/Kg i.p.) re-
sulted in resistance to depletion in some brain areas while 
a high dose (10.0 mg/Kg i.p.} uniformly depleted brain NE. 
Furthermore, Liebmann and Mattheis (1964) in a study on the 
influence of reserpine on cholinomimetic toxicity observed 
an increased toxicity at 1-2 hours after reserpine and 
maximal toxicity at 18-24 hours. This fluctuation in 
toxicity may be related to the circadian rhythm of the endo-
genous biogenic amines (Sterman et al. 1965, Reis et al. 
1968, Friedman and Walker 1968). Therefore, chronic admin-
istration of reserpine was employed in the present study 
and a uniform depletion was obtained. 
Depletion of brain NE by aMPT was linear with time and 
was maintained by chronic administration (Table III, cf. 
Table II). These findings are also in agreement with 
current literature (Spector et al. 1965, Brodie et al. 
1966, Kety 1967). The values shown in Table II served as 
control references for subsequent experiments in which 
brain NE was depleted by aMPT (cf. figs. 49 through 51). 
The linear decrease of brain NE by aMPT is dependent on 
maintaining an adequate tissue level of the rate-limiting 
enzyme inhibitor (Brodie et al. 1966a) compared with 
reserpine-induced depletion of biogenic amines which was 
rapid and associated with a rapid disappearance of the 
drug from the tissues. Single large doses of aMPT have 
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been reported to cause renal. toxicity but repeated lower 
doses resulted in no toxicity and a decreased catecholamine 
concentration (Moore et al. 1967). / Anden (1967) observed 
that dVIPT uniformly depleted brain NE compared with reser-
pine and that the level of nerve activity had a greater 
influence on aMPT-NE depletion than on reserpine-NE deple-
tion. In addition, Smookler and Buckley (1969) found 
that aMPT depleted NE 85% in male rats stressed by light, 
sound, and oscillation while non-stressed animals were 
depleted 45%. Stress also markedly increased NE turnover 
rates. Moreover, concentrations of endogenous amines have 
been implicated as factors in NE depletion. Nagatsu and 
Takeuchi (1967) showed that high concentrations of 
phenylalanine inhibited NE synthesis 80% in vitro. It was 
concluded that since tyrosine hydroxylase catalyzed the 
hydroxylation of phenylalanine to tyrosine as well as 
tyrosine to DOPA, abnormally high concentrations of 
phenylalanine would compete with tyrosine for tyrosine 
hydroxylase, thus decreasing the amount of NE being syn-
thesized. 
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Restoration of depleted brain biogenic amines 
necessitated consideration of mechanisms of biogenic amine 
depletion in the CNS. The mechanisms by which reserpine 
depleted endogenous NE (Holz4auer and Vogt 1956) throughout 
the neuron (Dahlstrom and Fuxe i964) and blocked reuptake 
of NE (Glowinski and Axelrod 1965, 1966) differ from aMPT-
NE depletion (Spector et al. 1965, Brodie et al. 1966a, 
Corrodi and Fuxe 1967). Depletion of the catecholamines, 
DOPA, dopamine (DA), NE and epinephrine (EPI), occurred after 
aMPT while reserpine depleted both catecholamines and indole-
amines to include serotonin (Hess et al. 1956, Pletscher et 
al. 1956, Brodie et al. 1957, Shore et al. 1958, Weil-
Malherbe and Bone 1959, and Kety 1967). Reserpine-induced 
sedation has been correlated with the initial rate of release 
of serotonin but not final concentrations (Brodie et al. 
1966). Koella and Czicman (1966) and Koella et al. (1968) 
suggested that serotonin was the mediator associated with 
......... 
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EEG synchronization and behavioral sedation (cf. also 
Marczynski 1967 for additional references). Jouvet (1967) 
postulated that serotonin-containing neurons supported 
slow wave sleep while paradoxical sleep was a function of 
NE neurons of the locus coeruleus. Pirch and Rech (1968), 
on the other hand, concluded that the depletion of brain 
NE or DA was a critical factor in behavioral sleep and 
electrocortical responses to aMPT and reserpine. Both 
catechol- and indoleamines may be involved in the mechanism 
of action of reserpine. At ~resent the issue is unre-
solved (Kety 1967). 
Restoration of brain biogenic amines by the parenteral 
administration of the putative transmitters DA, NE, or EPI 
failed to yield consistent results, and because of the BBB 
it is doubtful that direct CNS effects are observed (Longo 
1962, Baust and Nleczyk 1964, Wurtman 1966, Barchas et al. 
1968). Intravent~icular administration has been used to 
circumvent the BBB (Feldberg and Sherwood 1954) but results 
are difficult to interpret. The CNS stimulant effects of 
sympathomimetic amines such as amphetamine as well as other 
phenylethanolamines that penetrate the BBB, revealed de-
synchroniza tion of the EEG and behavioral arousal when 
given by different routes of administration (Van Meter and 
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Ayala 1961, Bradley 1968). Serotonin, which penetrates 
the BBB only to a slight extent, evoked an initial EEG 
arousal followed by an EEG synchronization while its 
precursor 5 hydroxytryptophan (5 HTP) readily gained access 
to the brain and caused an increased EEG synchronization, 
behavioral sleep and an associated rise in brain serotonin 
concentrations (Longo 1962, Koella 1966, Brodie et al. 
1966, Bradley 1968). Bradley (1968) noted that the action 
of amphetamine when applied iontophoretically to CNS 
neurons, resembled NE but not ACh, serotonin or histamine. 
He concluded that amphetamine induced central excitation by 
releasing endogenous NE but pointed out that catecholamines 
injected into immature animals with poorly developed BBB as 
well as intraventricular injections, resulted in sedation 
or sleep. Matsuda (1968) found similar responses to 
ventricular administration of EPI in rabbits where EEG and 
behavioral sleep appeared without changes in threshold of 
thalamocortical recruitment. 
There is evidence that the uptake-storage mechanism for 
catecholamines may be altered by reserpine. H~ggendal and 
Malmfors (1969) observed that adrenergic nerves of rats 
failed to take up exogenous NE and failed to show function-
al responses when stimulated 16 hours after reserpine-NE 
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depletion and monoamineoxidase inhibition. However, nerve 
stimulation in the presence of exogenous DA revealed 
functional responses and synthesis of NE from that pre-
cursor. Furthermore, DA uptake has been shown to exceed 
that of NE in rat brain homogenates and there was evidence 
for a common uptake path for NE and DA (Snyder and Coyle 
1969). In fact, dopaminergic transmission and pathways 
have been postulated in both the periphery and CNS 
(Hornykiewicz 1966, and Takagi et al. 1968). On the other 
hand, L-DOPA restored NE to aMPT-NE depleted but not 
reserpine-NE depleted rats unless a MAOI was used (Corrodi 
and Fuxe 1967). These authors observed that inhibition of 
MAO also increased the recovery level of NE in the aMPT-
DOPA treated animals and they concluded that the uptake-
storage mechanism was intact after aMPT-NE depletion but 
that the mechanism may have been altered by reserpine. 
Administration of the monoamine precursor L-DOPA in the 
presence of MAO inhibition effectively restored depleted 
brain biogenic amines and reversed reserpine depression 
of behavior (Everett 1961, Everett et al. 1963). In the 
present experiments, pargyline plus L-DOPA successfully 
reestablished depleted NE levels in brain and increased NE 
levels in non-depleted animals (cf. Table III and figs. 48, 
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54). 
Background EEG activity alters the stimulus threshold 
for evoking thalamocortical recruitment. Longo (1962) 
and Giaquinto (1968) showed that desynchronized EEG activity 
raised the threshold required for elicitation of thalamo-
cortical recruitment. This was also noted during pre-
liminary studies in the present research. Therefore, 
stimulus voltage for recruitment was established with back-
ground of desynchronized EEG activity (figs. 3.3, 57). 
Threshold values for thalamQcortical recruitment established 
prior to the administration of the particular drug in 
question were maintained during post-drug observations. The 
stimulus threshold required to evoke recruitment during 
periods of EEG arousal was effective in the presence of syn-
chronized EEG activity (figs. 33, 57, 64). 
Eserine (100-150 mcgm/Kg i.v.) induced an initial, slow 
wave, EEG sleep pattern of approximately 2 minutes duration 
followed by a transient desynchronized EEG pattern. The 
greatest intensity of the desynchronous EEG response 
occurred between 5 to 10 minutes after the injection. The 
same sequence of synchronized EEG activity followed by de-
synchronized activity was noted after the intracarotid 
administration of Eserine (vide supra, Part I) with the 
exception that the slow wave sleep pattern was of much 
shorter duration and lasted only a few seconds. Thalamo-
cortical recruitment was attenuated during the maximal 
intensity of desynchronization (fig. 34) but reappeared 
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about 20 minutes later during recovery from the Eserine in-
jection. The recovery of thalamocortical recruitment occur-
red prior to the reappearance of a synchronized EEG pattern 
(fig. 35). The EEG pattern resumed pre-injection charac-
teristics 30-40 minutes after the cholinesterase inhibitor 
had been given. The initial ~low wave EEG pattern was not 
reported previously in descriptions of the reversible 
effects of Eserine on the EEG of rabbits (Longo and 
Silvestrini 1957, Longo 1962). In addition, the present work 
revealed the reappearance of thalamocortical recruitment 
prior to the recovery of the synchronized EEG activity after 
Eserine. Similarly, DFP also evoked a desynchronized EEG 
pattern and attenuated thalamocortical recruitment (fig. 36) 
at least two hours at which time experiments were terminated. 
These events are probably closely associated with the in-
hibition of cholinesterase and the increased brain ACh con-
centrations. In an evaluation of the interrelationship of 
inhibition of cholinesterases, increases in brain ACh con-
centrations and cholinomimetic toxicity, Holmstedt et al. 
...... 
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(1967), noted lethal doses of organophosphates were not 
required to induce marked increases in brain ACh concen-
trations. Classical toxic responses to organophosphate 
poisoning occurred only when cholinesterases were inhibited 
and after ACh levels in the brain attained values of 60 
per cent or greater than controls. A similar relationship 
was noted with Eserine but the inhibition of enzyme was 
reversible. On the other hand, oxotremorine and arecoline 
provoked salivation, lacrimation, and tremor at brain ACh 
levels that were elevated only 20 per cent above control 
values. Leslie (1965) observed that oxotremorine and are-
coline were the most potent antagonists of drug-induced 
sedation in rabbits. Oxotremorine was the only cholino-
mimetic that produced prolonged excitation when ionto-
phoretically applied to ACh-excitable neurons of the pons-
medulla of the cat (Bradley et al. 1966). The effects of 
Eserine on the EEG and thalamocortical recruitment in cats 
have been described as muscarinic (Hance et al. 1963). 
They reported that atropine sulfate (l.O mg/Kg i.v.) was 
an effective antagonist of the EEG response to Eserine but 
had minimal action on evoked cortical potentials. While 
an accumulation of ACh may result from the inhibition of 
cholinesterases (as pointed out in Part I), other actions of 
232 
AntiChE's aside from enzyme inhibition should be consider-
ed, particularly during states of pronounced drug intoxica-
tion (cf. figs. 11 through 16). Moreover, as pointed out 
by Friedman (1967), oxotremorine was only one of a 
chemically and pharmacologically diverse group of compounds 
that promoted the release of ACh and other endogenous amines 
including DA as well as NE and EPI. In fact, low doses of 
nicotine (5.0-20.0 mcgm/Kg i.v.) have been shown by Domino 
(1967) to evoke an EEG arousal pattern in rabbits with 
midpontine brainstem transeations. Nicotine induced an EEG 
desynchronization that was concomitant with a behavioral 
arousal. However, Domino suggested that because nicotine 
released ACh, catecholamines, serotonin and vasopressin and 
evoked a cholinergic blockade in higher doses, its mechanism 
of action was obscured. Furthermore, in an earlier study, 
Monnier and Romanowski (1962) found that ACh, Eserine, and 
pilocarpine all evoked an EEG arousal in rabbits, induced 
an increased arousal reaction to sensory and reticular 
formation stimulation and increased the cortically evoked 
potential from caudate or hippocampal stimulation, but de-
creased thalamocortical recruitment. These drug effects 
were blocked by atropine. Also, Domino (1968) revealed that 
the muscarinic receptors had a greater sensitivity to 
evoked EEG desynchronization than did nicotinic cholin-
ergic receptors and he concluded that the cholinergic 
mechanisms for inducing arousal were more muscarinic than 
nicotinic. 
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Reciprocal antagonism between anticholinesterases and 
anticholinergics was demonstrated in Part I and is reiter-
ated in figure 37 that shows the scopolamine antagonism of 
DFP-induced desynchronization (cf. Longo 1962). Antagonism 
of the EEG arousal by scopolamine did not attenuate thalamo-
cortical recruitment per se (fig. 37, Hance et al. 1963) 
but antagonized the attenuation of recruitment by DFP (cf. 
Longo 1962). 
Chlorpromazine antagonized the transient attenuation 
of recruitment seen after Eserine (fig. 39) and the antag-
onism may be the result of alpha adrenergic blocking pro-
perties. Boakes et al. (1968) found that chlorpromazine 
was the most effective blocker of the excitatory effect of 
iontophoretically applied (-) norepinephrine on brain-
stem neurons. Rinaldi and Himwich (1955a, 1955b) have 
proposed anticholinergic properties for the chlorpromazine 
block of anticholinesterase evoked EEG desynchronization. 
Imipramine has properties similar to those of chlorpromazine 
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and Monnier and Krupp (1959) observed an increased thres-
hold to electrocortical arousal following the administra-
tion of either drug while Rinaldi (1967) noted convulsive 
activity subsequent to administration of high doses. Dasberg 
and Feldman (1968) investigated the EEG arousal blocking 
effect of imipramine. These authors found that imipramine 
raised the threshold for EEG arousal evoked by the i.v. in-
jection of Eserine and that the threshold for EEG arousal 
evoked by amphetamine was lowered. They concluded that 
imipramine acted by a cholin~rgic blocking mechanism. If a 
cholinergic-link concept is considered, Dasberg and Feldman's 
results could be interpreted to mean that Eserine promoted 
the release of biogenic amines in the CNS (Rosecrans et al. 
1968, cf. Marczynski 1967) which elicited the EEG arousal. 
The anticholinergic effect of imipramine antagonized the 
EEG alert by blocking the action of Eserine and ACh on the 
adrenergic component. Amphetamine would still act at the 
CNS by releasing NE (Bradley 1961, Bradley 1968). The 
decreased threshold for amphetamine-induced desynchroniza-
tion seen after imipramine could either be the result of 
cholinergic blockade or inhibition of catecholamine uptake 
(Glowinski and Axelrod 1966), by blockade of membrane 
transport of amines (Giachetti and Shore 1966). Imipra-
mine antagonism of Eserine-induced EEG arousal could also 
be attributed to the later adrenergic blocking effect. 
Furthermore, imipramine-antagonism of reserpine-induced 
sedation depended on the presence of catecholamine stores 
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in the CNS. Depletion of brain catecholamines resulted in 
failure of imipramine-antagonism of benzoquinolazine 
sedation (Sulser et al. 1964). Chlorpromazine, similar to 
imipramine, probably antagonized the effects of Eserine by 
a combination of cholinergic and adrenergic blocking 
effects. The brain stem reticular formation is a site of 
cholinergic activity (Rinaldi and Himwich 1955a, Rinaldi and 
Himwich 1955b). Cholinergic mechanisms are also implicated 
in EEG desynchronization at the level of the cerebral 
cortex, particularly with slow and prolonged excitatory 
effects (Krnjevit1967). Krnjevid (1967) also observed that 
repetitive responses of cortical neurons to thalamic 
stimulation were markedly enhanced by ACh or Eserine. 
Therefore, the antagonism of Eserine by chlorpromazine 
occurs in the cortex as well as brain stem and there is 
probably not a specific locus of action. 
Atropine evoked a synchronized EEG (fig. 40) and this 
has been reported to be dissociated from behavioral sleep 
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(Wikler 1952). However, thalamocortical recruitment was 
not attenuated. This finding with the observation that 
atropine also failed to alter caudatocortical recruitment 
has been shown in rabbits (Longo 1962). On the other hand, 
Domino et al. (1968) studied cholinergic mechanisms in 
sleep and wakefulness in cats. They found that physostig-
mine evoked an initial EEG desynchronization in both 
neocortical and limbic areas and that this response was 
associated with a behavioral arousal. These authors 
suggested that early findin~s of dissociation between EEG 
responses and behavior attendant to the administration of 
cholinergic agonists and antagonists (Wikler 1952, Bradley 
and Elkes 1957, Bradley and Nicholson 1962) were noted 
before the concepts of paradoxical or fast wave sleep 
cycles in cat were well established (Dement 1958, Jouvet 
1961). The observation of a fast wave sleep pattern then 
would be acceptable as a concurrent event with behavioral 
sleep. Moreover, in an earlier study, Yamamoto and Domino 
(1967) had shown in cats that the initial EEG alert after 
Eserine was associated with a behavioral arousal and that 
paradoxical sleep appeared after a delay of 30 minutes or 
longer, during the recovery from the injection. Pilo-
carpine also showed the same result. Furthermore, denial of 
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paradoxical sleep in rats has been noted to evoke a re-
bound increase in paradoxical sleep after the period of 
denial (Pujol et al. 1968). Turnover of cerebral NE was 
increased during the rebound phase of paradoxical sleep. 
Jouvet (1967) proposed that slow wave sleep depended on 
serotonergically-mediated events while paradoxical sleep 
appeared to be related to catecholaminergic mechanisms. 
The atony associated with fast wave sleep could be blocked 
by atropine and yet DOPA induced normal paradoxical sleep 
in cats treated with reserptne. Jouvet (1967) concluded 
that both cholinergic and adrenergic mechanisms were re-
quired to produce paradoxical sleep with total atony. 
A subconvulsant dose of sarin antagonized the EEG 
effects of atropine sulfate (3.0 mg/Kg i.v., fig. 41, cf. 
fig. 14 Part I). Thalamocortical recruitment was markedly 
attenuated (arrows) and this blockade persisted for two 
hours at which time the experiments were terminated. These 
observations are in agreement with Longo (1962) but not 
White (1966). The latter worker noted that 100 mcgm/Kg 
i.v. of Eserine in rabbits failed to evoke an EEG desyn-
chronization if given after l.O mg/Kg i.v. of scopolamine. 
The lack of agreement of the effects of an anticholinesterase 
in the presence of an atropinic anticholinergic blockade 
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undoubtedly lies in the doses used. Scopolamine is 
approximately 10-15 times more potent than atropine as an 
antagonist of EEG arousal in the rabbit and the effective 
dose for total inhibition of the EEG arousal response 
elicited by direct electrical stimulation of the reticular 
formation was found to be 0.04-0.05 mg/Kg i.v. (Longo 
1956). Furthermore, the reciprocal and competitive nature 
of the interaction between antimuscarinic and anticholin-
esterase drugs necessitates a consideration of the doses 
used, as well as the duratiqn of inhibition of cholin-
esterases. 
Chronic administration of reserpine effected (1) EEG 
activity (fig. 42), (2) brain levels of biogenic amines 
(Tables II, III), and (3) behavior (vide supra). EEG 
activity changed from alternating slow wave sleep and alert 
tracings to prolonged synchronization during which EEG 
arousal and thalamocortical recruitment were evoked (figs. 
42, 43). Initial disag~eement on the EEG re5ponse of 
laboratory animals to reserpine (Longo 1962) resulted from 
observations taken under markedly different conditions. 
Reserpine like amphetamine initially promoted the release 
of stored NE from nerve granules and brain (Vogt 1954). 
During this time there was a brief period of continuous 
--
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EEG desynchronization that began about 45 minutes after 
intravenous administration and persisted for about 2 hours 
(Rinaldi and Himwich 1955). The pattern of behavior was 
one of depression with the animal in a sleep-like state, 
attributable to paradoxical sleep (Jouvet 1967a) or perhaps 
due to interneuronal deamination of reserpine-liberated 
catecholamines which rendered them physiologically less 
active (Glowinski and Axelrod 1965, 1966). Only after 4-6 
hours, the synchronized EEG predominated and the brain 
catecholamines were beginnin~ to show marked depletion 
(fig. 42, Table III). Haggendal et al. (1967), in a recent 
study of the effects of chronic reserpinization on mono-
amine metabolism and behavior, noted that the first signs 
of reserpine activity appeared approximately one hour after 
injection at a time when the major part of the monoamines 
were still present. In the current work (Table III), long 
term treatment with reserpine revealed brain levels of 
monoamines similar to those seen at 4 hours through 24 
hours (Table II). Haggendal and co-workers (1967) were 
unable to restore brain biogenic amine levels to control 
values by DOPA alone. Everett (1961) and Everett et al. 
(1963) showed that DOPA plus a MAOI rapidly restored 
biogenic amine levels in brain tissue. Bueno et al. 
r 
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(1968) found that the appropriate combination of a MAOI 
and reserpine could evoke prolonged periods of alert EEG 
activity in rabbits. Brain concentrations of biogenic 
amines per ~, could not be correlated with the EEG 
response but an increased ratio of concentration of sero-
tonin to NE was seen with behavioral excitement and EEG 
desynchronization. Furthermore, as pointed out by Costa 
(1966) and Brodie et al. (1966a), synthesis rate and turn-
over time of tissue biogenic amines may correlate with 
physiological and behaviora1- activity more significantly 
than does actual tissue concentration. Moreover, turnover 
time as well as synthesis rate can be influenced by a 
variety of factors to include gonadectomy which increased 
brain NE turnover in rats (Anton-Tay and Wurtman 1968) and 
physical stress (Smookler and Buckley 1969). Gal (1961) 
found that reserpine evoked a greater prolonged depletion 
of serotonin and NE in rats fed on a tryptophan deficient 
diet than with animals fed a normal diet. Therefore, while 
changes in turnover and synthesis rate may be of value in 
correlation of experimental observations, the experimental 
conditions are of critical importance. 
Reserpine per ~ did not depress thalamocortical re-
cruitment (fig. 42). Gal et al. (1961) observed that 
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reserpine did not alter arousal threshold nor recruitment 
threshold in rats. White (1966) observed that reserpine 
facilitated the indirect action of mephenteramine and 
induced a desynchronized EEG but failed to depress evoked 
potentials in the reticular formation. In the same study, 
pretreatment with reserpine followed by mephenteramine 
failed to alter the Eserine-induced EEG desynchronization 
and blockade of reticular evoked potentials, while 
scopolamine in an extremely high dose (l.O mg/Kg i.v.) 
blocked the effects of Eseripe (vide supra). In the present 
studies, brain biogenic amine depletion by chronic admin-
istration of reserpine failed to alter the desynchronized 
EEG and attenuation of thalamocortical recruitment evoked 
by Eserine at doses of 100 mcgm/Kg i.v. (fig. 44) or 200 
mcgm/Kg i.v. (fig. 45). DFP (2.0 mg/Kg i.v.) also failed 
to block thalamocortical recruitment but evoked an EEG 
desynchronization (fig. 46). Restoration of brain bio-
genic amines by the combination of a MAOI, which by itself 
did not attenuate recruitment, and L-DOPA restored Eserine-
blockade of recruitment. While Everett (1961) pointed out 
that MAOI and DOPA combinations could evoke an EEG alert, 
the current study showed that thalamocortical recruitment 
could still be evoked and that Eserine could block this 
response. In fact, increased brain concentrations of NE 
by the administration of the MAOI and L-DOPA reduced the 
dose of Eserine required to attenuate recruitment, to 
50 mcgm/Kg (vide infra). 
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Depletion of brain NE by chronic inhibition of 
synthesis (cMPT) also evoked a marked increase in synchro-
nized EEG activity with evoked EEG arousal and recruitment 
responses (figs. 49 and 50). Eserine also failed to 
attenuate thalamocortical recruitment though an EEG desyn-
chronization was evoked (fig~ 51). Restoration of brain 
amines by MAOI and DOPA resulted in the same response as 
seen above for reserpine-NE depletion and restoration. While 
depletion of brain biogenic amines following the chronic 
administration of either reserpine or qvIPT is through 
different mechanisms, results were similar. EEG patterns 
showed a marked increase in slow wave sleep activity. Rats 
have also demonstrated an increase in integrated voltage of 
the electrocorticogram after multiple doses of aMPT and this 
response was antagonized by MAOI (Pirch and Rech 1968). 
These latter authors concluded that the effect of ctVIPT was 
similar to reserpine and that a decrease in brain-NE con-
centration was an important factor in the behavioral and EEG 
response induced by either drug. 
....... 
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Depletion of brain biogenic amines altered the response 
to cholinomimetics. In particular, the depletion of the 
catecholamines, DOPA, DA, NE, and EPI appears to be impli-
cated. Reserpine depleted both catecholamines and indole-
amines and thus either serotonin or the catecholamines may 
be involved. However, ~PT-NE depletion provides evidence 
that the catecholamines are an essential factor in Eserine-
attenuation of thalamocortical evoked potentials. Electro-
cortical activity of sleep may be associated with serotonin 
(Koella 1966, Koella et al. ;968, cf. Marczynski 1967), but 
it is unlikely that serotonin is an essential factor for 
the Eserine-attenuation of recruitment. In fact, with the 
marked depletion of serotonin that follows the administra-
tion of reserpine (Hess et al. 1956), recruitment can still 
be evoked and EEG sleep patterns are enhanced (cf. figs. 42 
and 43). 
In addition to the observation of responses in the 
presence of depleted brain NE and its subsequent restoration, 
the responses of drugs and stimuli in the presence of in-
creased brain NE in non-depleted animals were observed. 
Recruitment was not attenuated by 50 mcgm/Kg i.v. of Eserine, 
a dose which evoked an EEG desynchronization (fig. 52, cf. 
Longo 1962). Inhibition of MAO alone did not facilitate 
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Eserine-attenuation of recruitment (fig. 53). However, 
L-DOPA in the presence of inhibited MAO increased brain NE 
(cf. Table III, and Everett 1961), and enhanced Eserine-
attenuation of recruitment (fig. 54). Moreover, a transient 
blockade of thalamocortical recruitment was seen (fig. 55) 
which was attributable to the reversible nature of the anti-
cholinesterase (Longo and Silvestrini 1957, Longo 1962). 
While complete recovery of the evoked potential was not 
observed, levels of brain NE were increasing and contributed 
to the decrease in EEG arou$al threshold (Everett 1961, 
Kety 1967) and to the increased threshold of recruitment. 
Therefore, instead of depletion of brain NE with subsequent 
restoration of levels by MAOI plus L-DOPA, brain NE raised 
above control values in non-depleted animals (Table III, 
cf. Table II), enhanced behavioral and EEG arousal and 
lowered the dose of Eserine necessary to attenuate thalamo-
cortical recruitment. 
Phenoxybenzamine evoked a biphasic EEG response con-
sisting of a transient EEG desynchronization of less than 
two minutes followed by a continuous EEG synchronization 
(figs. 60 and 61). The initial desynchronization (fig. 60) 
was probably an alpha response and the EEG synchronization 
was the result of a beta response unmasked by alpha 
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blockade (Goldstein and Mu~oz 1961, Mu~oz and Goldstein 
1961). On the other hand, beta blockade by INPEA (Teotino 
et al. 1963) (fig. 65) unmasked only the alpha EEG response 
of desynchronization (Goldstein and Munoz 1961, Munoz and 
Goldstein 1961), and blocked recruitment. 
Integration of thalamocortical recruitment was carried 
out by a stimulator-controlled, relay operated unit. Inter-
recruitment EEG background activity was excluded since the 
integration unit was in operation only during the presen-
tation of stimuli (cf. Koella and Czicman 1966). Supra-
threshold stimuli evoked potentials that were relatively 
constant in the presence of synchronized or desynchronized 
EEG background activity (figs. 56 and 57). The amplitudes 
of the integrated potentials appeared constant but there 
was no determination made of the area under the curve and 
this may have varied. Eserine markedly attenuated the 
integrated thalamocortical potentials (fig. 58) which 
atropine methyl nitrate failed to antagonize (fig. 59). 
Eserine antagonized the EEG synchronization induced by 
phenoxybenzamine and blocked recruitment as well (fig. 62). 
An increase in the dose of phenoxybenzamine also blocked 
the EEG desynchronization evoked by Eserine. On the other 
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hand, beta blockade, attenuated the integrated thalamo-
cortical potentials similar to Eserine (fig. 65, cf. fig. 
58). White et al. (1965) noted that Eserine,catechol and 
amphetamine induced EEG arousal patterns and reticular 
evoked responses in rabbits. They found that phenoxy-
benzamine induced EEG synchronization but did not antagonize 
the reticular evoked potential nor the responses to Eserine. 
It was concluded that the reticular formation was not 
pharmacologically homogenous and there were examples of a 
drug-induced "dissociation" op responses. In an earlier 
study, White and Daigneault (1959) found that atropine 
antagonized adrenomimetic CNS stimulants and concluded that 
an interaction between cholinergic and adrenergic elements 
was involved in the action of the drug. 
Attenuation of thalamocortical recruitment by an anti-
cholinesterase is dependent on the maintenance of brain 
catecholamine levels but the mechanism is not clear. 
Eserine evoked an EEG desynchronization that enhanced the 
duration of paradoxical sleep in decerebrate or in pontine 
transected animals, yet evoked behavioral arousal in in-
tact preparations (Jouvet 1967a). Lederbur and Tissot 
(1966) noted that local injections of 5HTP or L-DOPA into 
the bulbo-pontine somnogenic structures described by Jouvet 
(1962) and Morruzzi (Magni et al. 1962) evoked a syn-
chronized EEG when 5HTP was given into the 11 center" 
described by Morruzzi, but EEG desynchronization when 
administered into the "center" described by Jouvet. DOPA 
evoked an EEG alert pattern when given into either center, 
and the response was attended by a marked decrease in 
muscular activity. It is of interest that 5HTP could 
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evoke either slow wave sleep or paradoxical sleep patterns. 
Jouvet (1967, cf. Marczynski 1967) suggested that sero-
tonergic mechanisms were inv9lved in the processes of 
falling asleep while noradrenergic mechanisms supported 
paradoxical sleep. Furthermore, sleep spindles were non-
existent during paradoxical sleep and the elicitation of 
recruitment during activated sleep was markedly attenuated 
(Yamaguchi et al. 1964). Early descriptions of thalamo-
cortical recruitment led to the conclusion that recruitment 
and rhythmical 8-14 c/s spindle bursts involved the same 
structures and were the same events (Morison and Dempsey 
1941-1942, Dempsey and Morison 1941-1942). Cortical and 
subcortical sites for the mechanism of recruitment were 
described by Verzeano et al. (1953). Ajmone-Marsan (1958) 
concluded that recruitment resulted from activation of 
longer or shorter chains of neurons and that the latency 
characteristic of recruited potentials was not due to 
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conduction times between thalamus and cortex. Latency was 
a result of events occurring at the level of the thalamus. 
On the other hand, Velasco and Lindsley (1965) observed 
that only ablation of the orbital cortex abolished recruit-
ment in thalamus and cortex and they concluded that orbital 
cortex played a crucial role in the regulation of thalamo-
cortical recruitment in cats. In a later study, Velasco 
~ al. (1968) showed that thaJ.amocortical recruitment and 
spindle bursts after mesencephalic reticular formation 
lesions, were abolished only by orbital-frontal cortical 
ablations. It was concluded that the orbito-frontal cortex 
was an essential link in the synchronizing systems of 
thalamocortical nature responsible for spindle bursts and 
recruitment. On the other hand, Demetrescu and Demetrescu 
(1962a) proposed an active ascending inhibitory pathway from 
the pontine reticular formation to the caudate nucleus and 
then to the cortex. The ascending inhibitory pathway 
paralleled and was ventral to the ascending excitatory 
reticular formation pathway and operated in a feedback 
servo manner. Rocha-Miranda (1965) showed caudate-cortical 
, 
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connections of a direct nature not dependent on collateral 
or corticopetal pathways from lower levels. Furthermore, 
limbic projections to the anterior thalamic nuclei have 
been demonstrated that altered their excitability and 
that of the cortex (Sparks and Powell 1966). It has been 
shown that septal neurons may act as pacemakers for 
rhythmic activity of the hippocampus (Gogolak et al. 1967), 
and the latter structure has been proposed as a pace-
maker for thalamic neurons (Manzoni and Parmeggiani 1965). 
Furthermore, Abeles (1967, 1967a, 1967b) in a series of 
studies on the excitability of thalamic and brain-stem 
neurons associated with EEG, synchronization and desyn-
chronization, observed that desynchronizing cells had lower 
chronaxies. He concluded that there were not two sets of 
neurons; one for synchronization and another for desyn-
chronization but rather one set that responded to both kinds 
of stimuli with desynchronization being more readily ob-
tainable. Yamaguchi et al. (1964) also had noted that low 
frequency stimulation of the thalamic nuclei evoked recruit-
ment while high frequency stimulation evoked both EEG 
desynchronization and behavioral arousal (cf. Longo 1962). 
Sleep-wakefulness cycles have been categorized into 
4 groups: (1) strong arousal with desynchronized EEG, a 
high level of EMG (electromyographic) activity and a high 
threshold for recruitment, (2) relaxed wakefulness with 
desynchronized EEG, no paradoxical sleep and a slightly 
elevated threshold for recruitment, (3) slow wave sleep 
with synchronized EEG activity, low EMG activity, and a 
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low threshold for recruitment, and (4) paradoxical sleep 
with a desynchronized EEG, low EMG activity and a thres-
hold for recruitment similar to that seen during relaxed 
wakefulness. An evaluation of the multiple unit activity 
of thalamic and reticular nevrons during wakefulness, sleep 
and stages of anesthesia led Gobdman and Mann (1967) to 
conclude that there were no unique differences in levels 
of activity among them and that characteristics of spon-
taneous unit firing from the thalamus and reticular forma-
tion could not be used to differentiate between waking 
states, sleep or anesthesia. However, Phillis and Tebecis 
(1967) found that pentobarbitone blocked the ACh excitatory 
and the NE inhibitory effect on thalamic neurons without 
altering the level of excitation of the neuron, which 
remained responsive. Findlay and Hayward (1966) observed 
that unit activity from the massa intermedia of the 
thalamus of rabbits fired biomodally during slow wave sleep 
but was silent ~uring EEG desynchronization. Pharmacolog-
ical studies on thalamic neurons have revealed a mixed 
muscarinic-nicotinic type of excitation (Andersen and 
Curtis 1964) in ventrobasal nuclei of cats. However, 
McCance et al. (1966) found that muscarinic agonists were 
the most potent and that atropine sulfate blocked more 
readily than dihydro beta-erythroidine. 
The role of the hippocampus as a pacemaker for the 
rhythmic activity of the anterior dorsal nuclei of the 
thalamus has been suggested (Manzoni and Parmeggiani 
1965). Intrathalamic pacemaker function has also been 
proposed by Andersen et al. (1967, 1967a). These authors 
concluded that the rhythm of the cortical spontaneous 
barbiturate spindles was under thalamic control while 
voltage was a function of cortex. And, that during 
barbiturate anesthesia small assemblages of thalamic 
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neurons generated independent rhythmic discharges that 
paced the rhythm of the cortexes via thalamocortical 
columns. It has been reported that rhythmic thalamic unit 
activity was blocked by electrophoretic application of 
serotonin and initially by ACh (Andersen and Andersson 
1968). However, a secondary excitatory response to ACh 
appeared during which rhythmic activity was increased. 
Also, these authors observed that single shocks in the 
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thalamus as well as electrophoretic application of glutamic 
acid, evoked rhythmic discharges in the ipsilateral 
nucleus caudatus. The caudate neurons are depressed by the 
electrophoretic application of NE, (Bloom et al. 1964). 
Herz and Ziegelgansberger (1968) observed that DA blocked 
firing of neurons in the caudate and putamen and that 
glutamate antagonized DA. Serotonin, NE, and oxotremorine 
inhibited unit discharges and ACh showed both excitation 
and inhibition. It was concluded that since the effect of 
DA and hyperpolarizing currents were the same, that the 
action of DA on the cell membrane was one of hyperpolariza-
tion. ACh content of the caudate has been shown to be 
increased during periods of increased sleep spindle activity 
and to be decreased during EEG desynchronization (Traczyk 
and Sadowski 1964). Chlorpromazine lowered the threshold 
to single shock-caudate spindles (Tokizane et al 1957), 
as well as, pentobarbital and synchronized EEG activity 
(Buchwald et al. 1961). On the other hand, stimulation of 
the reticular formation, or ablation of the nucleus ventralis 
anterialis of the thalamus blocked the caudate spindles. 
A ttcaudate loop" has been described in the pathway from 
reticular formation to ventralis anterialis, to caudate, 
back to ventralis anterialisand then to cortex (Heuser et 
253 
al. 1961). Caudate spindles as well as caudate induced 
EEG arousal depended on the integrity of the thalamic 
nucleus. Cortical sites that showed spindling in response 
to caudate stimulation were the same as recruitment sites 
(Buchwald et al. 196la), and Buchwald et al. (196lb) 
-- --
proposed an inhibitory caudate circuit to balance the 
mesodiencephalic activating system. Caudate recruitment 
has been shown to be dependent on cortical activity and 
anatomical connections from the anterior thalamic nuclei to 
the caudate have been established (Kaji et al. 1968). How-
, --
ever, Goldring et al. (1963) found that caudato-cortical 
recruitment differed between monkey and cat. In the 
macaque monkey, caudate stimulation failed to evoke cortical 
recruitment whereas stimulation of the internal capsule 
was successful. It was suggested that caudato-cortical 
recruitment in the cat was due to spread of the electrical 
stimulation of the caudate to the afferent sensorimotor 
cortical fibers in the internal capsule. These fibers lie 
adjacent to the caudate nucleus in the cat but are located 
more caudally in the monkey. While the work of Goldring 
et al. (1963) may explain neuroanatomical relationships in 
monkey it does not exclude the existence of caudato-thalamo 
fibers in the cats. 
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Cholinergic stimulation of the caudate nucleu.s evoked 
responses similar to those seen after stimulation of the 
ventralis anterialis of the thalamus both of whicl-l were 
blocked by atropine (McLennan and York 1966). These 
workers had also found that stimulation of the ventralis 
anterialis evoked a release of ACh from the caudate nucleus 
and concluded that a cholinergic link existed betw-een the 
thalamus and caudate. While a cholinergic link hypothesis 
is highly controversial (Burn 1966, Ferry 1966, Boura and 
Green 1965, Burn 1968), a cholinergic-adrenergic inter-
relationship may be involved in the mechanism of action of 
anticholinesterases on thalamocortical recruitment, with 
resulting implications on mechanisms of sleep and wakeful-
ness. The presence of cholinergic pathways ascending from 
(1) the dorsal mesencephalic reticular formation, through 
the dorsal tegmentum to specific and non-specific nuclei 
of the thalamus, to cortex and from the thalamus to caudate 
nucleus and then to cortex and (2) from the substantia 
nigra through the ventral tegmentum, hypo- and subthalamus 
to basal forebrain area, from which fibers project through 
the olfactory bulb and cerebral cortex, has been established 
in rats (Shute and Lewis 1963, 1965, 1966). KrnJevi~ and 
Silver (1965) confirmed these pathways in primates and Kania 
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and Szerb (1965) showed that ACh was released from the 
cortex during arousal evoked by stimulation of the mid-
brain reticular formation. The cholinergic nature of the 
mesodiencephalic activating system was described in early 
papers of Rinaldi and Himwich (1955a, 1955b). Frazier 
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and Boyarski (1967) observed that DFP or Eserine first 
stimulated and then blocked evoked potentials in the 
thalamus and cortex. While atropine antagonized these 
actions, its administration prior to either anticholin-
esterase did not prevent these effects. It was concluded 
that cholinergic responses were present at junctional sites 
of the primary afferent pathway. 
Monoaminergic pathways have also been established in 
the CNS. Andln et al. (1966) described 4 different ascend-
ing monoamine neuron systems beginning from the lower brain 
stem and ascending to the diencephalon and telencephalon: 
(1) Nigro-neostriatal DA system, (2) Mesencephalic to median 
forebrain bundle to olfactory tuberculum DA pathway, (3) 
NE pathway from bulbo-pontine reticular formation to limbic 
forebrain structures, neocortex and hypothalamus via the 
median forebrain bundle, and (4) a serotonergic pathway 
from the mesencephalon to the limbic forebrain and hypo-
thalamus via the median forebrain bundle. Histochemical 
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evidence has also been presented that demonstrates the 
presence of AChE and catecholamines in the same nerve trunk 
in guinea pig vas deferens (Jacobowitz 1965). Walker 
(1969) has demonstrated the presence of possible ACh 
vesicles at synaptic sites and adrenergic granules in the 
same terminal of hypothalamic neurons. 
Norepinephrine has been implicated in the mechanism 
underlying paradoxical sleep (vide supra). In addition, 
oxotremorine or carbachol administered by microinjection 
into the ponto-mesencephalic'reticular formation induced 
paradoxical sleep and was antagonized by atropine (George 
et al. 1964). Precollicular decerebration in cats induced 
subcortical paradoxical sleep and this activity appeared at 
random intervals. Eserine evoked the same pattern of para-
doxical sleep and this was antagonized by atropine (Mat-
suzaki et al. 1967). 
Malcolm et al. (1967) showed an interrelationship 
between adrenergic and cholinergic mechanisms in the cerebral 
cortex of rats and interpreted it to be similar to the 
Eccles-Libet scheme of transmission at the superior and 
cervical ganglion of the rabbit (Eccles, R. M. and Libet, 
B. cited in Eccles 1964). Phenoxybenzamine blocked the 
effect of NE, carbachol, Eserine, and ACh on the P wave 
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of evoked cortical potentials arising from stimulation of 
the fore paw of the rat, whereas atropine did not block 
effects of NE. Furthermore, both atropine and phenoxy-
benzamine enhanced the evoked potential, but phenoxybenza-
mine did not increase the effect of atropine while atropine 
increased the effect of phenoxybenzamine. Therefore, the 
effect of adrenergic blocking agent was enhanced by the 
presence of an anticholinergic while the reverse condition 
did not obtain. 
In the present studies ~n the CNS, the effect of the 
catecholaminergic system on the AntiChE-induced attenuation 
of recruitment could be interpreted as in figures 68 and 69. 
Eserine initially induces synchronization followed by a 
desynchronized pattern which is enhanced by NE. A more 
intense EEG alert is evoked and finally thalamocortical 
recruitment is attenuated. The direct effects of Eserine 
may also be contributing by acting on thalamic neurons 
(Bradley et al. 1966). The effect of Eserine is transient 
due to its rapid metabolism while that of an irreversible 
inhibitor such as DFP or sarin maintains an attenuation of 
recruitment (figs. 68 and 69). Adrenolytics, and anti-
cholinergic drugs antagonize this effect of anticholin-
-esterases as does the marked depletion of catecholamines 
by reserpine of aMPT. Restoration of depleted biogenic 
amines by MAOI plus L-DOPA restores the action of Eserine 
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on recruitment. Finally, the effective dose of Eserine 
required for attentuation of thalamocortical recruitment is 
lowered by increases in brain levels of catecholamines. 
The Burn-Rand hypothesis (Burn and Rand 1959, 1962, 1965) 
suggested that the presence of unbound acetylcholine 
released, for example by nerve stimulation, promoted an 
increased permeability of the presynaptic neural membrane to 
calcium ions and this in turn promoted the release of 
bound norepinephrine. Moreover, this hypothesis may be 
viewed as an "adrenergic-link" (Van Meter and Karczmar 1967) 
as well, in which case the action of acetylcholine may be 
contingent upon the availability of NE or even a mono-
aminergic substrate such as DA (Takagi et al. 1968). If the 
Burn-Rand concept as proposed for sympathetic postganglionic 
nerves :ill supported by further experimentation, a similar 
concept could apply to the CNS as well, and explain the 
results presented here. However, the Burn-Rand theory may 
not apply to all systems (Thoenen et al. 1966, Pscheidt et 
al. 1967). Moreover, it is apparent that the interaction 
of the systems is not a simple two-step "acetylcholine-
norepinephrine" process. Depolarization of neurons, 
ionic dependent release of NE (Burn 1966) as well as the 
possibility of a dopaminergic system (Takagi et al. 1968) 
may be only 'a few of the additional factors to be taken 
into consideration. Recent observations of Pohorecky et 
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al. (1969) have shown that phenylethanolamine-N-methyl trans-
ferase activity in the brains of rats, cats, hens, and 
turtles increased in the presence of the epinephrine sub-
strates, NE and phenylethanolamine. However, the enzyme 
activity was not homogenous .and the greatest activity was 
seen in the olfactory tubercle and bulb. Hypophysectomy 
abolished the effects while dexamethasone, which induces the 
synthesis of phenylethanolamine-N-methyl transferase, re-
sulted in an increased enzyme activity. Intraventricular 
administration of 3HNE resulted in the synthesis and 
storage of 3HEPI. These authors concluded that the activity 
of phenylethanolamine-N-methyl transferase activity in 
mammals was the same in brain and in the adrenals though the 
distribution and activity in the CNS appeared to be con-
centrated in olfactory areas. In other studies, evaluation 
of crude pellet fractions disclosed that the rostral brain-
stem which consisted of hypothalamus and diencephalon, had 
the highest synthesis rate of EPI in rats and dogs 
Figure 68 
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Eserine ----....-------...------........ -----
<Active l 
Direct Action 
( Inactive l Control 
AntiChE 
Increased ACh 
EEG Sleep 
Increased 
NE Released 
Desynchronized 
EEG 
Control 
Recruitment 
Present 
Attenuated 
Present 
260 
I: 
,: 
Figure 69 
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(Ciaranello et al. 1969). Differential untracentri-
fugation studies with the crude pellet revealed distribu-
tion of enzyme activity throughout subcellular fractions 
with highest activity in the 22,000g fractions. Ciaranello 
and co-workers concluded that the mcgm EPI formed per hour 
per gram tissue in vitro correlated with brain concentra-
tions in vivo and that regulation of endogenous brain EPI 
could be controlled by an inhibitor found in the particulate 
fraction as well as by metabolism. 
These findings suggest that EPI may also be a factor 
in the CNS as a neuroregulator or transmitter substance. 
Alpha blockade by chlorpromazine or phenoxybenzamine would 
then reflect an unmasked beta activity. Likewise, beta 
blockade then results in alpha desynchronization with the 
attenuation of thalamocortical recruitment (cf. fig. 65 ). 
Amphetamine has been shown to evoke an EEG arousal 
but not attenuate thalamocortical recruitment (Longo and 
Silvestrini 1967). It has also been reported (Barnes 1966) 
that while both Eserine and amphetamine evoke EEG alert 
patterns, the effect of both given together was less than 
that of either given separately. Either Eserine or 
amphetamine antagonized barbiturate EEG patterns, but when 
one was given in the presence of the antagonism induced by 
the other, then the degree of antagonism was lessened. 
Furthermore, in the presence of this attenuated antagonism, 
atropine always reversed the lessened antagonism and in-
duced a more desynchronized EEG. Barnes concluded that 
Eserine and amphetamine acted on the ascending reticular 
activating system on two separate "pools", one adreno-
ceptive and the other cholinoceptive. The action of 
amphetamine is probably dependent on the biosynthesis of 
NE (Bradley 1968), and it has been demonstrated that in-
hibition of NE synthesis in t,he CNS blocks its psychomotor 
stimulant effect (Dingell et al~ 1967). Gessa et al. 
(1969) has recently shown that p-hydroxynorephedrine, a 
metabolite of amphetamine, replaced NE stores in sympathetic 
nerve endings and acted as a false transmitter. They also 
noted that p-hydroxynorephedrine was released in preference 
to NE by subsequent administration of amphetamine and pre-
vented the entrance of the parent drug into the adrenergic 
granules. They concluded that amphetamine tolerance was 
the result of these actions. The presence of a false 
transmitter, p-hydroxynorephedrine may account for: the 
less intense desynchronization of the EEG seen with 
amphetamine as compared with that of beta blockers; in-
creased endogenous NE; and the failure of anticholinester-
ases, as well as the failure of amphetamine to attenuate 
thalamocortical recruitment. 
At this time it is not possible to specify that NE 
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has an absolute role and is the only factor involved in the 
mechanism of anticholinesterase-induced desynchronization 
and attenuation of recruitment. But this study does indi-
cate that one of the actions of anticholinesterases that 
is, the attenuation of recruited potentials from stimula-
tion of the anterior dorsal nuclei of the thalamus, may 
depend on the maintenance of.a catecholaminergic system that 
includes norepinephrine. 
V. SUMMARY 
Effects of anticholinesterases on the EEG and thala-
mocortical recruitment were evaluated in rabbits in which 
brain biogenic amines had been altered. Chronic reserpine 
treatment resulted in a marked and maintained depletion of 
NE which was measured in selected brain parts. aMPT evoked 
a linear decrease in brain NE that was maintained by chronic 
administration and also was measured in selected brain 
parts. Restoration of depleted amines was achieved by the 
administration of a MAOI and L-DOPA. 
EEG activity during states of depleted brain biogenic 
amines was predominately slow wave sleep with some 8-14 c/s 
burst activity from the cortices. Peripheral tactile, 
pain and sound stimuli evoked an EEG desynchronization. 
Thalamocortical recruitment was present. 
Eserine evoked a transient EEG desynchronization but 
failed to attenuate thalamocortical recruitment. DFP in-
duced an enduring EEG arousal but also failed to attenuate 
thalamocortical recruitment. The restoration of depleted 
catecholamines (vide supra) induced an EEG desynchroniza-
tion during which thalamocortical recruitment could be 
evoked. Anticholinesterases intensified the desynchroniza-
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tion and attenuated recruitment. 
Low doses of Eserine (50.0 mcgm/Kg i.v.) that did not 
attenuate recruitment in the control periods attenuated 
recruitment after brain biogenic amine levels had been 
raised by MAOI plus L-DOPA. 
Atropine and scopolamine antagonized the EEG effects 
and blockade of thalamocortical recruitment induced by the 
anticholinesterases. Alpha receptor blockade by phenoxy-
benzamine and chlorpromazine antagonized the EEG effects and 
attenuation of thalamocortic~l recruitment induced by 
Eserine. Phenoxybenzamine evoked a biphasic response con-
sisting of an initial brief EEG desynchronization followed 
by a maintained synchronized pattern. Chlorpromazine in-
duced a prolonged slow wave sleep pattern and also antagoniz-
ed the effects of the anticholinesterases. Beta receptor 
blockade by INPEA, evoked an EEG desynchronized pattern with 
an attenuation of recruitment. 
These results are discussed in terms of cholinergic and 
adrenergic relationships and it is concluded that the 
attenuation of thalamocortical recruitment by an anticholin-
esterase may be dependent on a catecholaminergic system. 
APPENDIX A 
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APPENDIX A 
ELECTRODE CONSTRUCTION 
Formvar insulated 0.005 inch diameter nichrome wire 
was used for the preparation of depth electrodes. A two 
foot length of the wire was formed into a loop, the free 
ends of which were placed into the jaws of a small table 
top vise. This loop was straightened by applying a steady 
upward force with a small rod placed in the loop. The 
vise was then released from ~he table and by carefully 
spinning it, the two sides of the nichrome wire loop were 
uniformly twisted together and the twisted pair remained 
linear. Twisted pairs of these wires were cut into 8.o 
cm lengths. One end was untwisted for about l.O cm and the 
insulation scraped off so that the bared wires could be 
soldered to a pair of two foot lengths of #37 gauge 
stranded cable. To solder the nichrome alloy, a Chromalloy 
flux was required. Small pieces of 3/64 inch diameter 
heat shrinkable tubing were used to insulate the solder 
joints. Electrode assemblies were constructed out of brass 
hubs and stainless steel tubing shanks according to the 
dimensions in figure 1 in the text. A short length of 
PE# 60 tubing was inserted into the stainless steel shank 
and trimmed flush with the twisted pair of nichrome wires 
which was subsequently inserted into the assembly (cf. 
fig. 2). Prior to the installation of the PE tubing, an-
other two foot of #37 gauge cable had been soldered to the 
brass hub. The cavity of the hub with the depth electrodes 
in place was then carefully filled with dental acrylic which 
was allowed to harden. A single piece of 1/8 inch diameter 
heat shrinkable tubing was used to cover the completed 
electrode. Several of these.electrodes were prepared in 
advance and trimmed to the desired stereotaxic coordinates. 
These electrodes could be used repeatedly for periods of 
several months in acute experiments. 
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STEREOTAXIC COORDINATESl 
Brain Site Lateral Anterior Posterior Depth 
LAC 6.5 4.o 2.0 
RAC 6.5 2.0 2.0 
LPC 6.5 4.5 2.0 
RPC 6.5 4.5 2.0 
RF 2.0 8.5-9.0 12.0 
THAL 1.5 3.0 10.0 
oc 2.0 8.5-9.0 2.0 
LC 1.5 3.0 2.0 
BOA 6.5 4.o 12.0 
LN 6.5 2.0 9.0 
LH 6.5 4.5 4.5-5.5 
RH 6.5 4.5 4.5-5.5 
1 The coordinates are given in mm and are applicable to 
New Zealand albino rabbits of 2.5-3.5 Kg body weight. 
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STAINING SCHEDULE: THIOCHOLINE FOR FROZEN SECTIONS 
A. Reagents: 
Incubation solutions were prepared from the following 
reagents. 
1. Copper glycine glycine 
CuS04°5H20 
dist. H2o qs 
3.75 Gm 
2.5 Gm 
100.0 ml 
2. Maleate buffer NaH Maleate 
NaOH (N) 
dist. H2o qs 
9.6 Gm 
51.2 ml 
100.0 ml 
5. AThCh 
Centrifuge for 
6. BuThCh 
Centrifuge for 
MgCl2 
di~t. H20 qs 
Na2S04 
9.52 Gm 
100.0 ml 
40% (w/v) adjust 
to pH 6.0; store 
at 38° C 
acetylthio- 46.o mg 
choline I 
dist. H2o 2.4 ml CuS04 (0.1 M) o.8 ml 
20 min. Save decanted supernatant. 
Butyrylthio- 50.0 mg 
choline I 
dist. H2o 2.4 ml CuS04 (0.1 M) o.8 ml 
20 min. Save decanted supernatant. 
7. Ammonium Sulfide NH40H (con.) 100.0 ml 
dist. H2o 50.0 ml 
H2S saturate 
Store in refrigerator as a stock solution. For 
use, dilute 1:25 (v/v) with distilled water, and 
prepare daily prior to use. Test for activity by 
adding a few drops of O.l M CuS04 solution to a 
few drops of the (NH4)2 S, a brownish black 
precipitate indicates usable strength. 
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8. CuThCh Copper thiocholine the reaction 
produce was obtained by initially 
running control samples through 
the procedure which saturated the 
solutions with the reaction pro-
duct. 
B. Solutions: 
1. Storage solutions for slides prior to incubation. 
(a) DFP 1.5 ml 
9.0 ml 
4.5 ml 
(b) 
(c) 
DFP prepared from stock solution of O.l M 
prior to use. 
All cholinesterases (solution "A") and 
butyrylcholinesterase (solution "c"). 
Na2S04 (40%) 
dist. H20 
10.5 ml 
4.5 ml 
Acetylcholinesterase (solution "B") and 
control (solution "D"). 
9.0 ml 6.o ml 
2. Incubation solutions for slides after appropriate 
storage solution treatment. 
All ChE AChE BuChE Control 
(solution "A") ( solutio~ 11B tr) (solution" Ctr) (solution 1tn1t) 
Reagents: 
CuGlycine o.6 ml o.6 ml o.6 ml o.6 ml 
H20 o.6 ml 2.1 ml o.6 ml 2.1 ml Mal. 
Buff er 1.5 ml 1.5 ml 1.5 ml 1.5 ml 
Naeso4 10.5 ml 9.0 ml 10.5 ml 9.0 ml 
Mg l& o.6 ml o.6 ml o.6 ml o.6 ml Cu Th trace trace trace trace 
AThCh 1.2 ml 1.2 ml 
Bu.Th Ch 1.2 ml 1.2 ml 
DFP pretreatment was carried ogt for solutions B and D 
where the concentration of 10- M specifically inactivated 
BuChE. Incubation time for brain sections was maintained 
at 60 minutes. 
C. Staining Schedule: 
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Frozen sections were cut in the cryostat at 16 microns, 
placed on slides and dried at room temperature for 5-10 
minutes prior to staining schedule: 
1. Appropriate storage solution for 30 minutes. 
2. Incubation solution for 60 minutes at 38° c. 
3. Rinse solution b20% Na 2S04 saturated with CuThCh) 5 minutes at 38 C. 
4. Rinse solution (10% Na 2so4 saturated with CuThCh) 1 minute at room temperature. 
5. Distilled water 1-2 sec. 
6. Ammonium sulfide developer solution (20 sec). 
7. Rinse solution (distilled water or 15% EtOH). 
8. Fixation in 10% formalin if desired. 
9. 35% alcohol (15 sec). 
10. 50% alcohol (15 sec). 
11. 70% alcohol (15 sec). 
12. 80% alcohol (15 sec). 
13. 95% alcohol (15 sec). 
14. abs. alcohol (1 min). 
15. abs. alcohol (1 min). 
16. Xylol (1 min). 
17. Xylol (1 min). 
18. Mount in permount cover and read. Store in 
absence of light. 
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STAINING SCHEDULE: THIONIN FOR FROZEN SECTIONS1 
A. Solutions: 
1. Thionin (o.5% in 20% alcohol) 
Thi on in 
Distilled water 
95% EtOH 
2. Eosin Y 
Eosin Y 
Distilled water 
95% EtOH 
475.0 mg 
150.0 ml 
4o.o ml 
2.0 Gm 
25.0 ml 
475.0 ml 
(Filter into staining dish and use as needed.) 
B. Staining Schedule: 
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Frozen sections were cut in the cryostat at 32 microns 
thickness, placed on slides and dried at room temperature 
for 5-10 minutes prior to staining. 
1 
1. Thi on in (30-60 sec) 
2. Distilled water (wash at least 1 min) 
3. 35% alcohol (15 sec) 
4. 50% alcohol (15 sec) 
5. 70% alcohol (15 sec) 
6. 80% alcohol (15 sec) 
Conn, H. J., Darrow, M. A., and Vector4 M. E. Staining Procedures, second edition, 1960. pp 7. The Williams 
and Wilkins Co., Baltimore, Maryland. 
7. 95% alcohol (15 sec) 
8. Eosin Y (dip) 
9. 95% alcohol (15 sec) 
10. Abs. alcohol (1 min) 
11. Abs. alcohol (1 min) 
12. Xylol (1 min) 
13. Xylol (1 min) 
14. Mount in permount, cover, and read. Store in 
absence of light. 
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Control 
Sarin 
DFP 
Control 
Sarin 
& 
AMN 
Sarin 
& 
AtS04 
ENZYME ACTIVITY1 
211.98(192.92-229.36) 2 
1.69( -1.61-8.92) 2 
17.75( 15.28-20.22) 2 
176.54(161.53-200.01) 3 
13.85( 10.07-20.20)3 
18.71( 13.34-24.20)3 
22.57(19.49-25.65) 2 
6.83( 3.58-10.07) 2 
3.58( 3.00-4.70) 2 
24.53(23.41-25.65)3 
4.81(0.0-9.62)3 
8.421(-----)3 
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1. Cholinesterase activity is expressed as microliters 
of co2 of a 1:50 brain to bicarbonate (0.03M) 
buffer dilutions from one-half brain samples 
divided at the midsaggital section. AChE deter-
minations were made in triplicate and the BuChE 
determinations in duplicate. 
2. Figures represent the average values at 60 minutes 
with the range expressed in parenthesis. 
3. Figures represent the average values at 40 minutes 
with the range expressed in parenthesis. 
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APPENDIX B 
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FLUOROMETRIC ASSAY 
A. Reagents: 
1. n-Butanol, purified with HCl and distilled water 
and the aqueous phase removed with NaCl. 
2. n-Heptane, washed with NaOH, HCl and distilled 
water. 
3. Iodine reagent 0.1 N (in abs. alcohol) 
4. Sodium thiosulfate 0.05 N 
5. Acetate buffer, 2.0 M, pH 5, prepared by 2:1 
(v/v) 2.0 M sodium acetate and 2.0 M acetic acid 
6. Acetate buffer, 2.0 M, pH 3, prepared by 50:1 
(v/v) acetic acid (2.0 M) and sodium acetate 
(2.0 M) 
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7. Alkaline ascorbate solution. Prepared just before 
use by 2:1 5.0 N NaOH and 1% aqueous ascarbate 
solution. 
8. Standard NE solution. A stock solution of 0.005% 
is prepared and refrigerated in a light tight 
container. From this concentration of 50.0 
mcgm/ml working standards are prepared. 
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B. Procedure: 
1. Chilled homogenization of weighed brain parts in 
2.0 ml of 0.01 N HCl. 
2. Homogenate transferred to 35 ml reaction vessel 
containing 2.0 Gm NaCl and 20.0 ml n-Butanol. 
3. Shake for one hour. 
4. Centrifuge 10 minutes at 1500 rpm. 
5. Butanol aliquotes (10.0 ml) are transferred to 
reaction vessels with 2.0 ml 0.01 N HCl and 15.0 
ml of n-Heptane and are shaken for 15 minutes. 
6. Centrifuge 15 minutes at 1500 rpm. 
7. Transfer 1.5 ml aliquote to test tube. 
8. Add 0.5 ml of pH 5.0 acetate buffer for NE. 
Add 0.5 ml of pH 3.0 acetate buffer for E. 
9. Add 0.05 ml of O.l N iodine reagent. 
10. Inactivate iodine with O.l ml sodium thiosulfate 
(0.05 N). 
11. Add 0.5 ml of alkaline ascorbate to all test 
tubes except reagent blank and tissue blank. 
12. Add 0.3 ml of 5.0 N NaOH to each of the tissue 
blanks and reagent blanks. 
13. Use 1.0 mcgm NE to determine reagent blank. 
14. Incubate 45 minutes. 
15. Add 0.2 ml of ascorbate solution 10 minutes prior 
to reading. 
16. Read in Aminco-Bowman spectrophotofluormeter at 
400 u activating wavelength and at 520 u fluorescent 
wavelength. 
17. Calculation: 
Tissue Factor (TF) = 1000/wt (mg) 
Corrected Reading = Initial Reading -
Tissue Blank 
Corrected NE Reading = Initial Reading of 
Standard-Reagent 
Blank Reading 
Standard NE Constant - Kn = Total mg NE/ 
total corrected NE 
readings 
NE Concentration = (TF) (K e) (Corrected Reading~ = NE mcgm/Gm 
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